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Abstract
Discrimination may contribute to poorer health outcomes experienced by non-dominant social
groups. While discrimination and health research has flourished over the past two decades, little
attention has been paid to the assessment of multiple forms of discrimination, nor to the health
effects of discrimination for transgender persons in Canada. Therefore, this thesis examines the
impacts of discrimination on health behaviours among transgender persons in Ontario and
develops a new instrument set for evaluating self-reported discrimination irrespective of
attribution, the Intersectional Discrimination Index (InDI). The first four manuscripts draw on
data from the Trans PULSE Project, a respondent-driven sampling survey of transgender
Ontarians aged 16+ conducted in 2009-2010 (n=433). Analyses were weighted using RDS-II
methods, and odds ratios or prevalence ratios were estimated from logistic regression models to
identify the impacts of discrimination, social exclusion, and gender transition. The first
manuscript investigates correlates of both past-year HIV-related sexual risk and sexual inactivity
among transfeminine (male-to-female spectrum) persons. Genital surgery for gender transition
was independently associated with lower odds of both outcomes. Discrimination was not
associated with sexual risk overall, but sensitivity analyses found that correlates differed by type
of sexual risk behaviour. The second manuscript examines HIV-related sexual risk among
transmasculine (female-to-male spectrum) persons who are gay, bisexual, or have sex with men.
Known correlates of sexual risk among cisgender gay and bisexual men were similarly predictive
of risk in this population, including sexual abuse, stimulant use, and depressive symptoms. The
third and fourth manuscripts focus on heavy episodic drinking (HED) and illicit drug use,
respectively, among all transgender Ontarians. HED, cocaine use, and amphetamine use were
more common among transgender Ontarians than expected based on the age-standardized
reference population. HED was associated with transmasculine gender and sex work, but not
with discrimination. Illicit drug use was associated with anti-transgender violence, homelessness
or underhousing, and sex work. The final manuscript describes the development and validation
of the InDI, which includes three components measuring anticipated, day-to-day, and major
discrimination. The bi-national validity and reliability study found consistent evidence of
construct validity and test-retest reliability. Finally, implications and future research directions
are discussed.
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Chapter 1: Introduction and Objectives

1.1

Thesis Objectives

This thesis aimed to explore the impacts of discrimination on health behaviours (substance use
and HIV risk) within a Canadian transgender population, and to contribute to the improved
measurement of discrimination in population health research. Specifically, the thesis had three
primary objectives:
Objective 1: To examine discrimination and gender transition factors associated with human
immunodeficiency virus (HIV)-related sexual risk behaviour among transgender persons in
Ontario, Canada, including:
a. transfeminine (male-to-female spectrum transgender) persons. Considering the high
prevalence of sexual abstinence in this group, associations with both high-risk sexual
behaviour and abstinence (versus low risk sex) were identified.
b. transmasculine (female-to-male spectrum transgender) persons who identify as gay,
bisexual, queer, or who have sex with men.
Objective 2: To describe the prevalence of hazardous substance use among transgender persons
in Ontario, Canada in comparison to the age-standardized reference population, and to examine
associations with discrimination and gender transition. Two outcomes were examined:
a. Past-year heavy episodic drinking.
b. Past-year illicit drug use. Based on data availability, disparities with the Ontario reference
population were estimated for past-year use of cocaine or amphetamines, while predictors
of illicit drug use were examined within the trans population.
Objective 3: To develop and evaluate the validity and reliability of the Intersectional
Discrimination Index, a set of self-report measures of anticipated and enacted discrimination for
use in intersectional population health research.

2

1.2

Thesis organization

The remainder of Chapter 1 consists of a review of literature pertinent to the thesis objectives.
Chapters 2 and 3 address Objective 1, for transfeminine and transmasculine persons,
respectively. A version of Chapter 2 is under revision with The Journal of Sex Research. A
version of Chapter 3 was published in the Journal of Acquired Immune Deficiency Syndromes.1
Objectives 2a and 2b are satisfied in Chapters 4 (heavy episodic drinking) and 5 (illicit drug use).
Versions of Chapters 4 and 5 have been published in Drug and Alcohol Dependence2 and
Addictive Behaviors,3 respectively. Chapter 6 describes the development and evaluation of the
Intersectional Discrimination Index, as per Objective 3. A version of this chapter will be
submitted for publication. Finally, Chapter 7 provides an integrated discussion and conclusion.
Questionnaires, letters of invitation and consent, and Research Ethics Board approval documents
are included as appendices.

1.3

Introduction

1.3.1 Defining discrimination
Public health interest in the impacts of stigma, prejudice, and discrimination on health has
increased in the past two decades,4 and various definitions and theoretical models of these
concepts have been developed, often in parallel. According to Link and Phelan,5 stigma involves
labeling of human differences, cultural beliefs that relate those labels to negative stereotypes, and
categorization of labeled persons to distinguish "us" from "them," followed by status loss and
discrimination. They also highlight the role of differential access to power and resources in
producing stigmatization. While theories of stigma have tended to focus on individual
characteristics (e.g., deviant behaviour, disease, disability), prejudice frameworks have more
commonly been applied to race/ethnicity, and other stigmas related to group (i.e., shared within
family) characteristics.6 These concepts have much in common, and can be subsumed under the
umbrella of stigma.
Phelan and colleagues6 developed a typology of functions of stigma that is informative for
studies of its manifestations and consequences: exploitation and domination (keeping people
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down), norm enforcement (keeping people in), and disease avoidance (keeping people away).
Others prefer to frame social inequities in health in terms of ‘oppression,’ but these definitions
also overlap greatly with the stigma concept. For example, Paradies defines privilege/oppression
as “a societal system in which actors are divided along socially constructed dimensions with
power unevenly distributed (or produced) based on these dimensions.”7 pg. 144
Stigma can be considered a fundamental cause of health inequalities8: one that (a) affects
multiple diseases via multiple pathways in a large number of people; (b) concerns access to
health-promoting resources; and (c) is robustly related to health inequities across time and
setting.9 Because new pathways arise to reproduce the relationship between the fundamental
cause and multiple outcomes, a fundamental cause approach suggests that intervening on those
mediators will not resolve health inequities over the long-term. Moreover, focusing on estimating
the impact of one type of stigma on one health outcome is likely to underestimate its effects.8
However, this does not imply that stigma universally leads to health inequalities between
dominant and non-dominant groups. For example, studies have repeatedly failed to find evidence
of mental health disparities between African-Americans and white Americans, despite robust
findings of mental health-harming effects among African-Americans.10
Enacted stigma (i.e., inequitable interpersonal or institutional treatment based on stigma) is most
often referred to as discrimination. Put differently, discrimination has been defined as “all means
of expressing and institutionalizing social relationships of dominance and oppression”,4 pg. 650
incorporating institutionalized oppression of social groups, direct or indirect discrimination in
law and policy, and subtle interpersonal slights. Multiple pathways link stigma and
discrimination to poor health outcomes. Krieger lists six primary pathways: economic and social
deprivation; excess exposure to toxins and pathogens; social trauma; health-harming responses to
discrimination; targeted marketing of harmful commodities; inadequate medical care; and
ecosystem degradation.4

1.3.2 Conceptualizing self-reported discrimination and its health impacts
Although ecological and multi-level data are increasingly being used to identify the impacts of
institutional and structural discrimination on population health,11 most research on discrimination
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and health has focused on self-reported discrimination, which is generally interpersonal, direct,
and overt.4 Such reported discrimination is necessarily perceived discrimination, most often in
the absence of a visible counterfactual contrast (i.e., knowledge of the treatment one would
receive in the same situation were all factors but minority group membership held constant).7,12
Moreover, even perceived discrimination may not be self-reported due to impression
management and internalized stigma (e.g., the belief that discrimination is just).12,13 Irrespective
of whether it coincides with objective discrimination, perceived discrimination communicates to
a target that they are unworthy, threatens their sense of belonging, stigmatizes potentially salient
group identities, and can contribute to feelings of powerlessness.14 Thus, perceived
discrimination represents a potential mechanism in the development and maintenance of health
inequalities within and across population groups, and an important exposure to investigate in
population health research aiming to ameliorate inequalities.15,16
Self-reported discrimination is most often conceptualized as a psychosocial stressor,17 informed
by Lazarus and Folkman’s Transactional Model and Stress and Coping18 and Pearlin et al.’s
stress process model.19 The Transactional stress model encompasses two primary stages:
appraisal and coping. The model posits cognitive appraisal processes following an experience,
wherein an individual first assesses a situation as potentially stressful (e.g., as a threat or loss),
and then assesses the availability of coping resources. Next, they will enact cognitive and
behavioural coping efforts to regulate their emotional response to the experience and/or to try
and change the stressful situation. Pearlin’s stress process model and its more recent
elaborations20 include three key domains: sources of stress (e.g., discrete event versus ongoing,
seriousness of threat) that negatively impact self-concept and sense of mastery; social and
personal resources which mediate the impacts of stress; and finally, symptoms of stress (i.e.,
distress). In addition to precipitating emotional, cognitive, and behavioural responses, chronic
discrimination may have negative physiologic effects (e.g., elevated cortisol levels).20
Discrimination is also a key stressor within minority stress theory,21,22 which builds on social
stress theories by describing the additional burden of stress experienced by sexual and gender
minorities, and potentially others with concealable stigmas. Meyer21,22 identified four
interconnected minority stress processes for gay, lesbian, and bisexual individuals, which have
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been extended to transgender persons23 They are (1) external, objective stressors (e.g., acts of
discrimination), (2) expectations of such stressful events (i.e., anticipated discrimination), (3)
internalized stigma (negative attitudes towards one’s own sexual or gender identity), and (4)
concealment of sexuality or gender identity to mitigate stigma.
Each of these frameworks posit that, as a stressor, discrimination may contribute to distress or
maladaptive coping strategies, depending on the availability of coping resources such as a
personal sense of mastery, social supports, or pride in minority identity. Self-reported
discrimination may also impact health directly or through mechanisms other than stress,4 for
instance, economic deprivation related to job loss, injury due to hate violence, or lack of medical
treatment due to discriminatory refusal of care.

1.3.3 Discrimination and intersectionality
Intersectionality is a theoretical framework based in African-American feminist scholarship,
particularly the work of legal scholar Kimberlé Crenshaw.24 She argued that various forms of
discrimination act in tandem and cannot be understood in isolation from each other, pointing to
how legal frameworks requiring discrimination claims based on gender or based on race could
not address experiences of African-American women that were both gendered and racialized.
Crenshaw argued that single-axis analyses of discrimination distort the experiences of Black
women whose experiences cannot be reduced to the "sum of their parts" (racism and sexism). In
a single-axis framework, discrimination is conceptualized by the experiences of otherwiseprivileged group members (e.g., defining sexism as the experiences of white women), through a
counterfactual definition of discrimination as a situation in which, "but for" a single given
characteristic, the individual would have had a different outcome. Over the past twenty-five
years, intersectionality has “travelled” extensively beyond its disciplinary origins,25 including
applications in qualitative and quantitative public health research.26
McCall27 has delineated three distinct intersectionality frameworks. Some intersectionality
scholars reject categories of social difference altogether (“anti-categorical”) while others prefer
to focus on heterogeneity within a single defined group, such as African-American women
(“intracategorical”). The version of intersectionality adopted within population health research
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tends to be the third approach (“intercategorical”), which recognizes categories of social
difference as socially constructed – yet real in their effects – and examines relationships and
inequities between groups defined by multiple categories of difference. In the context of
population health research, intersectionality frameworks highlight that effects of multiple social
positions (e.g., race, class, gender), and the bio-psycho-social processes associated with them
(e.g., racism, sexism) cannot be assumed to reflect simple “addition” of the effects observed for
each position or process individually. Rather, intersectionality researchers consider the potential
for qualitative and quantitative interaction between social positions and/or processes in their
effects on population health.15,28,29
Despite increasing interest in intersectional frameworks across diverse fields of scholarship,30-33
quantitative studies of discrimination and health have primarily examined one form of
discrimination at a time.30,34 Instead, intersectional discrimination research has largely been
qualitative, with some even arguing that quantitative methods are poorly suited to the study of
intersectionality.29 As in health inequities research more broadly, quantitative intersectionality
studies, when conducted, have often been limited by a focus on documenting inequalites across
groups cross-stratified by social position (i.e., socio-demographic characteristics) rather than on
understanding modifiable processes that lead to such inequalites.15,16,28,29 More recently, methods
for quantitative intersectionality research have been identified and summarized,28 and Bauer has
proposed a research agenda to advance analytic intersectional population health research,
including the development of intersectional measures of discrimination.15

1.4

Health impacts of discrimination

In 1999, a systematic review by Krieger35 found only 20 reports in the public health literature
that assessed self-reported discrimination as a determinant of health. Most studies examined
impacts of racial discrimination among African Americans, and focused on mental health
outcomes. A few considered physical health outcomes, chiefly hypertension. Negative
associations between discrimination and health were most consistent for mental health outcomes,
but conclusions were limited by heterogeneity in exposure operationalization and measurement.
By 2014, the field had burgeoned to the extent that Krieger was able to conduct a ‘review of
reviews’ on associations between discrimination and health,4 finding that evidence of the
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deleterious effects of discrimination has remained strongest for the impacts of racial and ethnic
discrimination on negative mental health outcomes. A 2015 meta-analysis of 333 studies on
racism and health published between 1983-2013 found that racial discrimination was associated
with negative effects on (in order of effect size) negative mental health, positive mental health,
general health, and negative physical health.36
The robustness of findings related to racial/ethnic discrimination is in part a function of research
focus: most discrimination and health research has examined racial discrimination, primarily
among African-Americans.4 However, meta-analyses of correlational and experimental data of
studies examining multiple bases of discrimination published through 2012 found that effects of
reported discrimination were larger for discrimination based on concealable stigma (e.g., sexual
orientation, mental illness) than based on visible non-dominant group membership (e.g. racial
minority status).14 This suggests that focus is warranted on a broader range of discrimination
experiences (including other forms of discrimination experienced by individuals who also report
racial/ethnic discrimination).
In addition to negative mental health, associations between discrimination and health risk
behaviours have been observed in many studies.4,37-40 However, associations with health risk
behaviours appear population-, behaviour-, and measure-dependent. For instance, a recent
systematic review of discrimination and alcohol use highlights that global associations are
inconsistent, with conclusions depending on the groups being compared, choice of exposure and
outcome measure, and moderating/mediating factors.40 The authors note that lack of standardized
discrimination measurement is a substantial obstacle to advancing scientific knowledge in the
area—if studies using inconsistent measures reach different conclusions, it is impossible to
determine whether the disagreement is due to differences in casual processes, or simply to
variation in operationalization of the exposure. The difficulty research participants may have in
attributing perceived discrimination to specific bases (e.g., race versus gender) also challenges
the validity of findings that are purportedly specific to each discrimination type.15
Another limitation of the discrimination and health literature is reliance on self-report and crosssectional data, which are subject to confounding by personality traits and to reverse-causation
(e.g., for those with poor health to perceive more discrimination).34 However, evidence to date
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suggests that while personality traits (e.g., neuroticism) are associated with reporting
discrimination, associations with health remain robust after control for personality
characteristics,34 and that discrimination may actually impact health through impacts on
personality.41 Further, documented prospective associations of discrimination with objective
clinical end-points and asymptomatic preclinical end-points (e.g., all-cause mortality,42,43
inflammation12) provide evidence against reverse causality as an explanation for this pattern of
findings.34

1.5

Discrimination and health behaviours in transgender populations

1.5.1 Who are transgender persons?
Transgender (trans) persons are those with a gender identity that differs from their birth-assigned
sex. This includes individuals who identify as transgender men or women, as well as those who
consider themselves neither male nor female, and who may use terms such as genderqueer, nonbinary, or Two Spirit.44 To be concise and respectful, this thesis refers to individuals who were
assigned a female sex at birth but who have a male or masculine gender identity as
transmasculine, and to those who were assigned male at birth but who have a female or feminine
gender identity as transfeminine. In the United States, an estimated 0.6% of the adult population
can be classifed as transgender.45 As no population-based survey in Canada currently includes
measures to ascertain transgender status, comparable figures are not available in the Canadian
context.
Historically, trans identities were pathologized within medicine, and trans people were labelled
with the psychiatric diagnosis of Gender Identity Disorder. In recent years trans identity has
increasingly come to be seen as part of a spectrum of gender diversity, that is sometimes, but not
always, associated with a need for medical or mental health care.46 Reflecting this understanding,
the most recent edition of the Diagnostic and Statistical Manual of the American Psychiatric
Association47 replaced Gender Identity Disorder with a diagnosis of Gender Dysphoria. This
nosologic change places the locus of “disorder” in clinically significant distress or impairment
related to an incongruence between one’s gender identity and birth-assigned sex or sexed
embodiment, rather than in the gender identity itself. Gender dysphoria is thus a condition that
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some trans people will have, at some points in their lives, and for which social and/or medical
transition is the standard of care. 48,49 However, whether due to personal choice or social
circumstances, trans people may not take steps to socially or medically transition. An estimated
30% of trans Ontarians continue to live day-to-day in their birth-assigned gender role.50 Among
those who do medically transition sex, treatment decisions are individualized. For instance, even
among those trans Ontarians who described themselves as having completed medical transition,
only 59% of transfeminine persons and 1% of transmasculine persons had undergone genital
reconstruction.50
Although trans people have often been overlooked in health and social research,51,52 there has
been a rapid growth in scientific interest in transgender health. A review of published
quantitative trans health research from 2008-2014 found approximately 10 articles per year from
2008 through 2012, approximately 30 in 2013, and 50 in 2014.44

1.5.2 Experiences of discrimination among transgender persons
The growing evidence base on trans health and well-being indicates that trans populations
experience high levels of stigma, discrimination, and violence.53 For example, in a 2015 survey
of over 27,000 transgender Americans,54 14% reported being denied equal treatment or service,
46% reported verbal harassment, and 9% reported physical assault due to transgender status, in
the past year alone. In Ontario, 98% of trans persons reported any lifetime experiences of antitrans stigma (transphobia),55 while lifetime verbal harassment and physical assault related to
being trans were reported by an estimated 35% and 21%, respectively.56 Stigma and
discrimination are also evident in primary and emergency healthcare settings, which can lead
trans people to avoid seeking care.57,58
In addition, as will be discussed in greater detail later in this thesis, a number of studies have
found inequalities in the mental, sexual, and behavioural health of trans persons relative to the
broader population, particularly related to depression, suicidality, HIV/AIDS, and substance
use.51,59 Within a minority stress framework, a causal link between stigma, discrimination, and
health inequalities has been proposed.23 A number of recent North American studies have
evaluated associations between discrimination and health outcomes in trans samples.53 Related to
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Objectives 1 and 2 of this thesis, the following sections review the literature pertaining to HIV
and substance use within trans populations, with particular emphasis on the roles of stigma and
discrimination.

1.5.3 HIV in transgender populations
Alarming HIV prevalence levels have been reported among transfeminine persons in some
settings. A 2012 meta-analysis60 combined seroprevalence estimates from 39 studies in 10
middle-income and 5 high-income countries (n=11,066) to estimate pooled seroprevalence at
19% globally, and 22% in high-income countries (n=3,869). These estimates correspond to odds
of HIV infection 48.8 times higher than the corresponding country-specific estimates for the
overall population. Behaviourally, this high prevalence has been attributed to frequent
engagement in condomless receptive anal intercourse with non-trans (cisgender) men.60 As
discussed in the following section, such behaviour is less common in the Ontario transgender
population. Studies of transmasculine persons have reported HIV prevalence rates of 0-4%,44,61-67
with most relying on self-reported status in small samples.
It is important to note that sampling bias appears endemic to seroprevalence studies in trans
populations.68 In the aforementioned meta-analysis of transfeminine persons, 32% of all
participants from high-income countries were sampled in San Francisco or Los Angeles,
California. Also, most transfeminine studies have oversampled communities disproportionately
impacted by HIV such as survival sex workers and African-Americans.69-71 Recent studies of
trans people in the United States employing large, broad convenience samples have found
reported HIV prevalences ranging from 2-8%.71-74 In Ontario, self-reported HIV prevalence was
estimated to be 3% among transfeminine persons and 0.6% among transmasculine persons, but
46% had never been tested.44 In comparison, HIV seroprevalence among all Canadians was 0.2%
in 2011.75

1.5.4 HIV-related sexual risk in transgender populations
In Ontario, HIV risk attributable to injection behaviours appears negligible among trans
persons.76 Thus, this thesis will focus exclusively on HIV-related sexual risk, which is quite
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heterogeneous among trans Ontarians.44 An estimated 19% of transfeminine persons and 7% of
transmasculine persons had engaged in any HIV-related high-risk sexual activity in the past year.
Sexual risk largely attributable to insertive genital sex among transfeminine persons and almost
exclusively attributable to receptive genital sex among transmasculine persons. Only an
estimated 4% of transfeminine persons reported high-risk receptive anal intercourse.
Prior research has found most HIV-related sexual risk among transmasculine persons to result
from vaginal intercourse.66,77,78 Among transfeminine persons, however, most studies have
focused exclusively on anal intercourse with cisgender men, and sometimes only receptive anal
intercourse.79-81 Where HIV risk attributable to insertive genital sex among transfeminine
persons has been measured, rates were low. For example, in one study, 2 of 392 transfeminine
participants reported condomless insertive genital sex.63 Although condomless receptive anal sex
poses the highest risk for HIV transmission, other forms of unprotected intercourse still present a
substantial risk for HIV transmission and acquisition,82 as well as for other sexually transmitted
infections (STIs). The unique sexual risk behaviour profile of Ontario’s trans population, as
compared to previous samples from the urban United States, highlights the need for research in
the local context. This variation in patterns of sexual risk may be accompanied by variation in
contributors to risk behaviour.

1.5.5 Substance use in transgender populations
Unlike the relatively straightforward HIV-related outcomes, describing the burden of substance
use and misuse among trans persons is complicated by the range of outcomes, variable
definitions, and reporting timeframes employed.51 Further, much published research on
substance use among trans persons has been conducted in the context of HIV prevention
research,83-87 in which higher-risk samples are purposefully recruited. These studies have found
high levels of heavy episodic (binge) drinking and illicit drug use among transfeminine persons.
For example, in samples recruited New York, Los Angeles, and San Francisco respectively, 25%
used cocaine use and 60% drank heavily the past six months,84 22% reported past-month
methamphetamine use,88 and 20% reported past-year methamphetamine use while 30% drank
heavily in the past six months.83
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More heterogeneous, mixed-gender convenience samples of trans persons have found higher
levels of binge drinking and/or illicit drug use among trans persons as compared to cisgender
survey participants or reference populations, particularly among youth.89-91 Among over 75,000
college students in the United States, cisgender males were more likely to report any heavy
episodic drinking, but trans students reported a greater number of recent heavy drinking days
(incidence-rate ratios comparing cisgender females and males to trans persons were 0.43 and
0.28, both p< 0.001).89 Compared to cisgender boys and adjusting for other socio-demographic
characteristics, trans adolescents in a national U.S. online survey were more likely to report any
use and regular use of alcohol and illicit drugs (adjusted odds ratios [AORs] ranging from 1.421.75, all p<0.01).91
Less research has focused on substance use disparities between cisgender and transgender adults.
However, in the 2014 Behavioral Risk Factor Surveillance System (BRFSS) survey, the only
population-based source of data on substance use among trans adults (in 19 U.S. states),92 they
were no more likely than cisgender persons to report binge drinking, confirming an earlier
finding from the 2007-2009 Massachusetts BRFSS.93 However, as alcohol use behaviours vary
by both sex and gender,94 overall transgender-cisgender comparisons may obscure disparities.
Methodologically, the BRFSS and other household probability surveys studies may
systematically under-recruit more marginalized trans persons (e.g., homeless individuals) and
will misclassify those who are uncomfortable disclosing transgender status to an interviewer.92 A
recent Canadian survey of gay and bisexual men—a population that is arguably less stigmatized
than trans persons in the United States—found that 30% would not disclose sexual orientation as
part of an interviewer-administered population survey.95 Further, BRFSS data pertaining to other
forms of substance use among trans people have not been published, leaving questions about
disparities in drug use unanswered. Related to the objectives of this thesis, the burdens of heavy
drinking and illicit drug use, as well as disparities with the cisgender population, have not been
characterized among trans Canadians.
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1.5.6 Understanding health behaviour disparities in transgender populations
1.5.6.1

Minority stress

As described in Section 1.3.2, minority stress theory posits that members of gender minority
groups will experience a higher burden of negative mental and behavioral health outcomes
related to social stigma.21,22 The framework also asserts that minority identity and within-group
solidarity can have protective mental health effects and foster resilience.23
Empirical research to date, primarily conducted in the United States, has associated exposure to
transphobia with greater substance use and HIV risk. Scores on a transphobia scale were
positively associated with condomless receptive anal intercourse with commercial (sex work)
partners among transfeminine persons in San Francisco (AOR= 2.56, 95% CI: 1.12- 5.87).96
Again among transfeminine San Franciscans, another study found that higher scores on a
transphobia measure were correlated with both recent condomless anal intercourse (AOR=1.45;
95% CI: 1.04, 2.00) and illicit drug use (AOR=1.47, 95% CI: 1.05, 2.04).97 Two studies found
interactions between youth status and transphobia, such that reporting high versus low levels
predicted HIV-related sexual risk behaviour among transfeminine youth of colour in San
Francisco (AOR=3.2; 95% CI: 0.9, 12.8)81 and among trans youth in Ontario (AOR=1.14, 95%
CI: 1.00-1.20).98 Results in both studies had borderline statistical significance, however sample
sizes were small (57-113 youth). Among adolescents, transphobic bullying mediated the
association between transgender status and alcohol or illicit drug use.91 For example, such
bullying mediated 32.9% (95% CI: 15.8, 50.1) of the effect of trans status on the odds of regular
non-cannabis illicit drug use. Finally, in a rare longitudinal study of transfeminine adults
conducted in New York City, transphobic harassment and/or violence was prospectively
associated with greater substance use (e.g., OR for any cocaine use was 3.17, 95% CI: 2.44,
4.11),84 HIV-related sexual risk behaviour (e.g., hazard ratio with casual partners= (HR 2.55;
95% CI: 1.73, 3.75),99 and incident HIV or other sexually transmitted infections (adjusted hazard
ratio, lagged effect=1.64; 95% CI: 1.02, 2.63).99
As suggested by the framework of intersectionality, stigma and discrimination based on
transgender status may act in concert with other forms to potentiate poorer health outcomes for
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transgender persons who are also racial/ethnic minorities. In the United States, estimates of HIV
prevalence among African-American and other transfeminine persons of colour are higher than
among white transfeminine persons—and all other at-risk groups.64,100 Some have speculated that
transfeminine persons of colour may be more likely to have sex with cisgender men and
therefore to be at higher risk of HIV acquisition.101 Supporting this hypothesis, one study found
that the higher HIV incidence among Black and Latina (relative to white) transfeminine persons
was largely mediated by sexual orientation.102 However, a minority stress approach suggests that
experiences of racism may also contribute to HIV-related sexual risk. In Ontario, while
Aboriginal and/or racialized trans persons were less likely than whites to report high-risk sex,
self-reported racism increased the odds of having had high-risk sex among racialized persons.55
However, the study’s use of parallel (and potentially overlapping) measures of transphobia and
racism limited the potential for an integrated analysis of the total effect of discrimination.
In addition to self-reported stigma and discrimination, research on health behaviours among trans
people must consider the indirect effects of stigma via experiences of social exclusion and socioeconomic marginalization. For example, approximately half of trans Ontarians reported annual
incomes under $15,000 CDN,44 and 33% were underhoused,103 while 13% reported being fired
from a job, and 18% not being hired, due to being trans.104 Unstable housing80 and extremely low
incomes105 have been associated with sexual risk among transfeminine persons. In this context,
trans people report high levels of engagement in sex work,106 including 15% of trans Ontarians
who reported lifetime engagement in sex work or exchange sex, and 2% who reported current
employment as a sex worker.44 A meta-analysis found that transfeminine sex workers were more
likely to be HIV-positive than non-transgender male or female sex workers, but not non-sex
working transfeminine persons.107 Sex work may not be an independent risk factor for HIV
acquisition, but rather an indicator of the presence of proximal risk factors related to
marginalization.107,108 Sex work has also consistently been associated with substance use among
transgender persons.84,109-111

1.5.6.2

Syndemics

Singer112,113 developed the concept of syndemics to describe the interaction among substance
use, violence, and HIV/AIDS resulting from social marginalization among low-income substance

15

users. He argued that these conditions were not simply co-occurring, but mutually re-inforcing
(i.e., that they interact synergistically), or in some cases, mutually causal. Syndemics in sexual
and gender minority communities are theorized to result from minority stress processes that
unfold over the life course and show associations with perceived stigma.97,114 Although
syndemics and intersectionality research have largely developed in parallel, they are highly
compatible. For instance, an intersectional syndemics approach could hypothesize and
investigate the concentration of interacting health conditions at the intersection of sexual
orientation, race/ethnicity, and HIV status.115 Syndemic theory has primarily been applied to
research on HIV infection or transmission risk as a primary outcome, particularly among gay
men and other men who have sex with men. Clustering psychosocial health problems (polydrug
use, depressive symptomatology, intimate partner violence, and childhood sexual abuse) have
been found to be associated with increased rates of HIV infection and HIV-related sexual risk
behaviour among gay men.116
Given evidence of high levels of psychosocial health problems and experiences of violence
amongst trans persons, Operario and Nemoto117 argue that syndemic conditions exist among
transfeminine persons and must be addressed in efforts to reduce their HIV vulnerability and
improve their overall health. Little research has specifically sought to test the applicability of
syndemic theory to HIV risk or substance use in trans populations, with a 2015 review
identifying 8 studies purporting to employ syndemic theory in trans samples globally.59 One
study of transfeminine youth found that having two or more potentially syndemic conditions
(polysubstance use, intimate partner violence, victimization, low self-esteem) was associated
with increased odds of unprotected anal intercourse (e.g., OR for 2 versus 0 conditions=5.46;
95% CI: 1.55, 19.12).118 For each additional condition reported by transmasculine persons who
have sex with men in a Massachusetts study (heavy drinking, polydrug use, depression, anxiety,
partner violence, childhood sexual abuse), the odds of condomless intercourse were higher, but
only among those who had socially transitioned gender (AOR=1.79; 95% CI: 1.42, 2.25).119
Despite the high level of interest and uptake of syndemic theory in the HIV research literature,
recent work by Tsai has drawn attention to some important conceptual and methodologic
problems.120,121 The “syndemic count” score approach described above – and used in most
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published syndemics research – captures neither synergistic interaction nor mutual causation
between health conditions, but rather, the cumulative effects of an increasing number of
adversity or health risk indicators.121,122 Further, effects attributed to the number of “syndemic”
conditions could in fact be driven by the difference between zero conditions and one
condition.123

1.5.6.3

Gender affirmation

Gender affirmation refers to the psychological, social, medical, and legal processes of validating
one’s own gender identity and acquiring social validation of that identity.51 Research to date,
almost entirely qualitative, suggests that gender affirmation may contribute to health risk
behaviours in a number of ways. First, to achieve gender affirmation, trans persons may strive to
conform to gendered norms of (health) behaviour.124,125 To date, this process has primarily been
investigated for transfeminine persons, among whom acquiescence in relationships with
cisgender men124,126 and disordered eating behaviours127 have emerged as risk behaviours related
to gender norms. Similarly, qualitative studies have identified a need for gender-related
validation or affirmation from sexual and romantic partners as a potential contributor to HIVrelated sexual risk.124,126,128-130 Sevelius126 argues that transfeminine persons have limited access
to gender affirmation, yet have increased need for it because of enacted and internalized
transphobia. Therefore, they may engage in behaviours that increase their access to gender
affirmation despite health risks, including condomless sex with male partners who provide
gender validation. For transfeminine persons in primary relationships with female partners who
are not accepting of their trans identities, outside partners may be an important source of gender
affirmation.131 Gay and bisexual-identified transmasculine persons have also described seeking
gender affirmation through sex with men; acceptance and desirability as a gay man is seen by
some as particularly validating of male identity.66,77
Lack of social and medical gender affirmation may also contribute to substance use and other
health risk behaviours as a coping strategy. Medical transition (hormones and/or surgery) is
associated with reduced mental health symptomology and suicide attempts among trans
persons.56,132,133 Evidence regarding the impact on both HIV risk and substance use behaviour
has been more mixed.
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Among transfeminine persons, two studies reported negative and positive relationships,
respectively, between transition and substance use. The first, in San Francisco, found that
hormone therapy was associated with less non-injection illicit drug use (OR=0.2; 95% CI: 0.1,
0.4), while hormone therapy (OR=0.4; 95% CI: 0.3, 0.7), breast augmentation surgery (OR=0.2;
95% CI: 0.2, 0.3), and genital surgery (OR=0; 95% CI: 0, 0.2) were associated with less binge
drinking.134 However, among cohort participants in New York, both social transition (presenting
in felt gender) and hormone therapy were associated with any substance use, the number of
substances used, and the number of past-month substance use days.84 For example, the odds of
any substance use were 1.29 times as high among those presenting in their felt gender (95% CI:
1.20, 1.38), and 3.08 times as high (95% CI: 2.10, 4.51) among those on hormone therapy. In the
same cohort, sexual risk behaviour was more common among those presenting in their felt
gender (OR for condomless intercourse with commercial partners= 1.22; 95% CI: 1.12, 1.33) and
those on hormone therapy (OR for condomless intercourse with casual partners= 2.97; 95% CI:
1.84, 4.79).99 In the San Francisco study, neither hormones nor surgeries were associated with
sexual risk behaviour.134
Finally, the social and physiological effects of gender transition may potentiate health risks. For
example, transmasculine persons frequently report a perception that testosterone use leads to
increased sex drive, and increased interest in sex with men.74,77,135,136 Among transfeminine
persons, feminizing hormones may cause erectile difficulties and thus challenges with condom
use,131,137,138 but can also contribute to reduced sex drive and activity.136,138

1.5.6.4

Rationale for examining the impacts of discrimination and gender transition on
transgender health behaviours in Canada

As summarized above, trans persons face high levels of discrimination and social exclusion
globally. In the United States and in other countries for which data are available, inequities in
mental, sexual, and behavioural health are evident. However, little is known about the prevalence
of substance use risks among trans people in the Canadian and Ontario contexts. Further,
predictors of both substance use and HIV risks have not been evaluated in a Canadian trans
population (with the exception of a previous thesis by Marcellin which focused on self-reported
racism and transphobia as predictors of HIV risk55,98). In the United States, observed inequities
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have been linked to experiences of stigma and discrimination. Within trans populations, access to
gender transition and affirmation may also play a role in shaping health behaviour. Yet, these
factors have seldom been analyzed in an integrative manner. Moreover, trans people’s
experiences in Ontario, relative to the United States, may be differentially shaped by access to
publicly insured health care, as well as human rights protections (e.g., under the Ontario Human
Rights Code139). Thus, the current thesis seeks to fill these gaps in knowledge pertaining to the
health of trans Ontarians, with the aim of informing interventions to prevent hazardous substance
use and new HIV infections.

1.6

The need for intersectional discrimination measures

1.6.1 Current approaches to measuring discrimination
Objective 3 of this thesis addresses the measurement of discrimination from an intersectional
perspective. Corresponding to the proliferation of discrimination research is a growing set of
instruments to measure discrimination, primarily focused on racial/ethnic discrimination. A 2006
review identified 152 self-report instruments for racism.38 Most (86%) were developed in the
United States, and 69% focused exclusively on African-Americans, limiting utility for research
with ethnically diverse samples globally. Highlighting the importance of appropriate
measurement of the discrimination construct, among the three most commonly used measures
(representing about one-quarter of studies), the proportion of statistically significant findings
ranged from 30-86%.38
In recognition of the need for instruments suitable to population health research with ethnically
diverse samples, efforts have been made to develop and evaluate the validity of measures for
racial/ethnic discrimination experiences across ethno-racial groups, including immigrant
populations,140,141 who may attribute discrimination to language rather than race/ethnicity.4
However, these efforts have rarely extended to creating instruments that can tap multiple forms
of discrimination.142
Single-item measures of intersectional discrimination have been described in the literature (i.e.,
in which either the base question or the sole question directly asks if the respondent has
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experienced discrimination143). Single-item measures that leave time and space unspecified,
however, will contribute to poor recall and under-reporting.144 To our knowledge, only one multiitem instrument has been developed specifically to assess discrimination across stigmatized
social groups from an intersectional perspective. Bastos et al.145 developed such a measure for
use in the Brazillian context, and evaluated its validity in a university student sample in Brazil. It
assesses so-called “explicit” interpersonal discrimination, ranging from minor interpersonal
slights to events that may affect life chances, such as employment discrimination. After each of
18 questions that ask about unfair treatment (without language regarding social position or
discrimination) a sub-item asks if the respondent attributes the experience to discrimination
based on several listed social positions. While this measure makes an important contribution, a
few key limitations are evident for adaptation in the Canadian context, including generic
language that encourages reporting of non-discriminatory unfair treatment, items specific to the
student context, and items that appear intended to tap experiences based primarily on
race/ethnicity or class (e.g., being mistaken for an employee rather than a customer).
Beyond this example, when investigating discrimination based on multiple social positions,
researchers have employed attribution-specific scales, parallel versions of the same scale with
multiple attribution-specific stems, or adaptations of popular measures that were developed to
assess race/ethnicity-based discrimination (without attribution in the stem). In the following
sections, each approach is briefly described.

1.6.1.1

Attribution-specific discrimination measures

Attribution-specific discrimination measures abound, including those related to discrimination
against specific ethno-racial groups,146,147 ethno-racial minorities overall,140,148 women,149 sexual
minorities,150-152 gender minorities (i.e., transgender persons),55,153 and people living with mental
illness or substance use disorders.154-156 To examine the effects of intersecting forms of
discrimination, some studies have employed two or more such measures.
For example, in the area of trans health, two recent studies employed non-parallel measures of
transphobia and racism on HIV risk behaviour 55 and mental health.157 In the study of HIV risk
among trans Ontarians, Marcellin et al. examined the interaction between racism and
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transphobia, using continuous scale scores.55 In the latter mental health study, the combined
effects of racism and transphobia were of interest. Given the different items and response scales,
this required categorizing respondents into those experiencing high versus low levels of each
racism and/or transphobia. In both cases, the scales included overlapping items (e.g., sexual
objectification, health care discrimination), and thus the independence of these exposures is
unclear. In addition, such measures are clearly unsuitable for use in broader population surveys
in which a small minority of respondents will be transgender.

1.6.1.2

Parallel, attribution-specific versions of the same discrimination measure

Bogart and colleagues developed the Multiple Discrimination Scale158 to assess race/ethnicity,
HIV, and sexual orientation discrimination concurrently among Black and Latino men who have
sex with men living with HIV. It includes ten binary items regarding interpersonal discrimination
and violence which are asked repeatedly, with each of the three scales employing a different
stem. Each scale is scored independently, to create separate but comparable measures of each
discrimination type. Another study of intersecting race/ethnicity, HIV, and gender stigma among
women living with HIV employed parallel measures of race and gender discrimination adapted
by Clark et al.159 from Williams’ Everyday Discrimination Scale,160 along with a separate
measure of HIV stigma.161 Following a similar approach, some investigators have adapted
Krieger et al.'s Experiences of Discrimination (EOD) questionnaire,162 a popular38,40 measure
designed to assess racial/ethnic discrimination among working-class Black, Latino, and White
U.S. adults, to investigate multiple forms of discrimination. The EOD asks respondents: “Have
you ever experienced discrimination, been prevented from doing something, or been hassled or
made to feel inferior in any of the following situations because of your race, ethnicity, or color?”
across nine situations (e.g., seeking employment, healthcare, or housing; in public spaces).162
When adapted, the end of the question has been modified to ask about discrimination based on
gender, sexual orientation, or other factors, with respondents asked to complete the measure for
each social position. 163-165
Such measures suffer from a few important limitations. The response burden of being asked to
answer the same questions multiple times (for each social position of interest) must be
considered. This approach also assumes that respondents can clearly identify and report the
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reason for being discriminated against,142 contrary to the expectations of intersectionality
theory.29 Further, to an even greater extent than the use of multiple, non-parallel discrimination
measures, this approach may facilitate reporting of a single event or experience multiple times
(e.g., being denied employment based on race and based on gender). Thus, the validity of
treating the subscales as independent exposures is questionable, as is summing responses to
estimate the overall frequency of discrimination. Indeed, in recent research using adapted EOD
items to explore the effects of race/ethnicity, gender, and sexual orientation discrimination on
mental health and substance use outcomes,163,164 discrimination was coded as experiencing
sexual orientation discrimination only, experiencing two types of discrimination, or experiencing
three types. Given that the original items included frequency information, this represents a
substantial loss of information.

1.6.1.3

Adapting “unfair treatment” race/ethnicity-based discrimination measures

The Everyday Discrimination Scale (EDS) by Williams et al.160 inquires about unfair treatment
in interpersonal contexts. A sample item asks respondents how often they “…are treated with
less respect than other people are”. Rather than inquiring about unfair treatment based on social
status or position initially, a follow-up item asks the respondent “what do you think was the main
reason for these experiences”, with a list of options. However, some surveys have modified the
original wording with a preface that primes the respondent to answer with respect to
discrimination (e.g., “how often have you experienced each of the following types of
discrimination”).166,167 Specific reference to discrimination in the stem may be important, as a
study of Asian-Americans found that almost 1/3 of respondents reporting no generic “unfair
treatment” did report racial/ethnic discrimination when more specific language was used.168
Williams et al. also developed a measure of major discrimination, with nine items probing
“unfair” treatment in specified contexts (e.g., “…have you ever been unfairly fired”), followed
by the same attribution question as the EDS. However, the EDS is often used in isolation,
without the corresponding major discrimination questions.34,169 This is problematic, as major
discrimination events must be understood in concert with more chronic, ‘everyday' stressors in
order to fully comprehend the impact of discrimination on health.39
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As the base questions do not refer to social position, the Williams Everyday and Major
discrimination items have been adapted for studies of multiple forms of discrimination by
revising the attribution question to allow or encourage multiple attributions167,170 (e.g., “what do
you think are the main reasons…”167). In other cases, the stem is not altered but interviewers
record additional attributions if they are provided.166,171 Irrespective of the exact wording, the
measures’ format allows investigators to model the effects of (a) total discrimination burden
irrespective of attribution,166,170,172 (b) the number of grounds discrimination is attributed to,171,173
and/or (c) variation in the effects of discrimination based on the grounds it is attributed
to.166,168,174 However, with respect to the third approach, evidence indicates that the health effects
of discrimination (when measurement is standardized) do not necessarily depend on the grounds
to which it is attributed.34

1.6.1.4

The need for intersectionality in the development of multiple-basis discrimination
measures

This overview of current practices in measuring discrimination has shown that developers of
discrimination measures have infrequently taken an intersectional perspective.15 Intersectional
population health research has sometimes drawn on secondary data sources in which
discrimination was assessed via multiple, non-intersectional indices, with associated analytic
limitations. In other cases, a single instrument has been employed, but one which was not
initially intended to demonstrate content validity across different kinds of discrimination. Thus,
both analytic flexibility and content validity may be improved if new measures are developed
within an intersectional framework.
Considering evidence of attributional ambiguity among members of groups who experience
multiple forms of stigma,29,175 intersectional measures would ideally not require participants to
disaggregate discrimination experiences based on the attribute being targeted. Whether posed in
the stem or in a follow-up question, these attribution items pose a high cognitive and
psychological burden, and measures that require attribution in the stem may lead to underreporting.176 Moreover, single-axis or select-axes measures will underestimate the overall
prevalence of discrimination experiences and their health effects. Instead, global measures of
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discrimination could be used, with social status and position data cross-stratified to analyze the
intersectional distribution and effects of discrimination.15
To ensure construct validity across intersecting groups, global discrimination measures require
attention to the commonalities, as well as the differences, in experiences of discrimination across
stigmatized groups. This is evident from the literature on developing race/ethnicity-based
discrimination measures for use with multiple ethnic groups. In some cases, measures developed
for use with African-Americans have been adopted for other populations without changing any
of the items.141,177,178 This is problematic as such measures (e.g., the Williams Everyday
Discrimination Scale160) do not include items addressing common manifestations of
discrimination for non-African-American and/or immigrant ethno-racial minority groups,
including discrimination related to language or accent, nativity, and “positive” stereotypes.177
Conversely, measures designed for Asian-Americans, for example, would be too specific and
thus unsuitable for comparative research or population health surveys.141,177
Even within a single target ethno-racial group, these measures may exhibit bias related to
intersectional social positions. The Williams Everyday and Major discrimination measures were
developed with the intention of measuring racial discrimination experienced by AfricanAmericans.160 “Everyday” items probe disrespectful or discourteous treatment; being treated as
frightening, unintelligent, inferior, or dishonest; and being called names or threatened. Among
African-Americans, a study found evidence of gender bias.179 Most items were endorsed by a
higher percentage of men versus women, and the proportion of variance explained by a latent
discrimination variable was higher for men. The authors note that some items are specific to
stigmas against African-American men (e.g., being perceived as frightening or criminal), while
none refer to gendered forms of racism that may be more commonly experienced by women
(e.g., in romantic relationships).
More broadly, to be applicable to discrimination based on a range of social statuses or positions,
items should sample from within all dimensions of the typology of stigma described in Section
1.1.1. Race/ethnicity-based discrimination items, as described above, appear to reflect
exploitation and domination to a greater extent than norm enforcement or disease avoidance. The
latter are particularly salient for stigmas related to characteristics considered voluntary and

24

mutable (e.g., sexual orientation, transgender identity), or threatening to the perpetrator’s sense
of well-being (e.g., mental illness, infectious disease).5

1.6.2 The need to consider multiple dimensions of discrimination
Scholars of stress have emphasized the need to measure stressors comprehensively to identify
their full effects on health,180 including those that differ with respect to chronicity, viewed on a
spectrum from continuous to discrete events, and with respect to level, from micro to macro (e.g.
interpersonal slights to structural impediments).181 As different types of discrimination may
produce different psychophysiological responses, and in turn different health outcomes, some
have cautioned against combining multiple types of discrimination into a single measure.41

1.6.2.1

Day-to-day and major discrimination

Following the classification scheme within social stress theory, major discrimination events
might be considered acute stressors – discrete events that are ‘objectively’ stressful – while dayto-day discrimination is akin to a chronic stressor – a subjective experience that lacks a clear
time frame and may be either ongoing or repeating.182 The measures developed by Williams et
al.160 are unique in separating major and everyday discrimination into separate scales. Consistent
with the prediction of social stress theory that chronic stressors are particularly pernicious,183-185
when employing both major and day-to-day discrimination components, the latter has been
found to more strongly predict psychological distress.37,160,166 However, this could also reflect the
stronger impact of more recent experiences, as the Williams measure assesses major
discrimination over the lifetime and everyday discrimination over an unspecified timeframe,
which is likely to be perceived as contemporaneous.166 Regardless, these findings highlight the
importance of considering both chronicity and timing in developing discrimination measures.
Domains in which discrimination occurs should also be incorporated in measurement (e.g.,
home, justice system, health care, in public). This is critical for cognitively grounding survey
items.4 In addition, a meta-analysis of experimental studies that manipulated perceived
discrimination (e.g., by telling subjects that a confederate was motivated by racial prejudice)
revealed that only studies assessing repeated (versus single-event) discrimination had a
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significant effect on mental health.14 This indicates that discrimination measures should include
assessment of frequency. Knowledge about the domains in which discrimination occurs is also
needed to inform efforts to prevent discrimination, and to monitor trends over time. Researchers
are advised to consider both domains and junctures at which discrimination may occur within
institutions (access, functioning, and movement, e.g., getting a job, evaluation within the
workplace, promotion).4,35,144 When multi-item measures are being used, adequate coverage of
domains is required to avoid underestimating discrimination by sampling from a small frame of
the discrimination ‘universe’.186 Finally, measurement should include traumatic or violent events
based on social position, which are often excluded from discrimination measures.34,39,176

1.6.2.2

Anticipated discrimination

As posited by social and minority stress theories, discrimination can constitute a chronic stressor
in the lives of stigmatized persons even without direct experience of discrimination events,
because of stress related to the possibility of experiencing it in the future.21,22,181 Anticipated
discrimination may lead minority group members to experience anxiety and/or a high level of
vigilance in interactions with dominant group members or institutions, taxing coping
resources.21,176 Correlational and experimental studies have found that anticipated discrimination
is associated with psychological distress and cardiovascular stress responses.187,188
Of the limited number of studies related to anticipated discrimination,176 some have investigated
impacts of stigma consciousness or awareness.88,189 While stigma consciousness is also related to
distress among members of target groups,189 one can be aware of stigma against members of
one’s group without worrying about facing discrimination personally.190,191 Anticipated
discrimination also differs from internalization of stigmatizing attitudes about one’s own group,
which has been measured and studied extensively in sexual minorities.152 An individual can
anticipate stigma without having a negative self-image related to the stigmatized status.187
Further, in some cases anticipated discrimination is conflated with responses to anticipation, or is
assumed to result only from experienced discrimination. For example, Williams et al.160 assessed
vigilance and consequent behaviour alteration only among respondents who reported
experiencing enacted discrimination. Considering these research gaps, stress related to
anticipated discrimination has been identified as an emerging research priority.34
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1.7

Data sources

This thesis employs three datasets to achieve its objectives. Each data source is described briefly
below; additional details are provided in the respective manuscripts.

1.7.1 Trans PULSE Project
Chapters 2 through 5 draw on data from the Trans PULSE Project, a community-based, mixed
methods research project that began in 2005. Project partners included unaffiliated community
members, The University of Western Ontario, Wilfred Laurier University, Sherbourne Health
Centre, Rainbow Health Ontario, and The 519 Church Street Community Centre. This thesis
focuses on the Trans PULSE respondent-driven sampling survey funded by the Canadian
Institutes of Health Research. Ethics approval was obtained from The University of Western
Ontario and Wilfred Laurier University. In 2009-2010, 433 trans Ontarians participated in the
cross-sectional survey through a self-administered questionnaire, completed online or using a
visually identical paper copy (see Appendix A).
Participants were recruited through respondent-driven sampling (RDS), an innovative method for
sampling hidden populations, for whom a sampling frame cannot be enumerated.192,193 RDS is a
modified chain-referral sampling method, in which participants recruit their peers. This aids in
the recruitment of stigmatized populations, which may be unwilling to identify themselves to
researchers. In addition to facilitating recruitment of hidden populations, RDS analytic methods
allow for the generation of asymptotically unbiased estimates and confidence intervals for the
networked target population through weighing on recruitment probabilities.194 RDS II weights
are based on personal network size (the number of eligible persons known, representing the
number of possible recruitment paths).195 Eligible participants needed to be 16 years of age or
older; living, working, or receiving health care in Ontario; and identify as trans following a broad
definition. Recruitment began with 16 diverse seed participants, who were each given three
coupons for recruitment of their peers. Upon completing the survey, participants were given
three coupons for further recruitment.
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1.7.2 Canadian Community Health Survey
In Chapters 4 and 5, data on the past-year prevalence of heavy episodic drinking, cocaine use,
and amphetamine use among Ontarians aged 16+ in 2009-2010 were obtained from Statistics
Canada’s Canadian Community Health Survey.196 The CCHS is an ongoing multi-stage, multimode, stratified, cluster sampling cross-sectional survey of Canadians aged 12 and above. The
sampling frame covers approximately 97% the Canadian population (excluding institutionalized
persons and those living on First Nations reserves). To date, measures of transgender status or
identity have not been included in the CCHS. Respondent sex/gender is classified as male or
female, usually classified based on the interviewer’s assumption.

1.7.3 Understanding Social Experiences and Health Survey
Chapter 6 reports on partial findings of the Understanding Social Experiences and Health
Survey. The survey’s primary objective was to evaluate the validity and reliability of the
Intersectional Discrimination Index (InDI). A secondary objective was to collect additional data
on indicators of social status and position, targetable attributes (i.e., visibility of minority status)
and mental and behavioural health outcomes (psychological distress, smoking, anxiety, and
hazardous drinking) for proof-of-concept analyses demonstrating the potential uses of the InDI.
Legerweb, a market and academic research firm, was hired to collect data through their online
survey panels in both Canada and the United States. Baseline data were collected between
August and November 2016 from 2642 adults aged 18+, including 1065 in Canada and 1577 in
the United States. As described in Chapter 6, quota sampling was employed with the aim of
achieving approximately equal numbers of participants from six major ethno-racial groups, and
an oversample of sexual and/or gender minorities. To assess test-retest reliability of the InDI, a
subsample of 150 participants (83 in Canada and 67 in the United States) completed a follow-up
survey between three and six weeks after baseline. Ethical approval was obtained from the NonMedical Research Ethics Board at the University of Western Ontario (see Appendix E).
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2

Chapter 2: HIV/STI risk and sexual inactivity among transfeminine
persons: A Canadian respondent-driven sampling survey

2.1

Introduction

Available data indicate an extremely high burden of HIV infection among transfeminine (i.e.,
male-to-female spectrum transgender) persons. A 2012 meta-analysis1 found pooled HIV
seroprevelance of 19% among 11,066 transfeminine persons in 15 countries. Sampling bias
appears endemic to seroprevalence studies in urban North American transfeminine
communities;2 however, studies of more heterogeneous and geographically dispersed transgender
(trans) populations have been limited to self-reported HIV status. In previously published results
from the Trans PULSE study, 3% of transfeminine persons identified as HIV-positive, but 42%
had never been tested; only 19% had engaged in any HIV-related high-risk sexual activity in the
past year, with insertive vaginal intercourse (i.e., a transfeminine person using her penis for
vaginal penetration) being the largest contributor.3
Minority stress theory4 posits that health risk behaviors among sexual and gender minorities are
attributable to the additional burden of stigma-related stress these groups face. Exposure to antitrans stigma and violence has been associated with condomless anal intercourse5,6 and incident
HIV/STI.7 Coping responses such as substance use can further increase sexual risk.8,9
Discrimination in education and employment contribute to high levels of poverty, unstable
housing, and survival sex work, which in turn exacerbate HIV/STI vulnerability.3,8 In addition,
sexual relationships can offer affirmation of gender identity for transfeminine individuals who
often face invalidation, and the need for such affirmation may take precedence over HIV/STI
prevention.10
Although public health research has emphasized the role of stigma in potentiating sexual risk,
stigma may also serve to limit sexual engagement. In Ontario, half of transfeminine persons
reported no past-year sex partners: more than twice the proportion who had HIV
transmission/acquisition risk.3 Periods of abstinence have been associated with health-promoting

45

behaviors among adults.11 However, determinants and consequences of sexual inactivity in a
population with average levels of sexual activity are unlikely to reflect the experiences of
sexually stigmatized groups. Transfeminine persons face threats of rejection, stigma, and
violence when disclosing trans status to potential sexual partners, as well as fetishization.12 Body
image concerns related to gender incongruence can also lead to avoidance of sex,13 as can
reduced sexual desire or function related to feminizing hormone therapy and surgical
complications.13,14 In the cisgender (non-trans) population, female sex,15 higher education,15
depression,16 and sexual abuse17 are associated with low desire and inactivity.
Sexual health studies among transfeminine persons have primarily sampled patients accessing
hormonal and surgical treatments, while HIV/STI studies have primarily sampled trans women
who have sex with men. These two groups do not represent Ontario’s transfeminine population,
among whom only 23% had sex with a cisgender man in the past year12 and 47% had never used
feminizing hormones.18 Addressing the limitations of both urban convenience and clinical
samples for understanding the spectrum of sexual health, the present study draws on a
respondent-driven sampling study of trans people in Ontario. Extending our team’s past
descriptive research on transfeminine sexualities12 and trans persons’ HIV risk,3 we sought to
identify factors associated with both past-year HIV/STI-related sexual risk and inactivity among
transfeminine persons. Of primary interest were the potential impacts of discrimination and
other forms of social exclusion on these outcomes, however, for this first exploratory analysis of
these outcomes in a Canadian population we also examined associations with gender transition
and other potential socio-demographic and psychological determinants of trans sexual health.

2.2

Methods

2.2.1 Study Design and Participants
The Trans PULSE community-based participatory research project surveyed 433 trans Ontarians
in 2009-2010 using respondent-driven sampling (RDS). RDS is a modified chain-referral
sampling method for hidden populations.19,20 In addition to facilitating recruitment of hidden
populations through the use of peers, RDS analytic methods can produce asymptotically unbiased
point estimates for the networked target population.21 We used RDS II weights, which are
estimated as the inverse of the number of target population members known, to adjust for unequal
recruitment probabilities due to personal network size.
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Participants completed a self-administered questionnaire, using visually identical online or paper
versions. Eligible participants needed to be 16 years of age or older; live, work, or receive health
care in Ontario; and identify as trans following an inclusive definition. Recruitment began with
16 diverse seed participants selected from the study’s community advisory committee who were
each given three coupons for recruitment of their peers. Upon completing the survey, participants
were given three coupons for further recruitment. Twenty-two seeds were added after 4 to 5
waves of recruitment were obtained; maximum chain length was ten waves beyond the seeds. All
but seven seeds were productive (i.e., recruited at least one participant). A recruitment network
diagram has been published previously.3
Ethics approval was obtained from The University of Western Ontario and Wilfrid Laurier
University. Gender spectrum was classified as transmasculine (i.e., assigned female at birth;
n=227) or transfeminine (i.e., assigned male at birth=205), including individuals who identified as
neither men nor women. This analysis includes 171 transfeminine participants who had ever had
sex and provided sufficient data (17 participants had no sexual experience and 17 were missing
data).

2.2.2 Measures
Demographic and background factors. Participants indicated their age, education, social
transition status (living in felt gender full-time, part-time, or not at all), surgical history, hormone
use, and the frequency with which they were socially perceived as cisgender. Ethnoracial group
was coded as Aboriginal, non-Aboriginal racialized (i.e. person of color), or white based on
answers to multiple check-all-that-apply items. Residence in metropolitan Toronto (Ontario’s
largest urban center) was ascertained by the first letter of the respondent’s postal code. Income-toneeds ratio was calculated by dividing the mid-point of household income categories by the
number of household members being supported. Sexual attraction was dichotomized as primarily
attracted to men versus primarily attracted to women, multiple genders, or not sexually attracted
to others. Background variables included sexual abuse (any unwanted sexual contact before age
16) and religiosity of upbringing (quite or extremely versus fairly or less). Self-reported HIV
status was measured, but not included in analyses because of small cell sizes. As previously
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reported, an estimated 3% of transfeminine Ontarians reported being HIV-positive, although only
40% had been tested in the previous two years.3
Social exclusion and inclusion. A scale of perceived transphobia (Cronbach’s a= 0.81) included
items pertaining to external (e.g. employment discrimination) and internalized (e.g. fear of dying
young) dimensions of trans-related discrimination.22 Participants indicated lifetime experiences
of transphobic physical or sexual assault, and harassment or threats. Social support was measured
with the Medical Outcomes Study scale;23 a= 0.97 in our data). Perceived parental support for
gender identity or expression was dichotomized to reflect the presence of potentially protective
strong support, including expected support for those who had not yet disclosed their gender
identity. Involvement in the local lesbian, gay, bisexual, and transgender (LGBT) community was
coded dichotomously based on participant report of past-year LGBT event attendance or group
membership. Attendance at a trans-specific bar or club night was included as a separate variable,
as these events more often emphasize sexual partner seeking.
Substance use, mental health, and sexual agency. Problematic alcohol use was operationalized
as a score of 2 or greater on the CAGE short screener.24 Stimulant use was defined as any pastyear use of cocaine, crack, crystal methamphetamine, or other amphetamines. Center for
Epidemiological Studies Depression scale25 scores were categorized into low (<16), moderate
(16-26), and high (27-60) symptomatology (a= 0.93 in our data). Sexual anxiety, fear, and
satisfaction (a= 0.92; 0.84; 0.96) were assessed with the relevant subscales of the
Multidimensional Sexual Self-concept Questionnaire.26 The research team developed a sevenitem measure of trans-related body image worries (a=0.80), and an eight-item trans-specific
condom/barrier self-efficacy scale (a=0.92) including items such as “…how certain are you that
you could ask a non-trans partner to use a protective barrier [for example, a condom, dental dam,
glove, or plastic wrap]?”.
HIV/STI-related sexual risk and sexual inactivity. Past-year sexual risk behaviour was
categorized as no risk (abstinent), low risk (only oral sex, vaginal/anal sexual activities without
fluid exposure, or fluid-exposed vaginal/anal sex with an HIV-seroconcordant spouse or longterm partner in a monogamous relationship), or high risk (fluid-exposed vaginal/anal sex outside
of a seroconcordant, monogamous relationship).

48

2.2.3 Statistical analysis
Weighted frequencies and associated 95% confidence intervals were calculated in SAS 9.3.1.27
Confidence intervals were estimated using Taylor linearization and adjustment for clustering by
shared recruiter. Odds ratios were estimated with weighted logistic regression models using a
domain analysis in SAS PROC SURVEYLOGISTIC. Polytomous models estimated effects for
past-year sexual inactivity or (separately) high-risk sex, with low-risk sex as the referent. After
estimating bivariate associations, we built a model containing all demographic and background
variables to identify independent demographic predictors. Next, we estimated adjusted odds
ratios separately for each of the social exclusion/inclusion and mental health, substance use, and
sexual agency variables of interest. To control for non-modifiable factors and to reduce
confounding, these models were adjusted for variables with p<0.25 in the demographic and
background model.28 Social transition status was included as a covariate regardless of p-value,
because of its potential to confound associations between trans-specific experiences and the
outcomes.
We did not enter all variables into a multivariable model because of the exploratory nature of the
analysis, the multitude of potential mediated pathways and consequent risk of adjusting for
mediators, multicollinearity, and the relatively small sample size. For multivariable analyses
only, simple imputation of the mean or mode was used for independent variables with less than
10% missingness. One variable (childhood sexual abuse) had 12.2% missing, and was imputed
using individual marginal predicted risks of sexual abuse (rounded to 0 or 1) generated from a
logistic regression model.
Approximately half of sexual risk was attributable to condomless vaginal intercourse as the
insertive partner, and we hypothesized that predictors of this behavior could diverge from other
forms of sexual risk. Therefore, we conducted a sensitivity analysis by repeating regression
analyses with a more narrowly defined risk outcome, reclassifying condomless insertive vaginal
intercourse into the “low risk” category (for proof-of-concept, not to imply that such behavior
necessarily presents low HIV/STI risk). Adjusted odds ratios were estimated using the same set
of adjustment variables as in primary analyses.
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2.3

Results

Among transfeminine people in Ontario age 16 and over, 11.7% (95% CI: 5.0, 18.4) had never
engaged in partnered sex (and were excluded from the following analysis). Of those who had
ever had sex, 40.8% (95% CI: 28.9, 52.6) reported no past-year sex partners, 38.3% (95% CI:
26.7, 49.9) engaged in low-risk sex, and 20.9% (95% CI: 11.7, 30.2) had at least one sexual
encounter that could pose high HIV/STI-related risk. Approximately half of high HIV/STIrelated sexual risk was attributable solely to vaginal intercourse as the insertive partner: 9.9%
(95% CI: 3.0, 16.9) had sexual risk related to anal intercourse or receptive vaginal intercourse.
Data on HIV testing and self-reported status have been previously published;3 in this analytic
subgroup three-quarters identified as HIV-negative (75.2%, 95% CI: 64.2, 86.2) and 1.2% (95%
CI: 0.0, 3.0%) as HIV-positive, while 23.6% (95% CI: 12.7, 34.6) did not know their status.
While analyzed as a single set of polytomous models (n=171), results for the two outcomes are
presented in separate tables for clarity. Findings for the first outcome – HIV/STI-related risk
behaviour– as well as weighted variable frequencies are presented in Tables 2.1 and 2.2. Crude
odds of sexual risk were higher among those not living in their felt gender. In the multivariable
model including all demographic and background variables, living in Toronto (AOR= 0.25, 95%
CI: 0.07, 0.93) and having completed genital surgery (AOR=0.08, 95% CI: 0.02, 0.46), were
statistically significantly associated with lower odds of HIV/STI risk behaviour. After adjusting
for demographic and background factors, attending trans-specific club or bar nights (AOR=5.11,
95% CI: 1.46, 17.94) was associated with sexual risk, while greater sexual anxiety (AOR=0.59,
95% CI: 0.35, 0.97) and higher condom self-efficacy (AOR=0.54, 95% CI: 0.34, 0.88) were
associated with lower odds of HIV/STI risk behaviour. Neither transphobia scale scores nor
transphobic violence were associated with HIV/STI risk behaviour.
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Table 2.1: Weighted demographic and background characteristics of transfeminine persons in Ontario, Canada and
associations with high HIV/STI sexual risk versus low-risk sex (n=171)
Weighted frequencies
Age (years)
Ethnoracial group
Aboriginal
Non-Aboriginal white
Non-Aboriginal racialized
Residence in metropolitan Toronto
Education
Less than high school
High school diploma
Some postsecondary
Postsecondary graduate
Income-to-needs ratio
<$10,000 CAD
$10,000-19,999
$20,000-29,999
>$30,000
Primarily attracted to men
Experienced childhood sexual abuse
Quite/extremely religious upbringing
Social transition status
Living in felt gender full-time
Living in felt gender part-time
Not living in felt gender
Perceived as cisgender (almost) always
Completed genital surgery
Using feminizing hormones

Full modela

Bivariate associations

% or x̄
38.7

95% CI
(34.8, 42.6)

OR†
1.05

95% CI†
(0.99, 1.10)

AOR†
1.04

95% CI
(0.99, 1.11)

9.6
84.3
6.1
27.6

(2.6, 16.6)
(76.7, 92.0)
(2.2, 10.0)
(17.4, 37.9)

0.14
1.00
1.03
0.56

(0.02, 1.17)

0.26
1.00
1.89
0.25

(0.01, 11.33)

6.1
6.6
29.0
58.4

(1.8, 10.3)
(2.0, 11.1)
(17.7, 40.2)
(46.6, 70.2)

0.61
0.58
0.29
1.00

(0.12, 3.15)
(0.10, 3.25)
(0.08, 1.10)

1.27
0.49
0.09
1.00

(0.18, 8.76)
(0.06, 4.14)
(0.02, 0.50)*

21.5
25.9
9.7
42.9
17.2
37.8
29.0

(11.0, 32.0)
(14.8, 37.0)
(2.7, 16.7)
(30.0, 55.8)
(8.9, 25.6)
(25.6, 50.0)
(17.3, 40.8)

0.76
1.31
4.30
1.00
0.51
0.26
2.02

(0.16, 3.68)
(0.24, 7.02)
(0.67, 27.8)

(0.30, 11.39)
(0.27, 14.22)
(0.94, 13.91)

(0.12, 2.22)
(0.07, 0.96)*
(0.52, 7.80)

1.84
1.96
3.62
1.00
1.05
0.16
4.52

53.3
22.3
24.4
36.5
14.8
59.6

(40.8, 65.8)
(12.8, 31.8)
(12.6, 36.1)
(24.3, 48.7)
(6.9, 22.8)
(47.0, 72.1)

1.00
1.30
5.31
1.62
0.22
0.32

(0.37, 4.54)
(1.12, 25.06)*
(0.44, 5.99)
(0.03, 1.49)
(0.10, 1.04)

1.00
0.48
1.86
1.22
0.08
0.48

(0.24, 4.46)
(0.15, 2.13)

(0.36, 9.97)
(0.07, 0.93)*

(0.16, 6.78)
(0.02, 1.27)
(0.96, 21.32)

(0.09, 2.57)
(0.34, 10.24)
(0.36, 4.10)
(0.02, 0.46)*
(0.10, 2.32)
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† OR = odds ratio; CI = confidence interval; AOR= adjusted odds ratio.
*Association statistically significant at p<0.05.
. a Nagelkerke R2=0.5302
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Table 2.2.2: High HIV/STI sexual risk versus low-risk sex: Crude and demographic-adjusted correlates and their frequencies
among transfeminine persons in Ontario, Canada (n=171)
Weighted frequencies

Lifetime transphobia scale score (range= 0-33)
Lifetime transphobic violence
None
Verbal harassment or threats
Physical or sexual assault
Social support (range=0-5)
Strong parental support for gender
LGBT community involvement
Attended trans bar or club night event
Problem drinking (CAGE ≥ 2)
Past-year stimulant use
Depressive symptoms
Low: CESD score <16
Moderate: CESD score 16-26
High: CESD score 27-60
Sexual body image worries (range=0-4)
Sexual anxiety (range= 0-4)
Fear of sex (range= 0-4;)
Sexual satisfaction (range= 0-4)
Condom self-efficacy (range= 0-6)

Bivariate
associations

Demographicadjusted associationsa

% or x̄
95% CI
15.3
(13.9, 16.7)

OR†
0.94

95% CI†
(0.85, 1.03)

AOR†
95% CI
1.01
(0.90, 1.14)

36.6
42.1
21.2
3.3
34.8
34.3
33.9
18.2
6.9

(24.8, 48.5)
(30.2, 54.1)
(12.2, 30.2)
(3.1, 3.6)
(22.9, 46.7)
(23.2, 45.3)
(22.8, 45.0)
(9.0, 27.4)
(3.0, 10.8)

1.00
0.17
0.26
0.98
0.72
0.85
4.82
0.43
0.81

(0.04, 0.70)*
(0.07, 0.95)*
(0.55, 1.72)
(0.20, 2.63)
(0.25, 2.93)
(1.41, 16.40)*
(0.12, 1.57)
(0.21, 3.04)

1.00
0.55
0.82
0.86
0.48
1.31
5.11
1.18
3.17

(0.12, 2.47)
(0.20, 3.35)
(0.46, 1.60)
(0.12, 2.02)
(0.36, 4.80)
(1.46, 17.94)*
(0.24, 5.75)
(0.36, 28.22)

38.1
23.7
38.3
2.0
2.1
1.7
1.3
5.0

(25.8. 50.3)
(13.6, 33.7)
(26.7, 49.8)
(1.8, 2.3)
(1.8, 2.4)
(1.4, 2.0)
(1.0, 1.6)
(4.8, 5.3)

1.00
0.65
0.21
0.48
0.58
0.76
1.64
0.74

(0.15, 2.88)
(0.05, 0.81)*
(0.27, 0.89)*
(0.36, 0.92)*
(0.44, 1.30)
(1.10, 2.45)*
(0.49, 1.13)

1.00
0.85
0.27
0.48
0.59
0.82
1.53
0.54

(0.21, 3.45)
(0.06, 1.27)
(0.23, 1.01)
(0.35, 0.97)*
(0.44, 1.52)
(1.00, 2.34)
(0.34, 0.88)*

† OR = odds ratio; CI = confidence interval; AOR= adjusted odds ratio.
*Association statistically significant at p<0.05.
a
Adjusted for social transition status and demographic/background variables significant at p<0.25: age, Toronto residence, education, income-to-needs ratio,
attraction, childhood sexual abuse and religiosity, genital surgery, and hormone use.
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Findings for the second outcome—past-year sexual inactivity—are presented in Tables 2.3 and
2.4. In the multivariable model including all demographic and background variables, higher age
(AOR for 1 year=1.11, 95% CI: 1.04, 1.19) was associated with greater odds of inactivity, and
Toronto residence (AOR=0.06, 95% CI: 0.01, 0.29) and genital surgery (AOR=0.01, 95% CI:
0.00, 0.09) with lesser odds. Sexual inactivity was inversely associated with education.
Childhood sexual abuse was positively associated with sexual inactivity (AOR=11.64, 95% CI:
2.02, 67.09), while primary attraction to men was negatively associated (AOR=0.10, 95% CI:
0.01, 0.97). As shown in Table 2.4, adjusting for demographic and background factors, social
support (AOR=0.53, 95% CI: 0.29, 0.95) and moderate depressive symptoms (AOR=0.18, 95%
CI: 0.03, 0.97) were negatively associated with sexual inactivity.
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Table 2.3: Past-year sexual inactivity versus low-risk sex: Associations with demographic
and background factors among transfeminine persons in Ontario, Canada (n=171)

Age (1 year)
Ethnoracial group
Aboriginal
Non-Aboriginal white
Non-Aboriginal racialized
Residence in metropolitan Toronto
Education
Less than high school
High school diploma
Some postsecondary
Postsecondary graduate
Income-to-needs ratio
<$10,000 CAD
$10,000-19,999
$20,000-29,999
>$30,000
Primarily attracted to men
Experienced childhood sexual abuse
Quite or extremely religious upbringing
Social transition status
Living in felt gender full-time
Living in felt gender part-time
Not living in felt gender
Perceived as cisgender (almost) always
Completed genital surgery
Using feminizing hormones

Bivariate associations
OR†
95% CI†
1.06
(1.01, 1.11)*

Full modela
AOR†
95% CI
1.11
(1.04, 1.19)*

0.29
1.00
0.06
0.10

(0.05, 1.60)

1.49
1.00
0.10
0.06

(0.10, 23.00)

0.46
0.61
0.73
1.00

(0.06, 3.55)
(0.10, 3.80)
(0.21, 2.53)

0.03
0.02
0.17
1.00

(0.00, 0.44)*
(0.00, 0.19)*
(0.04, 0.77)*

1.23
1.84
0.54
1.00
0.27
2.66
2.04

(0.26, 5.69)
(0.42, 8.01)
(0.11, 2.70)

(0.91, 33.67)
(0.24, 10.38)
(0.15, 11.06)

(0.06, 1.16)
(0.87, 8.17)
(0.52, 8.08)

5.54
1.57
1.30
1.00
0.10
11.64
3.04

(0.28, 4.00)
(0.60, 12.38)
(0.28, 3.28)
(0.03, 0.34)*
(0.32, 4.12)

1.00
0.38
3.18
1.14
0.01
8.03

1.00
1.06
2.73
0.95
0.09
1.14

(0.01, 0.63)
(0.03, 0.31)*

† OR = odds ratio; CI = confidence interval; AOR= adjusted odds ratio.
*Association statistically significant at p<0.05.
a

Nagelkerke R2=0.5302

(0.00, 4.60)
(0.01, 0.29)*

(0.01, 0.97)*
(2.02, 67.09)*
(0.43, 21.42)

(0.06, 2.40)
(0.48, 21.28)
(0.24, 5.50)
(0.00, 0.09)*
(0.98, 65.77)
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Table 2.4: Past-year sexual inactivity versus low-risk sex: Crude and demographicadjusted correlates among transfeminine persons in Ontario, Canada (n=171)
Bivariate associations

Demographic-adjusted
associationsa

OR†

AOR†

95% CI†

95% CI

Lifetime transphobia scale score

0.95 (0.87, 1.03)

0.94

(0.83, 1.05)

Lifetime transphobic violence
None
Verbal harassment or threats
Physical or sexual assault
Social support

1.00
0.87 (0.25, 3.08)
0.20 (0.05, 0.76)*
0.56 (0.33, 0.94)*

1.00
3.36
0.16
0.53

(0.60, 18.94)
(0.02, 1.19)
(0.29, 0.95)*

Strong parental support for gender

0.59 (0.19, 1.89)

0.90

(0.16, 5.06)

LGBT community involvement

0.39 (0.12, 1.27)

0.28

(0.07, 1.16)

Attended trans bar or club night event 0.71 (0.24, 2.09)

0.39

(0.10, 1.53)

Problem drinking
Past-year stimulant use
Depressive symptoms
Low: CESD score <16
Moderate: CESD score 16-26
High: CESD score 27-60

0.56 (0.13, 2.38)
0.20 (0.05, 0.90)*

0.58
0.36

(0.11, 3.15)
(0.03, 4.50)

1.00
0.83 (0.18, 3.77)
0.84 (0.22, 3.17)

1.00
0.18
0.24

(0.03, 0.97)*
(0.05, 1.23)

Sexual body image worries
Sexual anxiety
Fear of sex
Sexual satisfaction

1.31
0.95
1.27
0.72

(0.69, 2.48)
(0.62, 1.46)
(0.74, 2.19)
(0.46, 1.12)

1.00
0.86
1.08
0.64

(0.48, 2.09)
(0.53, 1.37)
(0.62, 1.90)
(0.36, 1.13)

Condom self-efficacy

0.98 (0.64, 1.51)

1.21

(0.70, 2.10)

† OR = odds ratio; CI = confidence interval; AOR= adjusted odds ratio.
*Association statistically significant at p<0.05.
a

Adjusted for social transition status and demographic/background variables significant at p<0.25: age, Toronto

residence, education, income-to-needs ratio, attraction, childhood sexual abuse and religiosity, genital surgery, and
hormone use.

Sensitivity analyses (results not shown) revealed changes in the magnitude, statistical
significance, and direction of some associations when insertive vaginal intercourse was recoded
into the category for “low risk” sexual activity. In bivariate analyses, living part-time (versus
full-time) in one’s felt gender (OR=0.13, 95% CI: 0.02, 0.75) became associated with reduced
sexual risk. Income-to-needs ratios of $10-29,999 CAD (versus $30,000 or above) were crudely

56

associated with higher odds of sexual risk, and this association persisted for incomes between
$10-19,999 when adjusting for other demographics (AOR= 10.70, 95% CI: 1.02, 112.65). In the
multivariable demographic model, the positive association between childhood religiosity and
HIV/STI risk behaviour became statistically significant (AOR=7.39, 95% CI: 1.48, 36.93).
Finally, adjusting for the same demographic and background variables as in the primary
analyses, higher transphobia scale scores (AOR=1.39, CI: 1.10, 1.76) and past-year attendance at
LGBT events (AOR=16.07, 95% CI: 1.91, 135.40) became significantly associated with HIV/
STI risk behaviour. Other findings remained consistent.

2.4

Discussion

We estimated the prevalence and correlates of both past-year HIV/STI-related sexual risk and
inactivity in the transfeminine population (age 16+) of Canada’s most populous province. To the
best of our knowledge, this is the first study to explore sexual inactivity among transfeminine
persons. Previously published results from our dataset indicated that 51% had no partnered sex in
the past year,3 and this proportion remains high (41%) when considering only those who had
ever had sex. Demographic and background correlates were similar to those identified as
predictive of low sexual desire and/or inactivity in cisgender populations, including older age,
higher education, and childhood sexual abuse (CSA). The prevalence of CSA in this population
(37.8%, 95% CI: 26.50, 50.0) appears higher than meta-analytic estimates for sexual minority
natal males (21% for gay men, 25% for bisexual men29). For transfeminine persons, CSA was
associated with sexual inactivity, but not HIV/STI risk behaviour. Residence outside
metropolitan Toronto was strongly associated with inactivity, which may reflect a smaller pool
of potential sexual partners, and fewer venues in which to meet potential partners. However,
sexual satisfaction scores were not significantly associated with sexual inactivity. As intentions
or desires for sexual behavior were not measured, our measure of past-year inactivity includes
intentionally chosen, involuntary, and circumstantial abstinence.
Having completed genital surgery had the largest magnitude of effect in independently
predicting both reduced sexual inactivity and HIV/STI risk behaviour, despite the fact that the
reference group included individuals with no desire for vaginoplasty, in contrast to clinical
research that has focused on trans women needing surgery.30 With respect to genital surgery and
HIV/STI risk behaviour, previous studies have largely found no association.7,31,32
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However, access to surgery was somewhat less common in these samples (7-10%); some
primarily sampled sex workers or trans women in primary partnerships, and definitions of
surgery were sometimes unclear. Future research in this area should capture detail on surgical
status, and neovaginal sexual risk, to inform behavioral and biomedical prevention interventions.
Aside from surgical status, other trans-specific background variables were largely unassociated
with HIV/STI risk behaviour, with the exception that before adjustment, sexual risk was
elevated among those not living in their felt gender.
Our findings were largely inconsistent with previous research on HIV-related risk among
transfeminine persons. We found little evidence to support minority stress or gender affirmation
theories of HIV/STI risk in this broad transfeminine population. However, lower income and
experiences of discrimination were positively, independently associated with high sexual risk in
sensitivity analyses (when risk solely attributable to insertive vaginal intercourse was coded as
“low risk”). This suggests that the factors that predict sexual risk for transfeminine persons
differ by the natal sex of their partners, contributing to the discrepancy between findings from
this sexually diverse population and from previous studies of trans women sexually active with
cisgender men. The use of respondent-driven sampling across a large geographic region, in the
context of a study not focused primarily on HIV risk, may also account for these differences.
Further research, including qualitative work, is needed to understand potential social and
psychosocial drivers of sexual risk among transfeminine persons who are not primarily sexually
active with cisgender men. In addition, data on sexual partner and network characteristics would
enhance understanding of the likelihood of HIV/STI exposure via reported condomless sexual
activity, particularly for sex with cisgender women, given low HIV prevalence among most
female population subgroups in Canada and countries with similar HIV epidemic profiles.
These findings also suggest that in future research with transfeminine persons, behavioral
components of sexual risk should be treated as separate outcomes where possible and that
engagement in low-risk sex and sexual inactivity should be disentangled. Excluding sexually
inactive participants could efficiently achieve this objective, but such an approach restricts
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applicability of prevalence estimates to a subgroup that, per our findings, could constitute less
than half of the transfeminine population.

2.4.1 Strengths and limitations
This study had several strengths including the use of respondent-driven sampling with a diverse
province-wide population, a community-based participatory research approach, multi-mode data
collection, and measures of sexual risk designed specifically to capture the diverse sexual
behaviors and embodiments of transfeminine persons. The study also had some important
limitations. Estimates are adjusted for bias related to network size, but RDS II weights do not
account for unrelated sampling biases.33 Confidence intervals are often wide, and should be
cautiously interpreted considering the wide range of plausible values. In addition, our crosssectional data preclude casual inference, although survey measures accounted for temporality to
the extent possible through use of lifetime and past-year measures.
We also note the small proportion (6% weighted) of non-Aboriginal racialized persons in this
study and particularly the absence of Black transfeminine participants,22 in light of observed
racial inequities in HIV infection among transfeminine Americans.34 Black people constitute
4.3% of Ontario’s population.35 Given that Aboriginal persons, who are disproportionately
impacted by HIV in Canada, were well represented (10% weighted) and that Black persons were
well-represented among transmasculine participants,3 we believe this may represent network
patterns that resulted in under-recruitment of Black transfeminine persons (approximately seven
Black transfeminine participants would be expected). In light of differences between American
and Canadian Black populations that are relevant to HIV (e.g., over half of Black people in
Canada were born outside the country36), we would urge caution in generalizing findings from
Black transfeminine persons in the United States to those in Canada.

2.4.2 Conclusion
Notwithstanding these limitations, our findings provide further evidence of the heterogeneity of
HIV-related risk in trans Ontarians, adding to previously published descriptive analyses.3 Most
prior research on HIV risk among transfeminine persons has focused on subgroups at increased
vulnerability due to the confluence of biological (e.g., engaging in receptive anal sex), social-
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structural (e.g., racialized poverty), and sexual-network (e.g., partnering with men who have sex
with men) factors. This emphasis is sensible and necessary given limited resources and evidence
of HIV crises in these subgroups. Yet, it results in research with limited generalizability. This
may be particularly true for high-income settings beyond the United States where HIV epidemics
are patterned differently (e.g., where ethnic/racial disparities are differentially shaped by unique
historical trajectories37), overall HIV prevalence is relatively low, explicit human rights
protections for trans people exist, and trans communities are highly heterogeneous in terms of
sexual attraction and behavior.
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3

Chapter 3: HIV sexual risk among gay, bisexual, and other
transgender men who have sex with men: A respondent-driven
sampling survey1

3.1

Introduction

Transgender men who have sex with men have been labeled a key population at disproportionate
risk of sexually transmitted HIV.1 Yet, there is a dearth of research evidence regarding the HIV
disease burden, prevalence of HIV-related sexual risk, and factors associated with sexual risk
among transmasculine persons who are gay, bisexual, or who have sex with men (T-GBMSM).
We use the term “transmasculine” to refer to individuals who were assigned a female sex at birth
but identify as male or masculine. Contrary to traditional assumptions that most transmasculine
persons identify as heterosexual and/or are exclusively sexually attracted to women, an estimated
63% of transmasculine Ontarians identified as gay, bisexual, or queer and/or reported past-year
sex with men, while 21% had a past-year cisgender (non-trans) male sex partner.2 Similarly,
three-quarters of transmasculine participants in the largest United States transgender survey
identified as sexual minorities.3
A review of research published through 2014 found only ten studies with laboratory-confirmed
HIV seroprevalence data for transmasculine persons,4 of which most found no HIV infections.
Three studies documented HIV seroprevalence ranging from 2.0% to 4.3%.5-7 Self-reported HIV
prevalence ranged from 0-10%.4 Most of these reports were based on small samples with one or
two HIV-positive cases. The sole population-based estimate of HIV prevalence among
transmasculine persons comes from Ontario, Canada, where an estimated 0.6% identified as
HIV-positive; however, half had never been tested.8 Two recent estimates of self-reported HIV
prevalence in the subgroup of transmasculine persons who have sex with men are available from

1

A version of this chapter has been published: Scheim AI, Bauer GR, Travers R. HIV-related sexual risk among
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internet-based studies in the United States9 and globally10, finding 1.2% (1/81) and 1.4% (1/69)
prevalence, respectively.
Thus, limited available data suggest a low burden of HIV among T-GBMSM relative to
cisgender (non-transgender) MSM and transgender women, though potentially higher than the
broader population. In Ontario, seroprevalence among cisgender MSM was estimated to be 16%
in 2011.11 Among transgender women, pooled seroprevalence from urban convenience samples
in high-income countries was 22%,12 while self-reported prevalence was estimated at 4.3% in a
broad, primarily online United States sample,3 and 3% across Ontario.8
Despite consistent findings of relatively low HIV prevalence among transmasculine persons who
have been tested for HIV, T-GBMSM are increasingly integrated in cisgender MSM sexual
networks13 where HIV prevalence is high. Estimates of HIV-related sexual risk behavior among
T-GBMSM are highly variable4 and most combine data from trans men of all sexual orientations,
including those at low risk of sexually transmitted HIV by definition (i.e., those who only have
sex with cisgender women). In one small study of transmasculine persons reporting recent sex
with cisgender men, 45% had condomless vaginal or anal intercourse in the past three months.9
Sexual mixing with cisgender MSM, combined with such levels of sexual risk behavior, may
potentiate an increase in seroprevalence among T-GBMSM. Therefore, HIV prevention
interventions targeted to T-GBMSM appear timely.
Only one study to date has identified correlates of HIV-related sexual risk in T-GBMSM,14
employing a syndemic framework, which posits that HIV risk is only one component of a set of
co-occurring, mutually reinforcing epidemics resulting from social stigma and deprivation.15
Reisner and colleagues14 found that among those living in their felt gender role, higher scores on
an index of potentially syndemic conditions (summation of indicators for binge drinking,
substance use, depression, anxiety, childhood abuse, and intimate partner violence) were
associated with lifetime STI diagnosis, multiple recent sex partners, and condomless anal or
vaginal intercourse at last sexual encounter. This suggests that T-GBMSM who are living in their
felt gender role share pathways to sexual risk with cisgender MSM, among whom syndemic
conditions have consistently been linked to HIV risk behaviour.16-18
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Studies of urban transfeminine (i.e., male-to-female transgender) persons who have sex with men
have found experiences of violence,19 transphobia or trans-related stigma,20 depressive
symptoms,19 substance use,21,22 unstable housing,23 and extreme poverty24 to affect HIV-related
sexual risk behaviour; in some cases these factors cluster together, suggesting syndemic
production of HIV risk.20,25
Specific to transmasculine persons, social and medical transition status may contribute to sexual
risk via increased sex drive related to testosterone therapy26 or transition-related sexual
experimentation,27 including perceived shifts in sexual desire and attraction.28 In addition, TGBMSM have described seeking gender validation and affirmation as a gay or bisexual man
through sexual activity, thereby reducing agency in negotiating condom use.27,29 The need for
gender affirmation may vary with transition status. As among transfeminine persons, experiences
of stigma and violence related to trans status26,30,31 have also been posited to increase risk
behaviour for T-GBMSM, but this relationship has not been empirically assessed.
Building upon our previously published descriptive findings regarding gay, bisexual, queer, and
other TMSM in Ontario,2 the current analysis sought to identify factors associated with past-year
HIV-related sexual risk for T-GBMSM. Within a minority stress framework, we assessed the
impacts of discrimination and other forms of social exclusion on sexual risk among T-GBMSM,
while also considering the role of gender transition, in addition to known correlates of sexual risk
among transfeminine persons and cisgender MSM.

3.2

Methods

3.2.1 Study Design and Participants
Trans PULSE was a community-based research project that explored the health of trans people in
Ontario, Canada’s most populous province. “Trans” was defined broadly for recruitment, and
included anyone whose gender identity did not match the sex they were assigned at birth; having
taken steps to socially transition (e.g., through changing one’s name) or medically transition
(e.g., by taking hormones) was not required. In 2009-2010, 433 trans Ontarians aged 16 and
above completed a respondent-driven sampling (RDS) survey via a self-administered
questionnaire, online or using a visually identical paper copy. RDS is an adapted chain-referral
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sampling method for hidden populations.32,33 Combining systematic recruitment through
participants’ social networks with analytic methods that weight data on recruitment probability
and account for non-independence within recruitment chains, RDS can generate estimates for all
networked members of the target population. RDS II weights,34 based on personal network size,
were used for this analysis. Recruitment began with 16 seeds; 22 were added after 4-5 waves of
recruitment were obtained (to ensure adequate chain length). Each participant received three
tracked (virtual or paper) coupons to recruit peers. Ethics approval was obtained from Research
Ethics Boards at The University of Western Ontario and Wilfrid Laurier University.
Of 227 transmasculine participants (i.e., those assigned a female sex a birth), 173 were coded as
T-GBMSM, based on (a) endorsing a sexual minority identity (e.g., gay, bisexual, pansexual,
queer) while not reporting exclusive attraction to cisgender women, or (b) reporting past-year
sexual activity with a cisgender or trans man. T-GBMSM were excluded from this analysis if
they were missing data for the outcome (n=13), or were missing data for more than 20% of
covariates (n=2), resulting in an analytic sample of 158 participants.

3.2.2 Measures
Network size (for RDS estimation). Participants completed three eligibility questions,
indicating whether or not they were 16 years of age or older; considered themselves “trans,” of
“trans experience,” or “trans-identified”; and currently lived, worked, or received healthcare in
Ontario. Next, they were asked: “How many other people do you personally know who could
answer yes to all three eligibility questions?”
Demographics and background factors. Participants indicated their year of birth, educational
attainment, lived gender (living in one’s felt gender full-time, part-time, or not at all,
dichotomized as full-time versus not for regression analyses), sexual orientation identity, and use
of masculinizing hormones. Ethnoracial group was coded as Aboriginal (First Nations, Inuit,
Métis, or another Indigenous group), non-Aboriginal racialized (i.e., person of color), or white.
Residence in Toronto, Ontario’s capital and most populous metropolitan area, was coded based
on the first letter of the respondent’s postal code. Income-to-needs ratio was calculated by
dividing the mid-point of reported household income categories (ranging from <$5000 CDN to
>$100,000) by the number of household members being supported. Sexual attraction was
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categorized as primarily attracted to men (including transmasculine persons); primarily attracted
to women (including transfeminine persons); attracted to multiple genders; or not attracted to
others, and dichotomized into primarily attracted to men versus not. Childhood sexual abuse was
defined as any unwanted sexual contact before age 16. Self-reported HIV status was not included
in regression analyses because no T-GBMSM participants reported being HIV-positive.
Social exclusion and inclusion. An 11-item scale of self-reported transphobic discrimination
(Cronbach’s a= 0.81) was adapted from a measure of homophobia,35 and assessed the frequency
with which participants experienced enacted (e.g. being denied employment) and felt (e.g.
hearing that trans people are not normal), trans-related stigma, with higher scores indicating
greater exposure.36 Separately, participants indicated whether they had ever experienced physical
or sexual violence related to being trans. The Medical Outcomes Study Social Support Scale was
used to measure social support.37 The study team developed measures of perceived support for
gender identity from a range of sources (or expected, for those who had not disclosed). For this
analysis, received or expected support from parents was included and dichotomized as strongly
supportive versus not (including “not applicable”), given evidence that parental support is
uniquely important for trans mental and behavioral health.38 Indication of past-year attendance at
an LGBT community event or membership in an LGBT student or religious group, and
attendance at a trans-specific bar or club night, were included as separate variables to reflect their
potentially divergent relationships with sexual risk.
Substance use and mental health. Those scoring 2 or greater on the CAGE screener39 were
coded as having problematic alcohol use. Past-year stimulant use included any use of cocaine,
crack, crystal methamphetamine, or other amphetamines. Center for Epidemiological Studies
Depression scale40 scores were categorized into low (<16), moderate (16-26), and high (27-60)
depressive symptomatology. A scale of self-efficacy for negotiating condom use41 was adapted
to include other barrier methods and trans-specific situations (e.g., “how certain are you that you
could ask a non-trans partner to use a protective barrier?”). This revised 8-item barrier
negotiation scale had high internal consistency (Cronbach’s a=0.92). The research team
developed a measure of trans-specific worries in sexual situations (7 items, Cronbach’s a=0.80),
as a validated measure of this construct was not available. It includes items such as “I worry that
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once I’m naked, people will not see me as the gender I am” and “I worry that there are very few
people who would want to have sex with me”.
HIV-related sexual risk. Participants reported whether they engaged in condomless receptive
intercourse to ejaculation in the past year, for both vaginal and anal intercourse, and the type of
partner involved (e.g., spouse, one-time partner, exchange partner). Sexual risk was classified as
high for participants reporting any such condomless intercourse, unless it occurred within a
monogamous relationship with a sero-concordant partner (i.e., if they were reported to have
received a negative HIV test result following their last sexual risk activity). Those who had any
other kind of past-year sexual activity with a partner were classified as low risk, while those with
no past-year sex partners were considered at no risk.

3.2.3 Statistical analysis
Weighted frequencies and their 95% confidence intervals were calculated in SAS 9.3.42 RDS II
weights (inverse of network size, rescaled to the sample size)34 were used to account for
differential recruitment probabilities. Confidence intervals were estimated using Taylor
linearization and variances were adjusted for clustering by shared recruiter. Crude and adjusted
prevalence ratios (PRs and APRs) for high sexual risk, versus low or no risk, were estimated
using average marginal predictions from logistic regression models43 in SAS-callable SUDAAN
11.44 For multivariable analyses only, simple imputation of the median, mean, or mode was used
for variables with less than 10% missingness. Two variables had more than 10% missing:
childhood sexual abuse (10.8%) and income-to-needs ratio (12.0%). These were multiply
imputed using weighted sequential hot-deck imputation in SUDAAN, with 5 imputations.
After identifying bivariate associations with socio-demographic and background variables, a
model was built containing all with p<0.25. Next, both bivariate and adjusted prevalence ratios
were estimated for each of the social exclusion/inclusion and substance use/mental health
variables of interest. These associations were adjusted for age, childhood sexual abuse, and
lived gender, based on the potential for these variables to act as confounders. Presentation of
prevalence ratios using average marginal predictions requires selection of reference values for
continuous variables, therefore ratios for scale variables are presented as comparisons of the
weighted 75th versus 25th percentiles and those aged 40 or 30 are compared to those aged 20. As
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this analysis was exploratory, and the absolute number of outcome events was small, we did not
enter all variables of interest into a single multivariable model.

3.3

Results

Figure 3.1 is a recruitment network diagram for the full study sample (n=433) coded by TGBMSM status and past-year HIV-related sexual risk.
Figure 3.1: Recruitment diagram for Trans PULSE respondent-driven sampling survey

Triangles=T-GBMSM; squares= other transmasculine persons; circles=transfeminine persons.
Red=high past-year HIV-related sexual risk; blue= low risk; grey=no past-year sex partners;
white=missing.

Characteristics of Ontario T-GBMSM are described in Table 3.1. A minority reported being
primarily or exclusively attracted to men (9.1%, 95% CI: 0.9, 17.3); most were attracted to
multiple genders (70.7%, 95% CI: 59.0, 82.4). Similar to previously published results for all
transmasculine Ontarians,2 the most commonly endorsed sexual orientation identities were
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queer, bisexual or pansexual, and gay. None reported being HIV-positive, but only 18.7% (95%
CI: 9.2, 28.3) had tested for HIV in the past year; 39.3% (95% CI: 26.4, 52.2) had never been
tested. An estimated 10.0% (95% CI: 1.5, 18.6) had past-year high sexual risk. Among the 34.2%
(95% CI: 22.2, 46.3) with a past-year cisgender male sex partner (data not shown), this
proportion rose to 29.3% (95% CI: 8.4, 50.2). Most risk was related to receptive vaginal
intercourse: of those reporting any high-risk sexual activity, 64% (unweighted) reported
condomless receptive vaginal intercourse only.

Table 3.1: Weighted characteristics of gay, bisexual, and other transmasculine persons who
have sex with men in Ontario, Canada (n=158)
% or
x̄

95% CI

Sociodemographic and background factors
Age, years (x̄ )
Ethnoracial group (%)
Aboriginal
Non-Aboriginal white
Non-Aboriginal racialized
Residence in Toronto area (%)
Education (%)
High school diploma or less
Some postsecondary
Postsecondary graduate
Income-to-needs ratio (%)
<$10,000 CDN per household member
$10,000-19,999
$20,000-29,999
>$30,000
Sexual attraction (%)
Primarily to male-identified
Primarily to female-identified
Multiple genders
Not attracted to anyone
Childhood sexual abuse (%)
Lived gender (%)
Living full-time in felt gender
Living part-time in felt gender
Not living in felt gender

29.8

(26.9, 32.7)

3.7
74.9
21.5
49.8

(0.2, 7.2)
(63.6, 86.1)
(10.6, 32.4)
(36.2, 63.4)

25.8
26.0
48.2

(12.7, 38.8)
(15.3, 36.7)
(35.3, 61.2)

24.0
33.6
25.4
17.0

(13.5, 34.5)
(23.0, 44.3)
(12.5, 38..2)
(9.3, 24.8)

9.1
16.3
70.7
3.9
58.6

(0.9, 17.3)
(6.5, 26.0)
(59.0, 82.4)
(0.0, 9.9)
(45.9, 71.4)

51.6
36.7
11.7

(38.3, 64.8)
(24.9, 48.6)
(2.9, 20.5)
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Currently using hormones (%)
Self-reported HIV status
Positive
Negative
Don’t know or prefer not to say
Tested for HIV
Yes, in the past year
Yes, more than one year ago
Never

39.0

(27.1, 51.0)

0.0
82.8
17.2

(--, --)a
(72.9, 92.6)
(7.4, 27.1)

18.7
41.9
39.3

(9.2, 28.3)
(29.0, 54.8)
(26.4, 52.2)

Lifetime transphobia scale score (range= 0-33; x̄ )

13.3

(11.6, 14.9)

Lifetime transphobic violence (%)
None
Verbal harassment or threats
Physical or sexual assault
Social support (range=0-5; x̄ )

43.2
37.6
19.3
3.7

(29.7, 56.7)
(26.3, 48.8)
(9.6, 29.0)
(3.5, 3.9)

18.0

(10.9, 25.0)

38.4

(26.3, 50.5)

27.3

(17.1, 37.5)

Problem drinking (CAGE ≥ 2; %)

32.1

(20.2, 43.9)

Past-year stimulant use (%)

12.9

(4.3, 21.5)

Depressive symptoms (%)
Low: CESD score <16
Moderate: CESD score 16-26
High: CESD score 27-60
Sexual worries scale (range= 0-4; x̄ )

31.8
25.8
42.4
1.7

(20.7, 42.9)
(14.5, 37.0)
(29.2, 55.7)
(1.5, 2.0)

Barrier negotiation scale (range= 0-6; x̄ )

5.0

(4.7, 5.3)

15.0
75.0
10.0

(6.3, 23.7)
(64.2, 85.7)
(1.5, 18.6)

Social exclusion and inclusion

Strong received or expected parental support for gender
identity (%)
Attended LGBT community, student, or religious event in
past year (%)
Attended trans-specific bar or club night, past year (%)
Substance use and mental health

Past-year HIV/STI sexual risk
No partnered sex (%)
Low-risk
High-risk
a

Cannot be estimated using RDS methods because 0 T-GBMSM reported being HIV-positive.
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Crude associations and a multivariable model for socio-demographic and background factors are
displayed in Table 3.2. Only childhood sexual abuse was associated with increased sexual risk
in bivariate analyses. In the multivariable model, CSA remained associated with sexual risk
behavior (APR=14.03, 95% CI: 2.32, 84.70). In addition, increasing age (APR for 40 years old
versus 20= 4.02, 95% CI: 1.23, 13.14), having some post-secondary education versus graduating
(APR=2.74, 95% CI: 1.18, 6.37), being primarily attracted to men (APR=5.54, 95% CI: 2.27,
13.54), and living in one’s felt gender full time (APR=5.20, 95% CI: 1.11, 24.33) were
associated with HIV-related sexual risk. Masculinizing hormone use was not associated with
sexual risk.
Table 3.2: Associations of sociodemographic and background factors with HIV-related
sexual risk among gay, bisexual, and other transmasculine persons who have sex with men
in Ontario (n=158)
Crude associations
PR†
Age
30 versus 20 years old
40 versus 20 years old
Ethnoracial group
Aboriginal or racialized,
vs. white
Residence in Toronto area
Education
High school diploma or less
Some postsecondary
Postsecondary graduate
Income-to-needs ratio
<$10,000 CDN
$10,000-19,999
$20,000-29,999
>$30,000
Primarily attracted to men

95% CI†

Demographic/
background model
APR†
95% CI

1.64
2.61

(0.61, 4.38)
(0.40, 17.25)

2.04
4.02

(0.98, 4.22)
(1.23, 13.14)

0.24

(0.05, 1.14)

0.37

(0.09, 1.54)

0.86

(0.16, 4.72)

--b

0.74
1.51
1.00

(0.09, 6.01)
(0.22, 10.35)

--b

1.01
2.74
1.00
--b

(0.23, 4.38)
(1.18, 6.37)
--b

1.00
1.06
1.40
0.33
4.36

(0.15, 7.65)
(0.19, 10.35)
(0.05, 2.09)
(0.76, 24.92)

5.54

(2.27, 13.54)

Childhood sexual abuse

18.78

(2.81, 125.35)

14.03

(2.32, 84.70)

Living in felt gender

1.99

(0.27, 14.72)

5.20

(1.11, 24.33)
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Crude associations
PR†
Using masculinizing
hormones

1.45

95% CI†
(0.27, 7.79)

Demographic/
background model
APR†
95% CI
0.35

(0.11, 1.11)

† PR = prevalence ratio; CI = confidence interval; APR= adjusted prevalence ratio.
Associations statistically significant at p<0.05 are bolded.
b

Not retained in multivariable model because p>0.25.

Crude and adjusted associations for social exclusion and inclusion, substance use, and mental
health factors are displayed in Table 3.3. Past-year stimulant use (APR=4.02, 95% CI: 1.31,
12.30) and moderate versus low depressive symptoms (APR=5.77, 95% CI: 1.14, 29.25) were
associated with increased sexual risk after adjustment for age, childhood sexual abuse, and lived
gender. Sexual body image worries were negatively associated with sexual risk for HIV
(APR=0.43, 95% CI: 0.21, 0.90).
Table 3.3: Crude and adjusted odds ratios for correlates of HIV-related sexual risk among
gay, bisexual, and other transmasculine persons who have sex with men in Ontario (n=158)

Crude associations

Lifetime transphobia scale score, 75th versus
25th percentile
Lifetime transphobic violence
None
Verbal harassment or threats
Physical or sexual assault
Social support, 75th versus 25th percentile
Strong received or expected parental support
for gender
Attended LGBT community, student, or
religious event in past year
Attended trans-specific bar or club night,
past year
Problem drinking

PR†
95% CI†
1.34 (0.43, 4.21)

Adjusted
associationsa
APR†
95% CI
(0.45, 2.84)
1.13

1.00
0.18
1.89
0.99
0.19

(0.03, 1.07)
(0.33, 10.72)
(0.49, 2.01)
(0.03, 1.12)

1.00
0.34
2.21
0.76
0.20

(0.06, 2.02)
(0.52, 9.43)
(0.43, 1.34)
(0.03, 1.25)

0.32

(0.09, 1.14)

0.49

(0.12, 1.97)

1.88

(0.52, 6.86)

2.12
4.11

(0.41, 11.09)
(0.96, 17.66)

3.40

(0.88, 13.17)
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Past-year stimulant use
Depressive symptoms
Low: CESD score <16
Moderate: CESD score 16-26
High: CESD score 27-60

3.96

(0.77, 20.45)

4.02

(1.31, 12.30)

1.00
7.25
1.73

(1.54, 34.06)
(0.31, 9.50)

1.00
5.77
1.58

(1.14, 29.25)
(0.22, 11.45)

Sexual worries, 75th versus 25th percentile
Barrier negotiation, 75th versus 25th
percentile

0.72
0.61

(0.42, 1.24)
(0.39, 0.94)

0.43
0.84

(0.21, 0.90)
(0.52, 1.37)

† PR = prevalence ratio; CI = confidence interval; APR= adjusted prevalence ratio.
Associations statistically significant at p<.05 are bolded.
a

Adjusted for age, lived gender, and childhood sexual abuse.

3.4

Discussion

Drawing on data that are generalizable to the networked trans population of Canada’s most
populous province, we found no self-reported HIV infections, but low uptake of HIV testing.
Thus, undiagnosed HIV infections are possible and should not be ruled out. This was a
population recruited based on trans identity and/or status and sampled through trans social
networks; participants were not recruited for being GB-MSM and were not necessarily living
their day-to-day lives as men or transmasculine. While the vast majority of Ontario T-GBMSM
(an estimated 91%) were not primarily or exclusively attracted to men, HIV-related sexual risk
was higher among those who were, suggesting need for interventions for this subgroup.
Considering preferences expressed by T-GBMSM,29 interventions could be delivered not only
through trans-specific initiatives, but also by meaningfully including interested transmasculine
persons in existing services designed for cisgender gay and bisexual men.
Our findings have additional implications for the development and tailoring of HIV and other
STI prevention interventions for T-GBMSM. They suggest that interventions should not focus on
youth to the exclusion of adults, nor on residents of major urban centres to the exclusion of those
residing in other settings. Residence in Toronto was unassociated with sexual risk, while
increasing age was positively associated. Older T-GBMSM, who will be more likely to have
lived substantial portions of their lives as women (potentially as sexual minority women), may
face unique challenges in negotiating (safer) sexual relationships with cisgender men that
deserve further investigation.
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Contrary to theories postulated by T-GBMSM themselves in the qualitative research
literature,26,31 masculinizing hormone use did not impact HIV-related sexual risk in this analysis.
While testosterone use may increase libido (and even sexual interest in cisgender men27,45), our
results indicate that this does not necessarily equate to engagement in sexual risk behavior.
Adjusting for other background and demographic factors, those living in their felt gender were
more likely to have high HIV-related sexual risk. This difference does not appear attributable to
being more likely to have any sexual partners (86% of T-GBMSM living in their felt gender had
any past-year sex, versus 81% of those living in their felt gender part-time or less, p=0.57).
Taken together, these findings suggest that social gender transition and affirmation may be more
salient for understanding engagement in sexual risk behaviour among T-GBMSM.
These analyses considered factors previously associated with HIV-related sexual risk behavior
among both transgender women and cisgender men who have sex with men. We found that
social determinants of health associated with HIV risk behaviour among transgender women
(low incomes,24 transphobia,20 and violence19) are not necessarily generalizable to T-GBMSM.
These findings also challenge our minority stress hypothesis that discrimination would predict
sexual risk. Rather, well-documented psychosocial correlates of sexual risk among cisgender
MSM were associated with HIV risk for T-GBMSM, including childhood sexual abuse
(CSA),46,47 moderate depression,48 and stimulant use.49
The reported frequency of CSA (58.6%, 95% CI: 45.9, 71.4) in this population is alarming, and
is higher than the already elevated levels reported by cisgender sexual minority females and
males (in the United States, this ranges from 19% of gay men to 44% of bisexual women47).
Gender variance in childhood is associated with increased risk of CSA,50,51 perhaps due to
targeting of non-conforming children for abuse. Our finding of a strong (albeit imprecisely
estimated) association between CSA and HIV-related sexual risk among T-GBMSM indicates
that CSA should be considered in the design and delivery of HIV prevention, sexual health, and
mental health initiatives. CSA is also related to increased risk of psychopathology and substance
use,52,53 sexual compulsivity,54 and intimate partner violence.55 These conditions may mediate
the association between CSA and HIV-related sexual risk,56 and CSA may confound associations
between psychosocial conditions and sexual risk. Studies of HIV risk behavior among trans
people have largely failed to collect data on CSA history. In light of these findings and the causal
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importance of CSA for many health outcomes later in life, sensitive collection of CSA data
should be considered in transgender sexual health research.
To inform interventions, future research could explore pathways between CSA, depression,
substance use, and HIV risk among T-GBMSM, and the extent to which they are shared with
cisgender MSM. For instance, does use of stimulants specifically to enhance sexual sensation
and libido contribute to HIV risk among T-GBMSM? Do these mental health and substance use
conditions interact to intensify HIV risk (above and beyond their combined individual effects) as
suggested by syndemic theory?57
Finally, this study re-affirms previous findings4 that despite sharing social vulnerabilities with
transgender women and cisgender MSM, T-GBMSM demonstrate comparatively low prevalence
of HIV infection and related sexual risk. While the present study did not identify any
intervenable protective factors, understanding of such factors could contribute to prevention
efforts both for transmasculine persons, and other sexual and gender minorities. However, we
note that two-thirds of T-GBMSM were at low sexual risk almost by definition, as they had no
cisgender male sex partners (transgender female sex partners were relatively uncommon for
transmasculine persons,2 and all HIV-related sexual risk was borne by the subgroup who had
cisgender male sex partners). Qualitative research with Ontario T-GBMSM58 has pointed to a
paradoxical role of the exclusion that some encounter from gay and bisexual men’s communities
and sexual networks: while potentially harmful for their overall well-being, the limited sexual
opportunities that result likely reduce HIV transmission risk. At the same time, trans men’s
resilient strategies for navigating sexual partnerships in the face of such exclusion, such as
clearly negotiating sexual activities online in advance of meeting partners, may contribute to
lower sexual risk among those who do have sex with cisgender men.

3.4.1 Strengths and Limitations
This represents only the second study to explore correlates of HIV-related sexual risk behavior
among T-GBMSM. It also represents one of the largest samples of this population to date (15 of
27 studies in a 2015 review4 had n<50). In addition to improving on previous research in this
area by drawing on respondent-driven sampling data collected across Canada’s most populous
province, the present analysis benefited from the use of sexual behavior and risk measures
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developed specifically for trans respondents, and from inclusion of key variables often excluded
in transgender studies (e.g., childhood sexual abuse). Nevertheless, this study was not without
limitations. First, the small number of outcome events (14, unweighted) limited statistical power.
Confidence intervals were often wide, and care should be taken to interpret estimates in relation
to the full range of plausible values.
Second, although RDS represents the best available strategy for obtaining a population-based
sample of transgender people, generalizability of estimates rests on assumptions that may not be
met in practice, and biases unrelated to network size are unaccounted for.59 The survey
questionnaire only inquired about condomless intercourse to ejaculation, and sexual risk was
further defined as such activity outside a seroconcordant monogamous partnership. To the extent
that delayed condom application,60 withdrawal before ejaculation, and inaccurate perceptions of
mutual monogamy and seroconcordance are prevalent, this measure will underestimate actual
HIV-related sexual risk. However, this definition will also misclassify some sexual activity as
high risk by including condomless intercourse with casual or non-monogamous partners known
to be seroconcordant (data on HIV status of non-primary partners were unavailable). Finally,
biomedical HIV prevention technologies (e.g., undetectable viral load, pre-exposure prophylaxis;
PrEP) were not captured in these data, which were collected before the introduction of PrEP as a
recommended intervention for MSM and transgender people.

3.4.2 Conclusion
In summary, we found that past-year sexual behavior posing high risk for HIV acquisition was
uncommon overall in this broad population of T-GBMSM, but this was largely because a
minority had any cisgender male sexual partners. Childhood sexual abuse emerged as a key
predictor of sexual risk behavior, and should be considered as a contributor to mental health and
health behaviour challenges for transmasculine persons in future research and interventions.
Continued research, focused on T-GBMSM sexually active with cisgender men, is required to
better understand HIV risk and vulnerability in this group. In the context of a perceived increase
in sexual mixing with cisgender MSM,13,31 identifying and intervening on predictors of sexual
risk behavior among T-GBMSM is particularly timely.
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4

Chapter 4: Heavy episodic drinking among transgender persons:
Disparities and predictors1

4.1

Introduction

Hazardous alcohol consumption contributes substantially to the global burden of morbidity and
mortality.1 Negative health consequences of alcohol use disproportionately impact poor and
socially marginalized groups,1 some of whom (e.g., sexual minorities2) also have higher rates of
disordered and non-disordered use. Less is known about alcohol use among transgender (trans)
people, those with a gender identity that differs from their birth-assigned sex. Trans people
represent an estimated 0.6% of the adult population in the United States.3 In a random sample of
substance use research published in 2007 and 2012, only 1.3% of articles reported data on
transgender identities.4 Population-based estimates of alcohol use are particularly scarce due to
the lack of measures to identify trans respondents in most population health surveys.
Understanding of the epidemiology of alcohol use among trans people is further challenged by
the limited and non-validated substance use measures often included in trans surveys, and
absence of comparison groups.5
Much trans substance use research has focused on urban trans women living with or at high risk
for HIV, who frequently report heavy alcohol use.6,7 Findings from broader trans populations in
the United States have been more mixed. In a population-based sample of Massachusetts adults
including 131 transgender persons, no difference was found in the prevalence of past-month
heavy episodic drinking (HED) by transgender status.8 Other studies have been limited to
national samples of U.S. adolescents and college students. Reisner and colleagues9 found that
trans youth reported higher past-year alcohol use than their cisgender (non-trans) peers, while
Coulter et al.10 found that trans students were less likely to report HED than cisgender (nontrans) males, but had a greater number of recent HED days.

1

A version of this chapter has been published: Scheim AI, Bauer GR, Shokoohi M. Heavy episodic drinking among
transgender persons: Disparities and predictors. Drug Alcohol Depend. 2016; 167: 156-162.
doi:10.1016/j.drugalcdep.2016.08.011
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Disparities in alcohol misuse between cisgender and trans populations may be mediated by social
stigma.9 Associations between stigma and alcohol misuse are well-documented in non-trans
minority populations.2 Among trans people, problematic substance use has been conceptualized
as a consequence of minority stress processes that result from a stigmatizing social environment.
These processes include external, stigma-related stressors (e.g., violence), anticipation of such
stressors, internalized stigma, and concealment of gender identity.11,12 For example, violence and
discrimination have been associated with increased risk of problematic alcohol use.6,10,13,14
Trans people face systemic barriers to employment, and may rely on sex work for income.15
Trans sex workers have reported higher levels of substance use than other trans people,5,6
perhaps due to greater minority stress,6 exposure to violence, and social network norms.15 In
addition to enacted stigma in adulthood, sexual and gender minority populations
disproportionately experience childhood sexual abuse. Such abuse is linked to increased risk of
problematic alcohol use later in life.16 However, while most trans people encounter some degree
of stigma, negative coping responses are by no means inevitable. Potentially protective factors
against alcohol misuse include family support.17
Gender transition, including social, medical, psychological, and legal processes of gender
affirmation,18 is associated with improved mental health for trans people19 and could also be
protective against alcohol misuse. However, findings regarding gender transition and alcohol use
have been inconsistent, which may reflect countervailing impacts of heightened exposure to
stigma resulting from transition. Among trans women in San Francisco, hormone therapy and
breast augmentation were associated with lower odds of past-year HED.20 Conversely, in a
cohort of trans women in New York, heavy alcohol use was higher among those living full-time
as women or taking hormones.6
In summary, findings regarding both disparities and predictors of HED in trans communities
have been somewhat inconsistent. To date, no published research has investigated alcohol use
among trans people in Canada, where the social and health context for trans people varies from
the United States by virtue of greater human rights protections and a universal health care
system. The objectives of the current study were (1) to describe the prevalence of HED among
trans people in Ontario, Canada; (2) to compare HED prevalence to the age-standardized
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cisgender population of Ontario; and (3) to assess the impacts of socio-demographic
characteristics, gender transition, and social exclusion (e.g., discrimination) on HED.

4.2

Methods

4.2.1 Transgender study population
The Trans PULSE community-based participatory research project recruited 433 trans Ontarians
via respondent-driven sampling (RDS) in 2009-2010, including 404 who completed alcohol use
measures. Eligible participants needed to be 16 years of age or older; live, work, or receive
health care in Ontario; and indicate that they identified as transgender, transsexual, or
transitioned. This definition included individuals who identified as genderqueer or another nonbinary gender identity, and participants were not required to have undergone any social or
medical gender transition.
RDS is a chain-referral sampling and analysis method for hidden populations.21 Beginning with
16 participants (commonly referred to as seeds) selected for maximum diversity, each respondent
was provided with three tracked recruitment coupons for recruiting their peers. Twenty-two
additional seeds were added after 4-5 waves of recruitment. Maximum chain length was ten
waves beyond the seeds. Respondents completed a 60-90-minute survey online or by visuallyidentical paper copy. They were compensated with a $20 gift card, or could opt to donate the
honorarium to a trans-related charity. Secondary incentives for recruitment of peers ($5 gift
cards) were added in the final months of the study, with no perceptible impact on recruitment.
Research ethics boards at The University of Western Ontario and Wilfrid Laurier University
approved this study. Research procedures and demographic characteristics pertaining to the
Trans PULSE study population have been described in greater detail previously.22

4.2.2 Cisgender study population
A portion of this analysis used data from the Canadian Community Health Survey (CCHS) from
Ontarians aged 16+ (n=39,980). The 2009-2010 data cycles were used to match the time of
recruitment of Trans PULSE data. CCHS is an ongoing cross-sectional survey of Canadians aged
12 and above employing a multi-stage, stratified, cluster sampling approach, with coverage of
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over 97% of the Canadian population (excluding institutionalized persons and those living on
First Nations reserves). Additional information about the survey methodology is available from
Statistics Canada.23 CCHS estimates describe the assumed cisgender population because the
survey did not include measures to identify trans respondents. Under the reasonable assumption
that the population prevalence of trans people in Ontario, Canada is relatively similar to that of
the United States (about 0.6%3), the inclusion of trans persons within the assumed cisgender
comparison group would not have a significant impact on results.

4.2.3 Measures
Heavy episodic drinking. Trans PULSE and CCHS participants were asked how often they
consumed five or more alcoholic drinks on one occasion in the past year. Response options
ranged from “never” to “more than once a week”. For comparisons between the two populations
and regression analyses, HED was defined as reporting consuming five or more alcoholic drinks
on one occasion at least monthly in the past year.
Sociodemographic factors. Socio-demographic characteristics included age, gender spectrum
(transfeminine or transmasculine, i.e. natal male or female respectively, including those who
identify as neither men nor women), Toronto residence (Ontario’s capital and largest urban
center, based on postal code), ethno-racial group (Aboriginal, white, or non-Aboriginal person of
color), educational attainment, and sexual minority identity (coded as yes if the respondent
endorsed any non-heterosexual identity). Reported childhood physical or sexual abuse was
included as a background factor.
Transition. Participants indicated how often they lived in their felt gender (dichotomized as fulltime versus part-time or less) and described their medical transition status as not planning,
unsure, or not applicable; planning but not begun; in process; or complete based on selfperceived needs.
Social exclusion and inclusion, sex work, and depression. The research team developed an 11item scale measuring the frequency of lifetime experiences of both external and internalized antitrans discrimination,24 adapted from a measure of homophobia.25, Other social exclusion and
inclusion variables included lifetime experience of physical or sexual assault related to being
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trans (yes versus no), Medical Outcomes Study social support scale26 scores (Cronbach’s a in
our data=0.97), employment status (full-time, part-time, student, or other), and low income status
(Statistics Canada low-income cut-off; LICO27). Underhousing was defined as current
homelessness, living in substandard or temporary housing, or trouble meeting housing costs in
combination with household income below the LICO. Perceived or expected parental support for
gender identity or expression was dichotomized as strongly supportive versus not. Both lifetime
and current sex work were assessed in the questionnaire, and the latter was included in this
analysis. Depressive symptoms were measured with the Center for Epidemiological Studies
Depression scale28 (Cronbach’s a= 0.93).

4.2.4 Statistical analysis
Weighted frequencies and their associated 95% confidence intervals (CIs) for Ontario’s
networked trans population were calculated in SAS version 9.4.29 RDS II weights were
employed, which are estimated as the inverse of the number of target population members
known, rescaled to sum to the sample size.30 These weights adjust for unequal recruitment
probabilities due to personal network size, generating estimates for the networked target
population. CIs were estimated using Taylor series linearization and variances were adjusted for
clustering by shared recruiter to account for non-independence within recruitment chains.31
For comparison with the trans population frequencies, overall and sex-specific past-year
weighted prevalence estimates for HED among Ontarians aged 16+ (CCHS data) were directly
standardized to the overall and gender-spectrum-specific age distributions of trans Ontarians. Six
age categories were employed: 16-24, 25-34, 35-44, 45-54, 55-64, and 65+. This method
(Giblon and Bauer, in preparation) enables comparisons of trans population prevalence with
expected prevalence in the general population, were its age distribution to match the younger age
distribution of the trans population, which is particularly pronounced among transmasculine
persons.22 We did not standardize for (assigned) sex, as proportions within the Trans PULSE
data were equivalent to the Ontario population. Comparisons of HED prevalence were made
between each gender spectrum and both (assumed cisgender) males and females in the broader
Ontario population (i.e., by both natal sex and group most closely aligned with current gender
identity), as alcohol misuse may have both biological and social components.
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Standardized prevalence differences (SPDs) were estimated by subtracting the expected
prevalences (age-adjusted from CCHS data) from observed prevalences of HED in the trans
population. Confidence intervals for differences between proportions were constructed from CIs
for single proportions using the Method of Variance Estimates Recovery.32 The basic idea is to
recover variance estimates needed for setting confidence limits for differences from CIs for
single proportions. The resulting CIs for difference provide a means of testing for statistically
significant differences between RDS-weighted proportions- for which standard statistical tests
are inappropriate,22,33 as well as proportions arising from different data structures. By definition,
values contained in a 95% CI will be not be rejected at the 5% significance level. Therefore, we
can conclude a difference in proportions is statistically different from zero at the 5% significance
level whenever the 95% CI for the difference excludes 0.
Weighted logistic regression models were used to estimate prevalence ratios (PRs) via average
marginal predictions34 in SAS-callable SUDAAN version 11.35 Age and scale scores were
entered into regression models as continuous, but PRs are presented as comparisons of reference
values, as required for their estimation. After estimating bivariate associations for all covariates,
a multivariable socio-demographic model was fit to estimate adjusted prevalence ratios (APRs)
for socio-demographic correlates. Next, a blockwise procedure was employed to fit multivariable
models for other covariates of interest, adjusting for age and socio-demographic factors
significant at p<.05 in the multivariable socio-demographic model. Blocks of variables related to
transition, social exclusion/inclusion, sex work, and depression were entered in turn. For
parsimony, variables were only retained in subsequent modeling steps if their p-value from a
Wald F-test was <0.25. This modeling approach aimed (a) to account for temporal ordering to
the extent possible with cross-sectional data and to control for non-modifiable demographic
characteristics, (b) to avoid inappropriate adjustment for mediators, and (c) to assess the impacts
of social exclusion above and beyond those of gender transition. Analyses were repeated with
stratification by gender spectrum, but results did not substantively differ, and thus only analyses
for the full sample are reported.
Of the 404 participants who completed alcohol use measures, seven were excluded from
regression analyses because they were missing data on more than 20% of covariates. Participants
excluded due to missing data were not significantly different than other participants with respect
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to the sociodemographic variables included in this analysis. For multivariable analyses only,
simple imputation of the median, mean, or mode was used to avoid participant loss in a complete
case analysis. Less than 2% of data were missing for all but three variables included in this
analysis; no variables were missing more than 10% of data.

4.3

Results

4.3.1 Prevalence of heavy episodic drinking
Approximately one-third of trans Ontarians reported heavy episodic drinking at least monthly in
the past year (33.2%, 95% CI: 26.3, 40.1), including 10.9% (95% CI: 5.8, 16.1) who engaged in
HED weekly or more. As shown in Figure 4.1, this estimated prevalence of HED at least
monthly was 1.5 times greater than the prevalence expected based on the age-standardized
assumed cisgender population of Ontario (21.9%, 95% CI: 21.1, 22.7), with 11.3% of trans
persons reporting HED beyond what would be expected (SPD=11.3%; 95% CI: 4.4, 18.2;
p=.001).
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Figure 4.1: Past-year heavy episodic drinking at least monthly among transgender
Ontarians and the age-standardized Ontario population, 2009-2010.

Note: Error bars indicate 95% confidence intervals.

By gender spectrum, 22.7% (95% CI: 13.5, 32.0) of transfeminine persons and 42.2% (95% CI:
32.3, 52.1) of transmasculine persons reported HED at least monthly, a prevalence difference of
19.5% (95% CI: 5.9, 33.0; p=.005). This difference was attributable to higher levels of
occasional binge drinking (one to three times per month) among transmasculine persons (31.1%
versus 12.0%); equal proportions of transmasculine and transfeminine persons reported heavy
drinking once a week or more (11.1% and 10.8% respectively). Transfeminine persons had a
higher HED prevalence than female (SPD=10.1%; 95% CI: 0.9, 19.5; p=.033), but not male
Ontarians (SPD= -6.4%; 95% CI: -15.7, 2.9; p=.177), age-standardized to the transfeminine age
distribution. Transmasculine persons were 2.7 times more likely to report HED than the agestandardized female population (SPD= 26.5%; 95% CI: 16.5, 36.5; p<.000). In addition, the
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higher HED prevalence among transmasculine individuals as compared to Ontario males
approached statistical significance (SPD= 9.8%; 95% CI: -0.2, 19.8; p=.055).

4.3.2 Trans population characteristics and associations with HED
Weighted frequencies for socio-demographic characteristics and their bivariate and adjusted
associations with HED are displayed in Table 4.1. In crude and adjusted sociodemographic
models, transmasculine gender remained associated with greater HED (APR= 1.82; 95% CI:
1.09, 3.06). No other sociodemographic characteristics were associated with HED.
Table 4.1: Weighted socio-demographic characteristics of transgender people in Ontario,
Canada and associations with heavy episodic drinking (n=397)
Weighted
frequencies

% or (95% CI)
mean
Age (years)b
30 versus 20 years old
40 versus 20 years old
Transmasculine
spectrum
Toronto residence
Race/ethnicity
White
Aboriginal
Non-Aboriginal person
of color
Childhood abuse
Education
Less than high school
High school diploma
Some college/university
College or university
Sexual minority

Heavy episodic drinking
Prevalence ratio
(bivariate)
PR

(95% CI)

Adjusted prevalence
ratioa
PR

(95% CI)

0.88
0.76

(0.72, 1.07) 0.98
(0.50, 1.16) 0.95

(0.81, 1.17)
(0.66, 1.37)

32.5
---

(30.3, 34.7)

55.5
38.8

(47.6, 63.4)
(30.9, 46.6)

1.93**
1.34

(1.19, 3.13) 1.82* (1.09, 3.06)
(0.88, 2.03) 1.39 (0.92, 2.11)

77.6
6.5
15.9

(71.5, 83.7)
(3.2, 9.8)
(10.5, 21.3)

1.00
0.60
0.72

1.00
(0.22, 1.60) 0.63
(0.36, 1.44) 0.58

(0.24, 1.62)
(0.29, 1.15)

70.0

(62.8, 77.1)

0.89

(0.56, 1.42) 0.89

(0.58, 1.35)

11.5
16.1
27.1
45.3
64.3

(6.8, 16.1)
(10.4, 21.8)
(20.1, 34.1)
(37.6, 53.0)
(56.5, 72.1)

1.95
1.17
1.52
1.00
0.77

(1.09, 3.49) 1.60
(0.58, 2.36) 0.91
(0.92, 2.53) 1.53
1.00
(0.50, 1.18) 0.75

(0.90, 2.84)
(0.46, 1.78)
(0.98, 2.38)
(0.52, 1.09)

*= p<.05, **= p≤.001 for Wald F-test
a

Adjusted for all other variables in the table; Nagelkerke R2=0.15

b

Modeled as continuous in logistic regression, reference levels required for presentation of prevalence ratios.
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Weighted frequencies for potential predictors of HED and their bivariate associations are
presented in Table 4.2, while results of blockwise regression analyses are presented in Table 4.3.
All multivariable models in Table 4.3 were adjusted for age and gender spectrum. Across models
1-4, the magnitude and statistical significance of the APR for gender spectrum varied little from
the initial adjusted value in Table 4.1 (results not shown; APRs ranged from 1.70-1.87, p-values
from .01-.03). This indicates that gender variation in heavy episodic drinking was not attributable
to differences in transition and social exclusion between gender spectra. In crude and adjusted
analyses, current sex workers had an approximately two-fold higher HED prevalence (APR in
final model=2.19, 95% CI: 1.36, 3.55). Neither transition status nor social exclusion/inclusion
variables were associated with HED.
Table 4.2: Weighted frequencies and bivariate associations for potential predictors of
heavy episodic drinking among transgender people in Ontario, Canada (n=397)
Weighted
frequencies

Living full-time in felt
gender
Medical transition status
Complete
In process
Planning but not begun
Not planning, unsure, N/A
Transphobia
Mean (range=0-33)
75th versus 25th percentile
Transphobic assault
Social support
Mean (range=0-5)
75th versus 25th percentile
Strong parental support
for gender
Below low income cut-off
Employment status
Full time
Part time

Prevalence ratio
(bivariate)

% or
(95% CI)
mean
51.9 (43.5, 60.3)

PR

(95% CI)

1.04

(0.69, 1.57)

27.0
24.3
28.5
20.2

(20.4, 33.7)
(18.1, 30.5)
(21.1, 35.9)
(13.1, 27.2)

1.00
0.93
1.46
0.85

(0.51, 1.72)
(0.87, 2.44)
(0.41, 1.75)

13.8
-20.3

(12.8, 14.8)

-0.89
1.36

-(0.65, 1.22)
(0.87, 2.12)

3.5
-24.7

(3.3, 3.7)
(18.5, 30.9)

-0.97
0.86

-(0.70, 1.36)
(0.50, 1.49)

43.7

(35.7, 51.7)

1.31

(0.81, 2.11)

34.7
15.8

(27.9, 41.4)
(10.3, 21.3)

1.00
1.03

(0.53, 2.00)

(14.5, 26.1)
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Student
27.5
Other
22.1
Underhoused or homeless 17.4

(20.5, 34.5)
(15.3, 28.8)
(11.5, 23.3)

0.94
0.84
1.26

Current sex work
Depressive symptoms
Mean (range=0-60)
75th versus 25th percentile

2.2

(0.0, 4.6)

2.36* (1.33, 4.18)

23.2
--

(20.9, 25.4)

-1.19

.
*= p<.05, **= p≤.001 for Wald F-test

(0.53, 1.66)
(0.42, 1.70)
(0.75, 2.11)

-(0.85, 1.65)
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Table 4.3: Blockwise logistic regression predicting past-year heavy episodic drinking among transgender people in Ontario,
Canada (n=397)

Living full-time in felt gender
Medical transition status
Complete
In process
Planning but not begun
Not planning, unsure, N/A
Transphobia: 75th vs. 25th percentile
Transphobic assault
Social support: 75th vs. 25th percentile
Strong parental support for gender

Model 1b
PR
(95% CI)
†
1.09 (0.65, 1.83)
1.00†
1.02
1.37
0.95

Adjusted prevalence ratiosa
Model 2
Model 3
PR
(95% CI)
PR
(95% CI)
-----

(0.56, 1.84)
-(0.74, 2.54)
(0.43, 2.09)
-0.80
-1.45
---

--

--

--

0.84†
1.36

0.90† (0.65, 1.26)

--

--

--

--

---

---

---

---

--

--

--

--

--

--

--

--

†

(0.54, 1.49)

1.18

†

(0.70, 1.97)

1.00†
0.94
0.78
0.81
1.19†

(0.52, 1.69)
(0.45, 1.38)
(0.42, 1.56)
(0.69, 2.04)

0.89

--

Employment status
Full time
Part time
Student
Other
Underhoused or homeless

--

Current sex work
Depressive symptoms: 75th vs. 25th
percentile
Nagelkerke R2

---

---

0.07

0.10

a

--

(0.57, 1.13)
(0.97, 2.15)

Below low income cut-off

--

--

Model 4
PR
(95% CI)
---

2.19*

(0.61, 1.16)
-(0.89, 2.09) 1.15

(1.33, 3.60) 2.19*
-1.16
0.08

-(0.76, 1.74)

(1.33, 3.61)
(0.86, 1.57)
0.09

All models control for age and gender spectrum. b Model 1=gender transition; Model 2= social exclusion/inclusion factors added; Model 3= sex work added;
Model 4=depressive symptoms added.
†
p>.25, not included in subsequent models. *= p<.05, **= p≤.001 for Wald F-test.
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4.4

Discussion

Despite the well-established public health impacts of alcohol use in Canada and the United
States, and well-documented burden of alcohol misuse in marginalized populations, little
research has addressed alcohol use among transgender adults. Drawing on data generalizable to
the networked trans population of Canada’s most populous province, we found that the estimated
prevalence of HED monthly or more (33.2%) exceeded what would be expected based on the age
distribution of trans Ontarians, particularly in comparison to the background female population.
With the exceptions of transmasculine gender identity and sex work, sociodemographic
characteristics, gender transition, and social exclusion factors were not associated with HED.
Transmasculine persons were more likely than transfeminine persons to engage in heavy
episodic drinking at least monthly, and this effect was robust to adjustment for all other
covariates in the regression models. Their HED prevalence far exceeded the age-standardized
female population of Ontario, and was almost significantly higher than that of age-standardized
males. This provocative finding indicates need for increased attention to the health behaviours of
transmasculine persons, which have arguably been overshadowed to date by research and
programmatic emphasis on substance use as it relates to HIV risk. The roles of gender
expectations and beliefs on alcohol use and misuse among transmasculine persons are
particularly worthy of further exploration. In the broader population, sex differences in alcohol
use, misuse, and dependence have declined over time, but remain evident.36 These shrinking sex
differences in alcohol behaviors are hypothesized to relate to shifting social norms related to
gender, and indicate that greater susceptibility to alcohol misuse among cisgender males cannot
be solely attributed to biological factors. Our findings similarly indicate that gender identity and
lived gender play a large role in alcohol misuse among trans people.
That gender disparities in the cisgender population are larger for heavy drinking behavior than
for alcohol abuse or dependence36 may help to explain our finding of no gender spectrum
difference in the prevalence of frequent HED (weekly or more). Occasional HED among
transmasculine persons may be influenced by sociocultural beliefs that equate excessive drinking
behaviour with masculinity, or alcohol use may represent a stress-coping response that is
relatively socially normative for transmasculine persons.
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Estimated HED prevalence among transfeminine Ontarians fell between that of the age-adjusted
cisgender female and male populations, and was only significantly different from the female
population prevalence. Regardless of whether alcohol use patterns are attributed to natal sex or
gender socialization, we might expect transfeminine persons to demonstrate greater HED
prevalence than cisgender females. The observed disparity may not, therefore, be indicative of a
health inequity.
With respect to other sociodemographic characteristics, age was, unexpectedly, not significantly
associated with HED within the trans population. As has been shown for sexual minorities,37
age-related declines in substance use may be less steep among trans people and therefore
difficult to detect in this relatively young sample. We also did not find evidence for an effect of
minority stress on HED, despite the frequency with which participants encountered transphobia,
violence, and social exclusion. As some degree of exposure to transphobia is ubiquitous among
trans people, we cannot conclude that minority stress does not play a role in hazardous alcohol
use in this trans population. Self-reported stigma and discrimination may not contribute to intrapopulation variation in alcohol misuse within the trans population, yet exposure to socialstructural transphobia could account for the inter-population disparities we have identified.
Finally, consistent with previous research among cisgender and transgender sex workers,15 we
found that current sex work was associated with HED, despite the low frequency of sex work in
this population (2.2% were current sex workers22). The small number of sex workers in our study
precludes exploration of specific contributors to alcohol use for this population; however,
drinking may represent a coping strategy in response to sex-work-specific stressors and one that
is normative within some sex workplace cultures.38

4.4.1 Strengths and limitations
The Trans PULSE survey employed validated alcohol use measures, including an HED measure
directly comparable with Statistics Canada data for the same time period. Our novel use of agestandardized comparison data from the Canadian Community Health Survey overcame a
consistent limitation of transgender health research, in which appropriate comparison groups are
often lacking. Considering that trans people (particularly transmasculine persons) are younger
than the background population, comparison of unstandardized prevalence can be misleading.
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Bias can be compounded by comparison of population-based survey findings to results of urban,
high-risk convenience samples that characterize many transgender substance use studies. In
contrast, these data were obtained from across the one province that contains two-fifths of
Canada’s population. Demographic characteristics largely mirrored the background population,
with the exception of younger age and lower incomes.22
Nevertheless, some limitations should be noted. CCHS data were standardized to RDS-weighted
point estimates for the age distributions of trans Ontarians. Were trans status ascertained in the
Canadian census, such census data would be preferable for standardization. However, given that
we employed standardization to make comparisons to the same population that gave rise to the
estimates, this limitation is unlikely to affect results. In addition, while these RDS II analyses
account for bias related to personal network size, other sampling biases may persist. Homophily,
the tendency to know and recruit like others, is of concern in chain-referral sampling, and
alternative RDS estimators explicitly adjust for homophily in recruitment. However, previous
unpublished sensitivity analyses with this data set revealed that with the exception of geographic
variables, results were not impacted substantially by the choice of estimator. Ultimately, while
respondent-driven sampling represents an improvement over convenience sampling, inclusion of
questions to capture transgender status in population-based surveys will be necessary to
overcome these limitations.

4.4.2 Conclusion
We identified disparities in heavy episodic drinking between transgender and cisgender residents
of Canada’s most populous province, which were particularly pronounced for transmasculine
persons. These results should stimulate development of public health interventions and further
research to address alcohol use among transmasculine persons.
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5

Chapter 5: Drug use among transgender people in Ontario, Canada1

5.1

Introduction

Transgender (trans) persons are those with a gender identity that differs from their birth-assigned
sex, including individuals who are transfeminine (male birth-assigned sex with female or
feminine gender identity) or transmasculine (female birth-assigned sex with male or masculine
gender identity). Although population size estimates are not available for Canada, data from the
United States indicate that trans persons constitute an estimated 0.6% of the adult population.1
Trans people continue to experience profound social stigma and exclusion, which contribute to
institutional and interpersonal discrimination, violence, limited health care access, and
internalization of anti-transgender attitudes.2-5 Little substance use research has explicitly
included trans persons,6 and quantitative data on substance use among trans persons in Canada
have been unavailable. However, limited existing evidence and the theory of minority stress7-10
suggest that trans populations experience disparities in drug use related to social stigma and
discrimination. Disparities in drug use may also be related to gender dysphoria, or psychological
distress caused by lack of alignment between one’s physical sex characteristics and gender
identity.
Research to date on substance use in trans populations has primarily focused on urban
transfeminine persons living with or at high risk of acquiring HIV, finding high levels of cocaine
and methamphetamine use.11-13 However, samples from HIV prevention studies are
representative of the broader transfeminine population in Ontario, among whom HIV risk is low
overall.14 Moreover, drug use is an important outcome in its own right, irrespective of its
association with sexually-transmitted HIV, given substantial impacts on morbidity and mortality
related to mental health, suicide, and infectious disease.15 In addition, a respondent-driven

1

A version of this chapter has been published: Scheim AI, Bauer GR, Shokoohi M. Drug use among transgender
people in Ontario, Canada: disparities and associations with social exclusion. Addict Behav. 2017; 72: 151-158.
http://doi.org/10.1016/j.addbeh.2017.03.022
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sampling survey (n=433) in Ontario, Canada, found that transmasculine persons had a higher
prevalence of binge drinking than their transfeminine counterparts.16 These facts underscore the
need to examine substance use in broader trans populations, inclusive of multiple gender
identities.
Data from mixed-gender convenience samples of trans adults indicate that drug use in these
samples is lower than in HIV prevention research settings, but potentially higher than in the
broader population. For example, one in five participants to a Massachusetts trans survey
reported any past-year non-cannabis illicit drug use,17 while one in ten participants to an online
survey of trans people in the United States reported any such drug use in the past three months.18
In comparison, non-cannabis illicit drug use was reported by approximately 2% of all Canadians
aged 15+ over the past year19 and 3% of all Americans aged 12+ over the past month20 in 2013.
Few data are available from high-income country settings outside the United States. However, in
a report from an Australian trans convenience sample, 29% reported past-year illicit drug use
(including cannabis).21
Discrimination and social exclusion have been associated with substance use among trans
persons, and may partially account for the higher levels of use observed. For example, studies in
the United States found that reported anti-transgender discrimination22,23 and violence11,24
predicted increased drug use among transfeminine adults. Depression, as a consequence of
exposure to discrimination, may mediate the association with drug use.11 Socio-economic
marginalization (e.g., unemployment, poverty), which is common in trans populations,25,26 is
associated with drug use in the broader population.27,28 In a context of barriers to formal
employment, trans people report high levels of sex work involvement,29 and sex work has in turn
been associated with greater drug use in trans samples.11,17 Conversely, social inclusion may be
protective against substance use within trans populations. For instance, family support has been
identified as a predictor of lower substance use among trans persons and sexual minority
individuals.30,31
In addition to discrimination and social exclusion, gender dysphoria may potentiate substance
use as a coping strategy. By alleviating gender dysphoria, medical gender transition through
hormones and/or surgery may contribute to improved mental health32 and reduced substance use.
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However, gender transition may also increase exposure to minority stressors. Findings on the
association between medical transition and substance use have been mixed, with one study of
trans women in San Francisco finding lower drug use among those who have taken hormones
and/or had surgery,33 and another in New York finding the opposite.11
The present study draws on data from a respondent-driven sampling survey of 433 trans people
in Ontario, Canada’s most populous province, and from the Canadian Community Health
Survey. We sought to compare past-year use of select substances (cocaine or crack and
amphetamines, based on data availability) to the age-standardized cisgender male and female
population of Ontario, hypothesizing that past-year prevalence would be higher among trans
persons overall. Considering that drug use may be impacted both by biological sex and social
gender, we did not have a priori hypotheses regarding transgender-cisgender disparities by
gender identity.
Next, we built exploratory blockwise regression models to evaluate the impacts of sociodemographic characteristics, gender transition, and discrimination or social exclusion factors on
past-year use of drugs associated with high risk of physical, psychological, and social harm to
users. Considering potential inter-relationships between discrimination and both sex work and
depression, these were included as covariates. We hypothesized that indicators of discrimination
and exclusion (transphobia, transphobic violence, lower social support, lack of parental support
for gender, lack of employment, low income, and underhousing or homelessness), sex work, and
depressive symptoms would be associated with higher prevalence of drug use.

5.2

Methods

5.2.1 Transgender study population
The Trans PULSE community-based participatory research project recruited 433 trans Ontarians
via respondent-driven sampling (RDS) in 2009–2010, including 406 who completed substance
use measures. Eligible participants needed to be 16 years of age or older; live, work, or receive
health care in Ontario; and consider themselves trans, based on self-identification. Participants
were not required to have undergone any social or medical gender transition. RDS is a chain-
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referral sampling and analysis method developed for stigmatized populations lacking appropriate
sampling frames.34
Recruitment began with 16 seed participants selected for demographic diversity. Each
respondent was provided with three tracked coupons for recruiting their peers. Twenty-two
additional seeds were added after 4-5 waves of recruitment, and data collection continued until a
maximum of 10 recruitment waves were obtained. Respondents completed the 60-90-minute
questionnaire online or by visually identical paper copy. They were compensated with a $20 gift
card, or could opt to donate the honorarium to a trans-related charity. Secondary incentives for
recruitment of peers ($5 gift cards) were only offered in the final months of the study, and had no
detectable impact on recruitment rates. The study received approval from Research Ethics
Boards at The University of Western Ontario and Wilfrid Laurier University. Additional
information about the Trans PULSE study has been published previously.25

5.2.2 Cisgender study population
Data on the prevalence of past-year cocaine or amphetamine use among Ontarians aged 16 and
above (n = 39,980) were obtained from the 2009-2010 data cycles of the Canadian Community
Health Survey (CCHS). Data on Trans PULSE-comparable items regarding use of other drugs
(e.g., heroin) were not made available by Statistics Canada due to small cell sizes. CCHS is an
annual multi-stage, stratified, cluster sampling cross-sectional survey of Canadians aged 12 and
above employing both computer-assisted personal and telephone interviews. CCHS covers over
97% of the Canadian population, excluding institutionalized persons and those living on First
Nations reserves. Additional information about CCHS methodology has been previously
published online.35 Measures to identify trans respondents are not currently included in CCHS,
and therefore we have assumed respondents to be cisgender. Applying national U.S. estimates,1
we would expect approximately 0.6% of this cisgender comparison group to be misclassified,
with no anticipated substantive impact on results.

5.2.3 Measures
Past-year cocaine and amphetamine use. Separate CCHS items asked about use of “cocaine or
crack” or “speed (amphetamines)” over the past year. Trans PULSE participants were provided
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with a list of illicit substances and asked to indicate which they had used in the past year.
Amphetamines were defined differently in the two surveys: in Trans PULSE use of crystal
methamphetamine and “other amphetamines” were queried separately, while CCHS participants
were only asked to report use of “speed (amphetamines)”. To be conservative (as CCHS
respondents may not have reported crystal methamphetamine use when asked about “speed”),
only reported use of “other amphetamines” in Trans PULSE data was compared to reported
amphetamine use in CCHS data, excluding crystal methamphetamine.
Past-year higher-risk drug use. A binary variable indicating any past-year drug use was created
for regression analyses with Trans PULSE data. Given that an indicator of frequency or severity
of use was not available, we limited attention to drugs posing significant risk of physical,
psychological, and social harm to the user, based on Nutt et al.’s multi-criteria decision
analysis.36 Evaluation criteria for their ranking of user-side harms included drug- specific and
drug-related mortality, morbidity, and mental impairment; risk of dependence; loss of tangibles
(including criminal justice involvement); and loss of relationships. While not included in the
ranking by Nutt et al., non-medical use of prescription opioids is a major source of drug-related
morbidity and mortality in Canada (e.g., related to overdose).37 Therefore, respondents were
coded as engaging in higher-risk drug use if they reported any past year use of heroin, cocaine
(crack or powder), crystal methamphetamine, other amphetamines, GHB, ketamine, or
prescription narcotics not prescribed by a physician. Drug types queried in our survey but
excluded from this outcome definition were cannabis, poppers (alkyl nitrites), hallucinogens, and
ecstasy/MDMA.
Personal network size. For RDS weighting, Trans PULSE participants were asked “How many
other people do you personally know who could answer yes to all three eligibility questions?”
These questions were the eligibility criteria listed above.
Covariates. Socio-demographic and background characteristics included age, gender identity
(transfeminine or transmasculine), ethno-racial group (Indigenous, white, or person of color),
residence in Toronto (Ontario’s capital and major urban center), report of childhood physical or
sexual abuse, educational attainment (dichotomized as high school completion or less, versus any
post-secondary education), and sexual minority identity. Gender transition variables were social
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transition (living in felt gender full-time, versus part-time or less) and medical transition. The
latter was self-reported as complete; in process; planning but not begun; or not planning, unsure,
or not applicable.
Social stigma and exclusion factors included transphobia, operationalized with an 11-item scale
of enacted and internalized transphobia (anti-transgender stigma; Cronbach’s α =0.813) and an
indicator of experiencing transphobic physical or sexual violence, both over a lifetime frame.
Social support was measured with the Medical Outcomes Study scale38 (Cronbach’s α in our
data=0.97). Participants reported whether a range of important people in their lives were
supportive of their gender identity or expression, or anticipated to be supportive if disclosure had
not taken place. Given evidence for a unique impact of strong parental support,32 a dichotomous
measure of strong parental support (versus moderate or weak support) was included. Other
factors indicating social exclusion were current employment status, low income status (below the
Statistics Canada low income cut-off 39), and homelessness or underhousing (defined as living in
temporary or substandard housing, or having low income in combination with trouble meeting
housing costs). Current sex work was self-reported in response to a question about current
sources of paid work. Finally, past-week depressive symptoms were measured with the Center
for Epidemiological Studies scale40 (Cronbach’s a in our data= 0.93).

5.2.4 Statistical analysis
To adjust for unequal recruitment probabilities, Trans PULSE data were analyzed with RDS II
weights, which are estimated as the inverse of network size, rescaled to sum to the sample size.41
Estimates are thus for the networked trans population in Ontario. Weighted frequencies and their
95% confidence intervals were calculated in SAS version 9.3,42 employing Taylor series
linearization and adjusting variances for clustering by shared recruiter.43 Comparisons with
CCHS data on the prevalence of past-year cocaine and amphetamine use were made by directly
standardizing overall and sex-specific weighted estimates for Ontarians aged 16+ to the overall
and gender-identity-specific age distributions of trans Ontarians. Six age categories were
employed: 16–24, 25–34, 35–44, 45–54, 55–64, and 65+. Comparisons were made by both birthassigned sex and current gender identity (i.e., between both gender identity groups and both
males and females in the broader Ontario population). This method has been used and described
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previously to compare the prevalence of heavy episodic drinking among transgender versus
cisgender Ontarians,16 while accounting for the substantially younger age distribution of the
transgender population. Standardized prevalence differences (SPDs) were estimated by
subtracting the age-standardized CCHS prevalence from observed prevalence in the trans
population. This can be interpreted as the excess prevalence in the trans population as compared
to what would be expected of the cisgender population, if the populations had the same age
distribution. Confidence intervals around the SPD were constructed using the Method of
Variance Estimates Recovery44 to allow for comparison given the different structures of the two
data sources. Differences in proportions are significant at p < 0.05 where the CI around the SPD
excludes 0.
Predictors of higher-risk drug use were examined using Trans PULSE data. Prevalence ratios
were estimated using average marginal predictions45 from weighted logistic regression models in
SAS-callable SUDAAN.46 Bivariate associations were estimated for all covariates. Next,
adjusted prevalence ratios (APRs) were estimated for socio-demographic and background
factors. Finally, a series of blockwise multivariable models were fit, with variables entered in the
following order: (1) gender transition, (2) social stigma and exclusion, (3) sex work, and (4)
depressive symptoms. This exploratory modeling approach was intended to account for temporal
ordering to the extent possible with cross-sectional data, and to assess the impacts of social
exclusion factors while adjusting for gender transition. Each model was adjusted for age and for
socio-demographic or background factors independently associated with the outcome at p<0.10
(ethno-racial group, Toronto residence, and childhood abuse). For each block, all variables were
entered simultaneously. Variables were excluded from the following modeling step only if their
p-value (for a Wald test in the multivariable model) was >0.25.47 Results of analyses stratified by
gender identity did not substantively differ and thus only analyses for the full sample are
reported.
All available outcome data (n=406) were used to generate prevalence estimates in Table 1. For
regression analyses, respondents were excluded if they were missing data on more than 20% of
covariates (n=7), resulting in an analytic sample of 399.
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5.3

Results

5.3.1 Drug use frequencies in the transgender population
As shown in Table 5.1, an estimated 12.3% (95% CI: 7.7, 17.0) of trans Ontarians had used at
least one higher-risk drug in the past year, with no significant difference detected by gender
identity. Powder cocaine was the most frequently reported drug (7.3%; 95% CI: 3.3, 11.4), and
crystal methamphetamine least common (0.4%, 95% CI: 0.0, 0.7). Only use of crack cocaine
varied significantly by gender identity, with transfeminine persons being more likely to report
use (4.5%, 95% CI: 0.0, 9.7 versus 0.7%, 95% CI: 0.0, 1.5).
Table 5.1: Past-year drug use among transgender Ontarians, by gender identity (n=406)
All Trans People

Crack cocaine
Powder cocaine
Crystal methamphetamine
Other amphetamine
Ketamine
Gamma Hydroxybutyrate (GHB)
Heroin
Non-medical use of prescription
narcotics
At least one of above
More than one class of drugb

Transmasculinea

Transfemininea

%
2.4
7.3
0.4

95% CI
(0.0, 4.9)
(3.3, 11.4)
(0.0, 0.7)

%
0.7*
9.4
0.4

95% CI
(0.0, 1.5)
(3.3, 15.5)
(0.0, 0.9)

%
4.5*
5.0
0.4

95% CI
(0.0, 9.7)
(0.0, 10.2)
(0.0, 0.9)

1.6
2.6
0.6
0.6
6.2

(0.5, 2.7)
(1.1, 4.2)
(0.0, 1.4)
(0.0, 1.4)
(2.9, 9.6)

1.4
2.9
0.8
0.8
7.5

(0.0, 3.1)
(0.6, 5.3)
(0.0, 2.1)
(0.0, 2.2)
(2.6, 12.5)

1.9
2.3
0.4
0.4
4.7

(0.5, 3.4)
(0.3, 4.3)
(0.0, 1.0)
(0.0, 1.2)
(0.0, 9.6)

12.3
4.1

(7.7, 17.0)
(1.7, 6.5)

13.2
5.2

(6.7, 19.7)
(1.1, 9.4)

11.4
2.8

(4.3, 18.5)
(0.8, 4.8)

a

Transmasculine= assigned female at birth and identifies as male or masculine; transfeminine= assigned male at
birth and identifies as female or feminine.
b

Classes were defined as: cocaine (powder or crack), amphetamines, “club drugs” (Ketamine and GHB), and
opiates (heroin, prescription narcotics).
*= p<.05 for difference between transmasculine and transfeminine persons.

5.3.2 Drug use frequencies in comparison to Ontarians overall
Comparisons to the reference population data from CCHS are displayed in Figures 5.1 and 5.2.
Compared to the age-standardized cisgender population, transgender Ontarians were more likely

108

than expected to use both cocaine (powder or crack) and amphetamines. Specifically, the
estimated prevalence of past-year cocaine use was 6.8% (95% CI for standardized prevalence
differences; SPD= 1.6, 10.9) greater among trans persons, while estimated amphetamine use was
1.6% (95% CI: 0.5, 2.7) greater. Put differently, there were an estimated 68 excess prevalent
cases of past-year cocaine use per 1000 trans people, and 16 excess prevalent cases of
amphetamine use, compared to what would be expected for the age-standardized reference
population.
Next, analyses were stratified by gender identity, with data from cisgender males and females
age-standardized to the relevant transgender age distribution (e.g., for comparisons with
transmasculine persons, both cisgender males and females were age-standardized to the
transmasculine age distribution). Transmasculine persons were significantly more likely to use
cocaine than the cisgender reference populations, but not amphetamines. Transmasculine persons
had a higher past-year prevalence of cocaine use as compared to both Ontario males (SPD=
7.2%, 95% CI: 1.0, 13.3) and females (SPD= 8.5%, 95% CI: 2.3, 14.6). In contrast,
transfeminine persons were more likely to use amphetamines than both cisgender males (SPD=
1.5%, 95% CI: 0.1, 3.0) and females (SPD= 1.8%, 95% CI: 0.4, 3.3). However, their prevalence
of cocaine use varied only in comparison to cisgender females (SPD= 5.9%, 95% CI: 0.3, 11.4).
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Figure 5.1: Past-year cocaine or crack use among transgender Ontarians and the agestandardized Ontario population, 2009-2010
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Figure 5.2: Past-year amphetamine use among transgender Ontarians and the agestandardized Ontario population, 2009-2010
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5.3.3 Trans population characteristics and associations with drug use
Weighted frequencies of socio-demographic characteristics and their associations with past-year
drug use within the transgender population are shown in Table 5.2. In both crude and adjusted
analyses, childhood physical or sexual abuse (APR=2.80, 95% CI: 1.18, 6.63), and Toronto
residence (APR=3.15, 95% CI: 1.42, 6.99) were associated with higher prevalence of drug use,
while people of color had a lower prevalence than whites (APR=0.24, 95% CI: 0.08, 0.65).
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Table 5.2: Weighted socio-demographic and background characteristics of transgender
people in Ontario, Canada and associations with past-year drug use (n=399)
Weighted
frequencies
%

b

Age (years)
Median, IQR
30 versus 20
40 versus 20
Gender identity
Transmasculine
Transfeminine
Toronto residence
Race/ethnicity
White
Indigenous
Person of color
Childhood abuse
High school education or
less
Sexual minority

(95% CI)

Prevalence ratio
(bivariate)
PR
-0.81
0.65

(95% CI)

Adjusted prevalence
ratioa
PR

(95% CI)

--(0.62, 1.07) 0.81
(0.37, 1.15) 0.66

-(0.59, 1.12)
(0.33, 1.29)

28.7
---

22.1- 38.7
---

55.6
44.4
38.8

(47.7, 63.4) 1.31 (0.57, 2.97) 1.09
(0.49, 2.43)
(36.6, 52.3) 1.00
1.00
(31.0, 46.7) 2.67* (1.13, 6.30) 3.15** (1.42, 6.99)

77.6
6.5
15.8
69.5
27.5

(71.5, 83.8)
(3.2, 9.8)
(10.5, 21.2)
(62.4, 76.6)
(20.1, 34.9)

64.3

(56.6, 72.1) 1.35

1.00*
0.79
0.29
3.08*
0.55

(0.28, 2.23)
(0.10, 0.79)
(1.29, 7.33)
(0.25, 1.20)

1.00*
0.63
0.24
2.80*
0.51

(0.59, 3.10) 0.95

(0.15, 2.62)
(0.08, 0.65)
(1.18, 6.63)
(0.20, 2.19)
(0.42, 2.19)

*= p<.05, **= p≤.001 for Wald F-test
a

Nagelkerke R2=0.18

b

Modeled as continuous in logistic regression, reference levels required for presentation of prevalence ratios.

5.3.4 Predictors of drug use
Results of blockwise logistic regression models predicting drug use are presented in Table 5.3,
alongside bivariate prevalence ratios and weighted frequencies for each covariate. Experiences of
transphobia, transphobic physical or sexual assault, homelessness or underhousing, and sex work
were crudely associated with drug use. Multivariable models were adjusted for age,
race/ethnicity, Toronto residence, and childhood abuse. In model 1, where transition status
variables were added, neither social nor medical gender transition was significantly associated
with drug use (results not shown). In model 2, including social stigma/exclusion variables,
transphobic physical or sexual assault (APR= 2.11, 95% CI: 1.07, 4.17), greater social support
(APR= 1.61, 95% CI: 1.11, 2.33), and being underhoused or homeless (APR= 2.34, 95% CI:
1.02, 5.38) were positively associated with drug use. In model 3, adding current sex work to
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retained social stigma and exclusion variables, sex work was associated with greater drug use
(APR=3.82, 95% CI: 1.22, 11.94). Social support remained positively correlated with drug use,
while associations with transphobic assault and homelessness or underhousing were attenuated
and lost statistical significance. In model 4, depressive symptoms were not associated with pastyear drug use.
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Table 5.3: Blockwise logistic regression predicting past-year drug use among transgender people in Ontario, Canada (n=399),
controlling for socio-demographic and background characteristics
Weighted
frequencies
% or (95% CI)
median or IQR
Living full-time in felt gender 52.0
(43.6, 60.4)
Medical transition status
Complete
27.1
(20.4, 33.8)
In process
24.3
(18.2, 30.5)
Planning but not begun
28.4
(21.1, 35.8)
Not planning, unsure, N/A
20.1
(13.1, 27.2)
Transphobia
Median, IQR
12.8
9.0-18.2
th
th
75 versus 25 percentile
--Transphobic assault
20.3
(14.4, 26.1)
Social support
Median, IQR
3.6
2.8-4.3
75th versus 25th percentile
--Strong parental support for 24.7
(18.5, 30.9)
gender
Below low income cut-off
43.8
(35.8, 51.8)
Employment status
Full or part-time
50.5
(42.9, 58.1)
Student
27.5
(20.5, 34.5)
Other
22.0
(15.3, 28.8)
Underhoused/ homeless
17.6
(11.7, 23.5)
Current sex work
2.2
(0.0, 4.6)
Depressive symptoms
Median, IQR
22.5
10.7-32.8
75th versus 25th percentile
---

Prevalence ratio
(bivariate)
PR

(95% CI)

Adjusted prevalence ratiosa
Model 2b
Model 3
Model 4
PR
(95% CI)
PR
(95% CI)
PR
(95% CI)

1.60

(0.68, 3.79)

--

--

--

--

--

--

1.00
0.64
0.42
0.83

(0.29, 1.38)
(0.11, 1.57)
(0.31, 2.22)

--

--

--

--

--

--

--

--

--

--

†

1.69* (1.10, 2.60)
3.09** (1.47, 6.47)

1.08
2.11*

(0.71, 1.67)
(1.07, 4.17) 1.84

1.37
0.49

(1.00, 1.90)
(0.23, 1.05)

1.61*
0.52

(1.11, 2.33) 1.59** (1.15, 2.19)
(0.25, 1.07) 0.55
(0.28, 1.07)

1.69

(0.78, 3.69)

0.95†

(0.47, 1.92)

1.00
1.16
0.79
2.74*
7.48**

(0.48, 2.81)
(0.31, 2.03)
(1.23, 6.08)
(3.97, 14.08)

1.06

(0.67, 1.68)

1.00†
1.01
0.78
2.34*

--

-(0.44, 2.31)
(0.34, 1.80)
(1.02, 5.38) 1.83
3.82*

(0.94, 3.57)

1.82

(0.92, 3.61)

1.61** (1.14, 2.27)
0.55
(0.29, 1.06)

--

--

--

--

--

--

(0.75, 4.44) 1.84
(1.22, 11.94) 3.82*
1.05

(0.77, 4.40)
(1.22, 11.99)
(0.67, 1.63)
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a

All models control for age, ethnoracial group, Toronto residence, and childhood sexual or physical abuse.

b

Model 1 (transition status variables) not displayed; p-values for all variables were > 0.25. Model 2= social exclusion/inclusion factors; Model 3= sex work
added; Model 4=depressive symptoms added.
†

p>0.25, not included in subsequent models. *= p<0.05, **= p≤0.001 for Wald F-test
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5.4

Discussion

Drawing on data from a province-wide respondent-driven sampling survey, we found that an
estimated 12.3% of trans Ontarians reported past-year use of illicit drugs associated with a high
risk of harm to the user, most commonly cocaine or non-prescribed opioids. In comparison to the
reference (cisgender) population in the same period, directly standardized to reflect the younger
transgender age distribution, trans persons were five to six times more likely to report past-year
use of cocaine and amphetamines. While data on non-medical prescription opioid use (NMPOU)
in the cisgender population were not available for standardized comparisons, an estimated 2.0 %
of Ontario adults reported NMPOU in 2008-9,48 as compared to the 6.2% we have estimated for
the trans Ontario population. Drug use within the trans population was associated with sociodemographic and background characteristics (white race, major urban residence, and childhood
abuse), transphobic violence, homelessness or underhousing, and sex work.

5.4.1 Strengths and limitations
This is the first study to estimate the prevalence of drug use among trans Canadians, and draws
on respondent-driven sampling data, which are, in theory, generalizable to the networked
transgender population of Ontario (i.e., those knowing at least one other trans person). However,
while RDS II weights adjust for unequal recruitment probabilities due to network size, other
sampling biases may remain.49 For instance, specific groups may be consistently under- or overrecruited, or be more likely to decline participation even if recruited. Ultimately, inclusion of
measures to identify trans respondents in Canadian population health surveys will be will be
critical to advancing understanding of health disparities. Comparison to CCHS was based on
availability of data for the same categories of drugs as included in Trans PULSE. To be
conservative, we compared reported use of “speed (amphetamines)” in CCHS to “other
amphetamines” in Trans PULSE. This underestimate the disparity in use to the extent that crystal
methamphetamine users responded affirmatively to the CCHS question.
The Trans PULSE survey did not collect data on the frequency of drug use in the past year.
Reported use may have been intermittent, or even a single event, and is not indicative of
problematic use or dependence. To mitigate the limitations of the available outcome data, we

116

restricted attention to drugs posing higher risk of harms to users. Nevertheless, respondents may
have experienced high risk related to problematic use of other drugs. Self-reporting of drug use is
also subject to social desirability bias. While Trans PULSE was self-administered (with the
option to retain anonymity), the CCHS was interviewer-administered, and therefore reporting
bias may contribute to overestimation of prevalence differences. In addition, the data are crosssectional and thus causality cannot be inferred. Further, some exposures were measured over the
same time frame as drug use (e.g., sex work), and are potential effects of drug use.

5.4.2 Implications
Consistent with prior research, indicators of social stigma and exclusion were associated with
drug use within the trans population.20-22 Interestingly, while discriminatory violence was
related to drug use, transphobia overall was not. The addition of sex work to regression models
attenuated the estimated prevalence ratios for transphobic assault and underhousing, suggesting
that sex work may mediate and/or confound associations between these factors and drug use. A
previous study in New York found that sex work was prospectively associated with transphobic
violence, and in turn, with depressive symptoms and substance use.11 Research including larger
numbers of transgender sex workers, ideally longitudinal, is required to elucidate the
relationships between these factors over time and across geographic contexts.
Greater social support was consistently positively associated with drug use. This unexpected
finding warrants future investigation. As we examined any past-year drug use, much of which
would be occasional recreational use, it is plausible that individuals engaging in such use are
more socially well-connected.
Gender identity was not associated with drug use among trans persons. Few studies have
directly compared substance use by gender identity, and those studies have had conflicting
findings.17,18 In this same study population, transmasculine gender was robustly associated with
heavy episodic drinking, while social exclusion variables—with the exception of sex work—
were unassociated.16 However, there was no gender identity difference in the prevalence of very
frequent (weekly or more) binge drinking. Taken together, these findings suggest that the impact
of gender norms on transgender substance use behavior may be stronger for more socially
normative use (e.g., occasional heavy drinking), with social marginalization more salient for
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predicting higher-risk substance use or dependence. Social and medical gender transition statuses
were also not significantly associated with drug use, suggesting that factors other than gender
dysphoria may account for the high prevalence of drug use in this population. Indeed, results
indicate that drug use is particularly elevated among trans Ontarians who have experienced
victimization (childhood abuse, transphobic assault), homelessness or underhousing, and sex
work. Culturally competent substance use prevention and treatment services that consider the
impact of these experiences are warranted.

5.5
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6

Chapter 6: The intersectional discrimination index: Development
and validation of measures of self-reported experienced and
anticipated discrimination

6.1

Introduction

6.1.1 Discrimination and health
Discrimination refers to a range of explicit and implicit policies, practices, and behaviours that
perpetuate inequities between socially defined groups, including institutionalized and legal
subjugation, de facto discrimination by ostensibly neutral policies, and interpersonal slights.1
Most research on discrimination and health has focused on perceived discrimination selfreported by its targets.1 Such discrimination represents one mechanism by which non-dominant
group membership may be linked to poorer health outcomes, and thus represents an important
area of investigation for research aiming to intervene on the processes that maintain health
disparaties.2,3
Perceived discrimination is frequently understood as a psychosocial stressor that contributes to
the higher overall burden of stress experienced by non-dominant social groups,4,5 within the
psychological and sociological stress frameworks first elaborated by Lazarus and Folkman6 and
Pearlin, respectively.7 Discrimination may also impact health via social resistance, whereby
discriminated group members actively engage in risk behaviours as a means of expressing their
dissatisfaction with discriminatory social arrangements, and alienation from dominant society
and its norms.8,9 Further, discrimination events can diminish health directly when they involve
loss of economic resources to maintain health, physical injury, or denial of health care.1 A
growing body of research links self-reported discrimination with poorer health outcomes, with
the most robust evidence for deleterious impacts of racial and ethnic discrimination on
psychological distress and negative mental health outcomes among racial and ethnic
minorities.1,10,11
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6.1.2 Intersectional discrimination
A meta-analysis of research on self-reported discrimination and health published from 19862007 found that most focused on racism (66%), and less commonly on sexism (17%) or
discrimination against sexual minorities (6%).12 Some studies have explicitly investigated
discrimination on the bases of multiple social statuses,13-17 however, this appears rare.18,19
Intersectional research on discrimination and health has been identified as an area in need of
development.2,18 Crenshaw20 coined intersectionality to describe how Black women’s
experiences of discrimination were qualitatively unique, rather than merely a combination of
experiences of white women and Black men. Intersectionality has become a central framework
for understanding the multiple, interacting, and context-dependent forms of social and health
advantage or disadvantage that individuals experience on the bases of social status and
position.21,22
Intersectionality scholars are heterogeneous in their ontological and methodological
orientations.21 Social scientific and population health research approaches tend to apply an
intercategorical approach to intersectionality, one that takes the critical realist perspective that
while existing categories of social status and position (e.g., race, gender) are socially constructed
and provisional categories, they nevertheless reflect real and socially meaningful groupings. As
applied to the study of discrimination and health, intercategorical intersectionality involves
examining the potentially interacting impacts of multiple, multidimensional categories of social
status and position on outcomes of interest.2,21 Intersectionality argues that health inequalities do
not necessarily increase linearly with each additional marginalized social status, and that the
study of one form of discrimination or privilege at a time (e.g., racism, sexism), will obscure the
experiences of groups facing intersecting forms of discrimination.2,22 Moreover, an intersectional
perspective also suggests that individuals belonging to multiple socially marginalized groups
may be unable to identify a single basis for any given act of discrimination they experience,
raising questions as to the validity of survey measures which require participants to do so.23

6.1.3 Measuring intersectional discrimination
Corresponding to a remarkable growth in public health and social science research on
discrimination over the past two decades,1 the set of instruments available to measure
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discrimination has expanded rapidly. For instance, a 2006 review identified 152 self-report
instruments for racism alone.24 Despite this proliferation of discrimination measures, few have
been developed specifically to assess discrimination across multiple social statuses or positions.
Two exceptions are scales developed by Bastos et al. for the Brazilian context25 and by Bogart et
al. to evaluate racial/ethnic, sexual orientation, and HIV stigma concurrently.26
Of the most commonly used and widely validated measures of (racial/ethnic) discrimination,11
two have particular potential to be used for cross-group discrimination: Krieger et al.’s
Experiences of Discrimination (EOD)27 and Williams et al.’s Everyday and Major
Discrimination measures.28 The former asks “"Have you ever experienced discrimination, been
prevented from doing something, or been hassled or made to feel inferior in any of the following
situations because of your race, ethnicity, or color?" across 9 domains, but has been adapted to
include other stem endings (“e.g., “because of your sex”), such as in the 2004–2005 United
States National Epidemiologic Survey of Alcohol and Related Conditions.17,29 Williams’
measures28 inquire about “unfair” treatment in interactions with various institutions or domains
(major discrimination), or about specific instances of poor or inferior treatment (everyday
discrimination). Those endorsing any discrimination experiences are asked to indicate the main
reason they attribute to the experience (or in some adaptations, multiple main reasons15).
While these extant measures are candidates for use in intersectional analyses, they present
substantial challenges. First, their items were not developed to tap into the manifestations of
discrimination across non-dominant social groups. For example, the Everyday and Major
Discrimination measures28 were designed to ascertain racial discrimination against AfricanAmericans. Thus, they include items which may be less salient for other racial and non-racial
minority groups30,31 (e.g., related to perceptions of the respondent as frightening) – and even for
Black women32 – and exclude items relevant to a number of discriminated groups (e.g., being
ostracized in public).
Measures that employ parallel question sets for each type of discrimination17,26 impose a high
respondent burden and preclude valid assessment of total discrimination burden because
respondents may report the same discrimination experience (e.g., being harassed) multiple times
(e.g., related both to gender and to race). Without the ability to estimate exposure to
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discrimination overall, researchers are limited either to conduct analyses within subgroups at risk
of the exposure (e.g., intersecting effects of racial, sexual, and HIV-related discrimination among
ethnic minority men who have sex with men living with HIV26) or, in broader population
samples, to analyzing the effect of exposure to any discrimination in combination with the
number or combination of attributions reported.17 These limitations severely limit ability to
evaluate the role of self-reported discrimination in mediating health inequities in population
health research, and to testing hypotheses consistent with scientific knowledge about the impacts
of cumulative and chronic stressors.33-35

6.1.4 The present study
Considering the limitations of existing measures for intersectional population health research
concerned with the impacts of multiple forms of discrimination, we sought to develop a new
measure, which we titled the Intersectional Discrimination Index (InDI). The index consists of
three components which assess anticipated, day-to-day, and major discrimination respectively.
Considering evidence that perceived discrimination’s deleterious impact is not dependent on the
grounds it is attributed to,18 and following the approach recommended for evaluation by Bauer,2
we aimed to develop a single index that can be administered and scored without need for
attributions to specific grounds. Instead, data on social status and position (i.e., sociodemographic measures) can be used to compare the experiences and outcomes of groups at
relevant intersections.
The InDI was developed and refined through literature review, expert consultation, and pilot
testing. To evaluate the InDI’s validity and reliability, it was administered to survey panel
members in Canada and the United States sampled for maximum racial/ethnic and sexual
diversity, along with socio-demographic, mental health, and substance use measures. A subgroup
completed a follow-up survey including the InDI and the most comprehensive versions of
Williams’ Everyday28 and Major36 Discrimination. These data were used to examine
acceptability and data quality, internal consistency and dimensionality, construct validity
(including associations with the Williams measures and established health correlates of
discrimination), and test-retest reliability. Considering the need for a well-developed empirical
and theoretical basis for validation hypotheses, as well as sufficient sample sizes, these analyses

126

of validity and reliability consider one axis of social status or position at a time (e.g.,
race/ethnicity, sexual orientation). A companion paper (Bauer and Scheim, in preparation) will
demonstrate the utility of the InDI for intersectional analyses of health outcomes through worked
examples.

6.2

Methods

6.2.1 InDI Development
Development of the InDI began with a narrative review of public health and social scientific
literature on (a) intersectionality, (b) theoretical models linking stigma, discrimination, and
mental health, (c) measuring self-reported discrimination, and (d) development of self-report
measures. Informed by this review, we decided to develop a multidimensional index to reflect
the nature of discrimination-related stressors, including major or disruptive life events, chronic or
ongoing stressors, traumatic or violent events (frequently excluded in discrimination measures37),
as well as anticipatory stress related to expecting future discrimination.18,38 Many items were
adapted from existing discrimination and victimization measures, while others were generated by
the investigators to cover manifestation of discrimination not included in extant measures (e.g.,
dissolution of personal relationships). A construct map39 was used to ensure balanced coverage
of all discrimination domains (e.g., institutional settings,1,40,41 interpersonal relationships,32 and
chronic slights42) and of discrimination types reflecting various affective bases of prejudice (e.g.,
disgust versus fear). Further detail on item development for each component is provided below.
To gather input on the draft InDI, we held telephone and videoconference consultations with
eight experts from Canada, the United States, and Australia, including epidemiologists,
psychologists, and policy analysts from the Canadian and Ontario Human Rights Commissions.
After revising item content and wording based on expert feedback, we pilot-tested the second
version of the InDI with ten graduate students to obtain feedback on item and instruction clarity,
face validity, and sufficiency of response options. The index was also reviewed for readability
using the Flesch-Kincaid Grade Level, and wording was revised until a 7th grade level was
reached. The final index contains the three sub-measures described below: anticipated, day-today, and major discrimination. The InDI is included as Appendix B. Rather than asking
respondents to attribute the bases of discriminatory experiences or expectations (i.e., social
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identities or statuses), the InDI solicits experiences “because of who you are”, with the following
definition provided at the outset and midway through the questionnaire:
These questions are about experiences related to who you are. This includes both how you
describe yourself and how others might describe you. For example, your skin colour, ancestry,
nationality, religion, gender, sexuality, age, weight, disability or mental health issue, and income.
Anticipated discrimination. The minority stress framework suggests that the stress and
vigilance associated with anticipation of discrimination are important contributors to stigmarelated mental health inequities.43,44 Yet, the construct is rarely included in measures of
discrimination.38 Existing measures tend to either simultaneously evaluate anticipated stigma and
subsequent behavioural reactions (i.e., include double-barreled questions), inquire only about
generalized expectations of discrimination against one’s social group, or focus on specific
concealable stigmas (e.g., mental illness).45,46 Therefore, we developed items to assess
anticipation of discrimination, as well as expectations of safety and equitable treatment. Items
were based on the domains covered by the Major Discrimination component. For each of 11
statements, respondents were asked to indicate agreement on a 5-point Likert-type scale
(strongly disagree to strongly agree). For example, one item reads: "Because of who I am, I
might have trouble finding or keeping a job.” To avoid priming respondents to anticipate
discrimination by recalling past discrimination events, these items were asked first.
Day-to-day discrimination. This component included 18 items assessing the frequency and
recentness of day-to-day discrimination (never, lifetime but not past-year, once or twice in the
past year, many times in the past year). Day-to-day discrimination items were informed by
Williams’ Everyday Discrimination scale and Sue’s42,47 framework of microaggressions:
“...everyday verbal, nonverbal, and environmental slights, snubs, or insults, whether intentional
or unintentional, that communicate hostile, derogatory, or negative messages to target persons
based solely upon their marginalized group membership.”42 To ensure representation of items
that reflect both the overlapping and distinct biases and stereotypes that contribute to
discrimination across non-dominant social groups, we referred to Cuddy et al.’s Stereotype
Content Model (SCM) and Behaviour from Intergroup Affect and Stereotypes (BIAS) map.48
The SCM delineates two dimensions on which positive or negative group stereotypes are based –
warmth and competence. In turn, the BIAS map predicts affective and behavioural responses to
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social groups based on their position along each dimension. For example, groups socially
stereotyped as high in competence but low in warmth tend to be envied, and thus treated with a
combination of active harm and passive facilitation, whereas groups stereotyped as low on both
dimensions actively harmed and neglected based on feelings of contempt. As reporting of dayto-day discrimination may be particularly susceptible to confounding with current mental health
status, we tried to avoid items requiring extremely subjective appraisals or comparisons (e.g.,
“people act as if they’re better than you are”). A sample item reads: “Because of who you are,
have you heard, saw, or read others joking or laughing about you (or people like you)?”
Major Discrimination. Eleven items measured major events over the lifetime (never, once, or
more than once). To generate past-year frequencies, respondents endorsing any lifetime
discrimination were asked whether the specified event had occurred at least once in the past year.
For utility in monitoring the prevalence of justiciable forms of discrimination,49 and to limit
confounding with current health status, items referred to specific manifestations of
discrimination (rather than asking respondents to report “discrimination” per se) and included
objective end-points where possible (e.g., stopped or arrested by police, rather than ‘harassed’).
For example, health care discrimination is assessed with: “Because of who you are, has a health
care provider ever refused you care?” Items related to violence and property damage were
adapted from measures by Herek50 and the Statistics Canada General Social Survey
Victimization Survey.51

6.2.2 Data Collection
Legerweb was contracted to collect data from a target sample of 3000, split evenly between
residents of Canada and the United States. Legerweb is a Canadian web survey panel provider
and builder. Since 2004, they have managed a panel with over 400,000 active members. They
conduct market research, opinion research, and scientific research for academic clients. Eligible
participants were Canadian or American residents aged 18+ who participate in English-language
Legerweb survey panels. Quota sampling was employed with the following targets per country:
250 in each of six major ethno-racial groups (Middle Eastern, Asian, Black, Indigenous, Latino/
Hispanic, White) and 250 who identify as lesbian, gay, bisexual, or transgender (LGBT, of any
ethno-racial background). Race/ethnicity demographic questions and a screening question to
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ascertain LGBT status (“Do you consider yourself lesbian, gay, bisexual, or transgender, or a
similar identity?") were employed for quota sampling. At baseline, participants completed a 30minute questionnaire including the InDI; mental health and substance use measures; and
indicators of socio-demographics characteristics and targetable attributes (e.g., perceived
race/ethnicity, apparent disability, wearing religious garb). A random sample of 150 participants
participated in a 10-15-minute follow-up survey 2-4 weeks after completing the baseline survey.
The follow-up survey included the InDI, as well as Williams’ Everyday28 and Major36
Discrimination measures. The Non-Medical Research Ethics Board at the University of Western
Ontario approved this study (see Appendix E).

6.2.3 Measures
Copies of the baseline and follow-up questionnaires are included as Appendices C and D. All
measures were based on self-report.
Intersectional Discrimination Index. Responses to anticipated discrimination items were
scored from 0 (strongly disagree) to 4 (strongly agree). Mean scores (0-4) were calculated for
individuals who completed at least 9/11 items, with positively worded items reverse-scored.
Each lifetime major discrimination item was coded as 0 (never), 1 (once), or 2 (more than once),
for a lifetime major discrimination tally ranging from 0-26. Each past-year major discrimination
item was coded as 0 (no) or 1 (yes), for a past-year major discrimination tally ranging from 0-13.
Lifetime day-to-day discrimination was coded as 1 for yes (versus 0 for no) for each item that
respondents endorsed (lifetime or past-year), for a tally ranging from 0-18. Past-year day-to-day
discrimination items were coded as 0 for no (never, or not in the past year), 1 for once or twice in
the past year, and 2 for many times in the past year, for a tally ranging from 0-36. For major and
day-to-day discrimination, missing values were imputed to “no/never” if respondents had
completed at least 80% of items; if 20% or more of items were missing, sum scores were not
calculated.
Conceptually, major and day-to-day discrimination events are not indicators of a unidimensional
underlying cause, and are not necessarily expected to be correlated with each other.37 Therefore,
a priori decision was made to analyze both sub-components as causal indicators (i.e., items that
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aggregate to form a construct, rather than items that reflect the level of a single underlying
construct39,52,53), and thus not to subject them to procedures that assume effect indicators (e.g.,
measures of internal consistency, factor analysis). Scores for each of the three components are
not intended to be summed into a single overall score.
Attributions. Although attributions to specific grounds are not part of the InDI, a universal
attribution question was included for exploratory purposes. It asked: “Thinking of all of the times
that you have been treated unfairly or poorly because of who you are, how often do you think
each of the following was a reason why others treated you this way?”. An expansive list of
possible reasons was provided (see Table 6.12), including a write-in option for “other”. For
clarity, each attribution was proceeded by the word “your” (e.g., “Your mental health or
substance use disorder”). A four-point response scale included the options “never a reason”,
“sometimes a reason”, “always a reason”, and “not sure if this was a reason”. In these analyses,
attributions were dichotomized as sometimes or always a reason versus never or unsure.
Williams Everyday and Major Discrimination (follow-up survey only). The Williams
Everyday Discrimination scale (see Items in Appendix D) asks about experiences “in your dayto-day life”, without specifying a timeframe. It was summed overall (ignoring attributions), with
each item assigned a score from 0 (never) to almost every day (5) for a total possible range of 45
points. The Williams Major Discrimination measure includes 9 binary items over a lifetime
frame, and was scored from 0 (no specified major discrimination event) to 9 (all events).
Demographics. Participants reported their sex assigned at birth and the gender in which they
lived in day-to-day life. This information was used to classify respondents as cisgender (nontransgender) men, cisgender women, transgender women (male birth sex, lives as female,
sometimes female, or non-binary), and transgender men (female birth sex, lives as male,
sometimes male, or non-binary). Individuals who were classified as transgender and/or who
reported a gay, lesbian, or bisexual sexual orientation were classified as LGBT.
Race/ethnicity was assessed with a check-all-that-apply item, using separate response options for
each country to reflect differences in ethno-racial categorization. To create consistent and
mutually exclusive ethno-racial categories across countries, respondents were assigned to
race/ethnicity categories using the following hierarchical coding sequence: white (white
race/ethnicity only), Indigenous (any First Nations/Inuit/Métis or Alaska Native/American Indian
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ancestry), Latino/Hispanic (any Hispanic or Latin American ethnicity), Middle Eastern (any
Middle Eastern/Arab ethnicity), Black (any Black, African-Canadian, or African-American
race), and Asian (any East, Southeast, or South Asian ethnicity, or Native Hawaiian/Pacific
Islander in the United States). These criteria were applied such that individuals were assigned to
the first category (in the ordered list above) that they endorsed. For instance, someone who
indicated being Indigenous and Latino was classified as Indigenous. For analyses stratified by
racial/ethnic minority status, respondents were coded as Indigenous and/or racialized (i.e., of
color) versus white. Parallel questions ascertained immigration history in Canada and the
United States, and a binary variable was created to reflect native-born versus immigrant status
in the respondent’s country of residence.
A dichotomous item asked participants to indicate if they had a physical, sensory, learning, or
psychiatric disability. Income-to-needs ratio was calculated by dividing annual household
income by the number persons supported, in CAD and USD respectively. For regression
analyses, country-specific income quartiles were calculated, and a single income quartile
variable (1st to 4th) was created for both countries. Missing values were imputed based on the
country-specific median income-to-needs ratio. Other demographic and background variables
included age (continuous), educational attainment, urban/suburban or rural residence, and
religion.
Health outcomes. Considering that psychological distress is the outcome most consistently
associated with self-reported discrimination,1,11,12 as well as the potential for health effects of
discrimination to vary by group (e.g., greater average impacts on affective disorders and anxiety
for women, and on substance use for men),54,55 we evaluated the impacts of discrimination on a
composite outcome including one or more of the following: psychological distress, hazardous
drinking, and current smoking.
Psychological distress was measured with the six-item K6 measure developed by Kessler.56
Items are scored from 0 (never) to 4 (all the time), for a total score of 0-24. The K6 was
developed to estimate the prevalence of serious mental illness, and has shown good sensitivity
and excellent specificity in U.S. population samples when dichotomized at a score of 13 or
above and compared to DSM-IV diagnoses via structured clinical interviews.56,57 Therefore, we
defined psychological distress as a K6 score greater than or equal to 13.
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The Alcohol Use Disorders Identification Tool (AUDIT) identified probable hazardous or
harmful drinking, using the recommended cut-point of 8 or more (of 40 possible points).58,59
TheAUDIT is a widely-used and well-validated measure, and was found to have high sensitivity
and specificity when initially validated among primary care patients in six countries.58 Current
smoking was defined, consistent with the Canadian Community Health Survey and the BRFSS,
as indicating (1) having smoked at least 100 cigarettes over the lifetime (defined as 4 packs in
Canada and 5 in the U.S.) and (2) currently smoking daily or occasionally. Childhood physical or
sexual abuse (before age 16) was included as a potential confounder, classified as yes, no, or
unsure/rather not say/missing.

6.2.4 Statistical Analysis
Dimensionality and internal consistency of anticipated discrimination. For the effect
indicator subscale (anticipated discrimination), exploratory (EFA) and confirmatory (CFA)
factor analyses were conducted in MPlus v7.4.60 An a priori decision was made to split the data
by country, with Canadian respondent data used for EFA, and United States respondent data used
for CFA. The MLR estimator (maximum likelihood with robust standard errors) was used to
account for non-normality (platykurtosis) in the outcome distribution and the use of Likert items.
For EFA, 1 and 2 factor solutions were requested, using Geomin oblique rotation to allow for
correlated factors. Eigenvalues, factor loadings, and goodness of fit statistics were examined to
evaluate dimensionality. Goodness of fit for CFA was evaluated using parsimony, incremental,
and absolute indices (Root Mean Square Error of Approximation, Comparative Fit Index,
Standardized Mean Square Residual).61 Internal consistency (Cronbach’s alpha) and item-total
correlations were estimated in SAS 9.4.
Frequencies. Descriptive statistics stratified by country were calculated in SAS v9.4,62 including
median and mean item responses and mean scores for anticipated discrimination and item
endorsement, frequency tally, and proportion reporting any exposure for both day-to-day and
major discrimination. Data quality, acceptability, and scaling were evaluated by examining
missing data patterns, maximum endorsement frequencies (to identify floor and ceiling effects),
and distribution of scores across the full possible range. Attributions were described for the full
sample, stratified by racial/ethnic minority status (white versus racialized and/or Indigenous) and
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by LGBT status, with chi-square tests for differences in proportions.
Construct validity. Known-groups comparisons were conducted to ensure that, as
hypothesized, members of minority groups report more discrimination than members of majority
groups. Median scores on each InDI component were calculated for racial/ethnic and sexual/
gender majority and minority groups (white versus racialized and/or Indigenous; LGBT versus
non-LGBT) and Wilcoxon rank-sum tests were used to identify statistically significant
differences in medians at p<0.05.
Next, to determine if InDI scores were associated with well-documented effects of perceived
discrimination, logistic regression models were fit (separately for each of the three components
over the lifetime and past year) to estimate associations with the composite variable including
one or more of the following: psychological distress, hazardous drinking, and smoking. Models
were adjusted for age, childhood physical or sexual abuse, and income quartile. Models were fit
for the full sample, as well as stratified by racial/ethnic minority and LGBT status.
Finally, for the subgroup of 150 who completed the follow-up survey, day-to-day and major
discrimination frequency scores on the InDI were compared to the corresponding Williams
measures. Moderate correlation and agreement were expected, as the InDI was designed to
capture a wider range of discrimination experiences relative to existing discrimination measures.
Spearman correlations and their 95% confidence intervals were calculated for both day-to-day
and major discrimination. In addition, respondents were classified as reporting low, moderate, or
high discrimination on each measure by splitting each distribution into tertiles. Agreement
between these classifications for both day-to-day and major discrimination was assessed with the
kappa statistic.
Test-retest reliability. Using data from the follow-up survey, test-retest reliability was assessed
for anticipated discrimination scale scores and lifetime frequencies of both day-to-day and major
discrimination. Test-retest reliability was quantified using intraclass correlation coefficient
(ICC) estimates and their 95% confidence intervals. These estimates were obtained using a
model adjusted for the number of days between baseline and follow-up surveys, via the ICC9
SAS Macro.63
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6.3

Results

6.3.1 Sample Characteristics
The final baseline sample included 2642 respondents, including 1065 in Canada and 1577 in the
United States. The follow-up questionnaire included 150 participants, including 83 in Canada
and 67 in the United States. Demographic characteristics are described in Table 6.1.
Table 6.1: Demographic characteristics of survey participants, stratified by country
Baseline
Canada
(n=1065)
n (%)
Age (median, IQR)
Lived gender
Cisgender male
Cisgender female
Trans man or transmasculine
Trans woman or transfeminine
Missing
Sexual orientation
Straight or heterosexual
Bisexual
Gay or lesbian
Not sure
Asexual
Missing
Lesbian, gay, bisexual, and/or
transgender
Race/ethnicity
White
Indigenous
Latin American/ Hispanic
Middle Eastern
Black
Asian
Born in Canada/United States
Yes
No

Follow-up
Canada
(n=83)
n (%)

United States
(n=67)
n (%)

36 (48-27)

United
States
(n=1577)
n (%)
44 (57-34)

30 (2541)

49 (36-61)

466 (43.8)
559 (52.5)
20 (1.9)
19 (1.8)
1 (0.1)

749 (47.5)
764 (48.5)
31 (2.0)
31 (2.0)
2 (0.1)

38 (45.8)
45 (54.2)
0 (0.0)
0 (0.0)
0 (0.0)

30 (44.8)
36 (53.7)
1 (1.5)
0 (0.0)
0 (0.0)

865 (81.2)
99 (9.3)
50 (4.7)
35 (3.3)
10 (0.9)
6 (0.6)
174 (16.3)

1322 (83.8)
65 (4.1)
161 (10.2)
15 (1.0)
10 (0.6)
4 (0.3)
255 (16.2)

71 (85.5)
6 (7.2)
4 (4.8)
2 (2.4)
0 (0.0)
0 (0.0)
10 (12.1)

53 (79.1)
5 (7.5)
9 (13.4)
0 (0.0)
0 (0.0)
0 (0.0)
14 (20.9)

187 (17.6)
162 (15.2)
114 (10.7)
112 (10.5)
245 (23.0)
245 (23.0)

198 (12.6)
251 (15.9)
261 (16.6)
247 (15.7)
246 (15.6)
374 (23.7)

11 (13.3)
7 (8.4)
4 (4.8)
5 (6.0)
15 (18.1)
41 (49.4)

8 (11.9)
18 (26.9)
4 (6.0)
1 (1.5)
12 (17.9)
24 (35.8)

581 (54.6)
484 (45.4)

1121 (71.1)
456 (28.9)

40 (48.2)
43 (51.8)

52 (77.6)
15 (22.4)
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Has a disability
Yes
No
Missing
Educational attainment
High school or less
Community college/ trade
school
Some university
Bachelor’s degree
Graduate degree
Missing
Income-to-needs ratioa
Less than $10k
$10-19.9k
$20-29.9k
$30-49.9k
$50k or more
Missing
Residence
Urban or suburban
Rural
Missing
Religion
Christian or Catholic
Buddhist
Hindu
Jewish
Muslim
Sikh
Other or no religion
Missing
a

210 (19.7)
848 (79.6)
7 (0.7)

333 (21.1)
1236 (78.4)
8 (0.5)

15 (18.1)
68 (81.9)
0 (0.0)

16 (23.9)
51 (76.1)
0 (0.0)

186 (17.5)
343 (32.2)
96 (9.0)
302 (28.4)
136 (12.8)
2 (0.2)

209 (13.3)
379 (24.0)
204 (12.9)
483 (30.6)
300 (19.0)
2 (0.1)

15 (18.1)
22 (26.5)
7 (8.4)
27 (32.5)
11 (13.3)
1 (1.2)

9 (13.4)
18 (26.9)
5 (7.5)
21 (31.3)
14 (20.9)
0 (0.0)

185 (17.4)
258 (24.2)
168 (15.8)
211 (19.8)
123 (11.6)
120 (11.3)

200 (12.7)
341 (21.6)
263 (16.7)
386 (24.5)
270 (17.1)
117 (7.4)

14 (16.9)
18 (21.7)
17 (20.5)
21 (25.3)
8 (9.6)
5 (6.0)

12 (17.9)
11 (16.4)
15 (22.4)
14 (20.9)
11 (16.4)
4 (6.0)

935 (87.8)
128 (12.0)
2 (0.2)

1327 (84.2)
243 (15.4)
7 (0.4)

75 (90.4)
8 (9.6)
0 (0.0)

59 (88.1)
8 (11.9)
0 (0.0)

523 (49.1)
23 (2.2)
29 (2.7)
6 (0.6)
92 (8.6)
15 (1.4)
376 (35.3)
1 (0.1)

904 (57.3)
56 (3.6)
54 (3.4)
33 (2.1)
146 (9.3)
0 (0.0)
382 (24.2)
2 (0.1)

38 (46.8)
5 (6.0)
3 (3.6)
1 (1.2)
7 (8.4)
4 (4.8)
25 (30.1)
0 (0.0)

33 (49.3)
3 (4.5)
2 (3.0)
2 (3.0)
0 (0.0)
0 (0.0)
27 (40.3)
0 (0.0)

Household income divided by number of persons supported, in Canadian and United States dollars, respectively

6.3.2 Structure of Anticipated Discrimination
In initial exploratory factor analyses including Canadian participants who provided anticipated
discrimination data (n=1063), the two positively worded scale items (“I am confident that I will
be treated with as much respect as my peers” and “I feel safe in my neighbourhood”) were found
to have weak loadings (0.337 and 0.277 in the one-factor model, respectively). Loadings
remained below 0.40 when a two-factor solution was evaluated. In addition, both items had
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lower item-total correlations (0.30 and 0.26). As these items assess expectations of positive
treatment and safety, which are conceptually distinct from the absence of anticipated
discrimination, these items were excluded from further analyses. Results of subsequent
exploratory factor analyses including the remaining 9 items are presented in Table 6.2. One and
two-factor solutions were requested. Examination of eigenvalues (5.175 for Factor 1 and 0.741
for Factor 2) and the scree plot (Figure 6.1) supported a one-factor solution. However, model fit
was improved from suboptimal (RMSEA=0.091; CFI=0.927) to good (RMSEA=0.06;
CFI=0.976) when a two-factor solution was applied. Conceptually, items that loaded primarily
on the first factor pertained to anticipated discrimination in interactions with institutions (e.g.,
health care, employment) while items which loaded primarily on the second pertained to
anticipated discrimination in interpersonal interactions (e.g., violence and harassment, difficulty
forming relationships).
Table 6.2: Exploratory Factor Analysis of Anticipated Discrimination among Canadian
respondents (n=1063)
Item

1. Because of who I am, a doctor or nurse,
or other health care provider might treat me
poorly.
2. Because of who I am, I might have
trouble finding or keeping a job.
3. Because of who I am, I might have
trouble getting an apartment or house
5. I worry about being treated unfairly by a
teacher, supervisor, or employer.
6. I may be denied a bank account, loan, or
mortgage because of who I am.
8. I worry about being harassed or stopped
by police or security.
9. Because of who I am, people might try to
attack me physically.
10. I expect to be pointed at, called names,
or harassed when in public.

One-factor
model
loadings
0.72*

Two-factor model
loadings
1
2
0.69*
0.04

0.75*

1.08*

-0.31*

0.80*

0.78*

0.04

0.72*

0.73*

0.01

0.72*

0.51*

0.23*

0.66*

0.35*

0.34*

0.74*

0.00

0.83*

0.75*

0.01

0.83*
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11. I fear that I will have a hard time finding
friendship or romance because of who I am.

0.63*

0.30*

Eigenvalue
Correlation between factors
Root Mean Square Error of Approximation
(95% CI)

--0.091
(0.082, 0.102)
0.927

5.175

Comparative Fit Index

0.38*

0.741
0.818*
0.06
(0.050, 0.075)
0.976

Note: Models fit with Maximum Likelihood Estimator with robust standard errors, with Geomin oblique rotation
method. Coefficients statistically significant at p<0.05 are indicated with an asterisk.

Figure 6.1: Scree Plot, Exploratory Factor Analysis of Anticipated Discrimination among
Canadian respondents (n=1063)

To validate a two-factor solution, data from participants in the United States who provided
anticipated discrimination data (n=1577) were subjected to confirmatory factor analysis. A twofactor solution was requested with original Anticipated Discrimination items 1, 2, 3, 5, 6, and 8
loading on Factor 1, and items 9-11 loading on Factor 2. Results are shown in Table 6.3. The
specified model fit the data well, with all indices showing good-to-ideal fit (RMSEA=0.052;
CFI=0.980; SMSR=0.020).61 However, the two factors were highly correlated (0.93).
Cronbach’s alpha coefficient (not shown in tables) for the full 9-item scale was 0.93. Values for
the institutional (6 items) and interpersonal (3 items) anticipated discrimination subscales were
0.90 and 0.84, respectively. Item-total correlations with the full 9-item scale ranged from 0.68 to
0.79.
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Table 6.3: Confirmatory Factor Analysis of Anticipated Discrimination among United
States respondents (n=1577)
Item

1. Because of who I am, a doctor or
nurse, or other health care provider
might treat me poorly.
2. Because of who I am, I might have
trouble finding or keeping a job.
3. Because of who I am, I might have
trouble getting an apartment or house
5. I worry about being treated unfairly
by a teacher, supervisor, or employer.
6. I may be denied a bank account, loan,
or mortgage because of who I am.
8. I worry about being harassed or
stopped by police or security.
9. Because of who I am, people might
try to attack me physically.
10. I expect to be pointed at, called
names, or harassed when in public.
11. I fear that I will have a hard time
finding friendship or romance because
of who I am.
Standardized correlation between factors
Root Mean Square Error of
Approximation (90% CI)
Comparative Fit Index
Standardized Mean Square Residual

Factor Loadings
Factor 1- Institutional
Factor 2- Interpersonal
UnstanStandarUnstanStandardized
dized
dardized
dardized
(SE)
(SE)
1.00 (--)
0.81

1.07* (.03)

0.80

1.10* (.03)

0.86

1.02* (.03)

0.78

0.99* (.03)

0.79

0.98* (.03)

0.73
1.00 (--)

0.83

1.03* (.02)

0.86

0.99* (.03)

0.80

0.93*
0.052
(0.043, 0.060)
0.980
0.020

Note: Models fit with Maximum Likelihood Estimator with robust standard errors. Coefficients statistically
significant at p<0.05 are indicated with an asterisk.

Taken together, these results indicate that the Anticipated Discrimination scale has two
substantively interpretable factors, Anticipated Institutional Discrimination and Anticipated
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Interpersonal Discrimination. Nevertheless, considering the high inter-factor and item-total
correlations observed, it is acceptable to create a composite score for the full scale.

6.3.3 Discrimination Frequencies and Data Quality
Frequencies for anticipated, day-to-day, and major discrimination are displayed in Tables 6.4 to
6.7 (Canada) and 6.8 to 6.11 (United States). All items took the full range of possible values in
both countries. Less than 1.0% of data were missing for almost all items, except for past-year
major events (range from 0.4%-1.7%), which were measured with a follow-up question after
respondents indicated experiencing a major discrimination event over the lifetime. As shown in
Tables 6.4 and 6.8, on average, respondents slightly disagreed that they anticipated
discrimination (mean score [SD]= 1.5 [0.9] in Canada; 1.4 [1.0] in the United States). In Tables
6.5 and 6.9, most respondents reported any day-to-day discrimination over the lifetime (87.8% in
Canada, 79.1% in the United States), any day-to-day discrimination over the past year (63.4% in
Canada, 54.1% in the United States), or any major discrimination over the lifetime (70.8% in
Canada, 62.5% in the United States). In both countries, just under one-third of respondents
reported major discrimination in the past year (32.9% in Canada, 27.5% in the United States).

140

Table 6.4: Anticipated discrimination* reported on the Intersectional Discrimination Index
among participants in Canada (n=1065)
Median
(IQR)

Mean
(SD)

[Min,
Max]

Missing
(n)

1 (0-2)

1.4 (1.2)

[0,4]

3

2 (1-3)

1.8 (1.3)

[0,4]

3

I might have trouble getting an apartment or
house.
I worry about being treated unfairly by a
teacher, supervisor, or employer.
I may be denied a bank account, loan, or
mortgage.
I worry about being harassed or stopped by
police or security.
People might try to attack me physically.

1 (1-3)

1.5 (1.2)

[0,4]

5

2 (1-3)

1.8 (1.2)

[0,4]

8

1 (0-2)

1.2 (1.1)

[0,4]

6

1 (0-3)

1.5 (1.2)

[0,4]

2

1 (0-2)

1.4 (1.2)

[0,4]

3

I expect to be pointed at, called names, or
harassed when in public.
I fear that I will have a hard time finding
friendship or romance.
Mean score (range= 0-4)b

1 (0-2)

1.2 (1.1)

[0,4]

6

1 (0-2)

1.4 (1.2)

[0,4]

2

1.4 (0.9-2.1)

1.5 (0.9)

[0,4]

2

Because of who I am….
A doctor or nurse, or other health care
provider might treat me poorly.
I might have trouble finding or keeping a job.

*0=strongly disagree, 4=strongly agree; higher scores equal stronger agreement
a

For participants who completed at least 80% of items.
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Table 6.5: Enacted discrimination reported on the Intersectional Discrimination Index among participants in Canada
(n=1065)

Day-to-day discrimination, lifetime
(range=0-18)
Day-to-day discrimination, past-year
(range=0-36)
Major discrimination, lifetime
(range=0-26)
Major discrimination, past-year
(range=0-13)

Frequency score*
Median (IQR)
[Min, Max]
8 (3-14)
[0, 18]
2 (0-7)
[0, 36]
2 (0-6)
[0, 26]
0 (0-1)
[0, 13]

*Total scores computed for those who completed at least 80% of items.

Proportion reporting
any
n (%)

Missing
n (%)

935 (87.8)

4 (0.4)

675 (63.4)

4 (0.4)

754 (70.8)

2 (0.2)

350 (32.9)

10 (0.9)
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Table 6.6: Frequency of day-to-day discrimination reported on the Intersectional Discrimination Index among participants in
Canada (n= 1065)

Treated poorly or unfairly by a healthcare provider
Treated poorly or unfairly by a teacher or professor
Treated poorly or unfairly by a supervisor or employer
Treated poorly or unfairly by a coworker or classmate
Treated poorly or unfairly by a customer service
representative
Treated poorly or unfairly by police, border, security
officer
Treated poorly or unfairly by a transportation provider
Treated poorly or unfairly by a landlord
Treated poorly or unfairly by a relative or friend
Heard, saw, or read others joking or laughing about you
(or people like you)
Treated as if unfriendly, unhelpful, or rude
Called names or heard/saw identity used as an insult
Treated as if others are afraid of you
Stared or pointed at in public
Told that you should think, act, or look more like others
Heard that you or people like you don’t belong
Asked inappropriate, offensive, or overly personal
questions
Treated as if you are less smart or capable than others

Never
n (%)

Lifetime
only
n (%)

Many
times in
past year
n (%)
33 (3.1)
27 (2.5)
58 (5.5)
72 (6.8)
90 (8.5)

Missing
n (%)

239 (22.4)
333 (31.3)
370 (34.7)
424 (39.8)
315 (29.6)

Once or
twice in
past year
n (%)
85 (8.0)
74 (7.0)
130 (12.2)
119 (11.2)
185 (17.4)

707 (66.4)
629 (59.1)
502 (47.1)
445 (41.8)
470 (44.1)
665 (62.4)

245 (23.0)

100 (9.4)

49 (4.6)

6 (0.6)

708 (66.5)
742 (69.7)
621 (58.3)
334 (31.4)

214 (20.1)
208 (19.5)
254 (23.9)
374 (35.1)

95 (8.9)
71 (6.7)
117 (11.0)
195 (18.3)

44 (4.1)
40 (3.8)
69 (6.5)
160 (15.0)

4 (0.4)
4 (0.4)
4 (0.4)
2 (0.2)

491 (46.1)
439 (41.2)
635 (59.6)
582 (54.7)
570 (53.5)
548 (51.5)
458 (43.0)

300 (28.2)
344 (32.3)
235 (22.1)
279 (26.2)
271 (25.5)
293 (27.5)
332 (31.2)

187 (17.6)
164 (15.4)
120 (11.3)
129 (12.1)
129 (12.1)
125 (11.7)
173 (16.2)

83 (7.8)
113 (10.6)
70 (6.6)
69 (6.5)
90 (8.5)
94 (8.8)
98 (9.2)

4 (0.4)
5 (0.5)
5 (0.5)
6 (0.6)
5 (0.5)
5 (0.5)
4 (0.4)

491 (46.1)

287 (27.0)

173 (16.2)

109 (10.2)

5 (0.5)

1 (0.1)
2 (0.2)
5 (0.5)
5 (0.5)
5 (0.5)

143

Table 6.7: Frequency of major discrimination events reported on the Intersectional
Discrimination Index among participants in Canada (n= 1065)

Refused health care
Missing
No
Yes
Yes, more than once
Fired, dismissed, or turned down for a job postinterview
Missing
No
Yes
Yes, more than once
Evicted or denied housing
Missing
No
Yes
Yes, more than once
Unreasonably stopped, searched, or arrested by
police or security
Missing
No
Yes
Yes, more than once
Unreasonably suspended or expelled from school
Missing
No
Yes
Yes, more than once
Unable to open a bank account or get a loan
Missing
No
Yes
Yes, more than once
Had to move to another city, state/province, or
country
Missing
No
Yes
Yes, more than once

Lifetime
n (%)

Past year
n (%)

2 (0.2)
950 (89.2)
80 (7.5)
33 (3.1)

4 (0.4)
1005 (94.4)
56 (5.3)

3 (0.3)
666 (62.5)
243 (22.8)
153 (14.4)

11 (1.0)
930 (87.3)
124 (11.6)

5 (0.5)
889 (83.5)
129 (12.1)
42 (3.9)

8 (0.8)
1003 (94.2)
54 (5.1)

5 (0.5)
755 (70.9)
182 (17.1)
123 (11.6)

17 (1.6)
948 (89.0)
100 (9.4)

3 (0.3)
948 (89.0)
88 (8.3)
26 (2.4)

9 (0.9)
1038 (97.5)
18 (1.7)

6 (0.6)
914 (85.8)
97 (9.1)
48 (4.5)

10 (0.9)
992 (93.2)
63 (5.9)

7 (0.7)
888 (83.4)
133 (12.5)
37 (3.5)

12 (1.1)
1008 (94.7)
45 (4.2)
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Lost a close relationship
Missing
No
Yes
Yes, more than once
Repeatedly harassed at work, school, home, or when
accessing services
Missing
No
Yes
Yes, more than one place
Threatened with violence
Missing
No
Yes
Yes, more than once
Physically assaulted
Missing
No
Yes
Yes, more than once
Sexually assaulted
Missing
No
Yes
Yes, more than once
Property stolen, vandalized, or damaged
Missing
No
Yes
Yes, more than once

Lifetime
n (%)

Past year
n (%)

4 (0.4)
719 (67.5)
213 (20.0)
129 (12.1)

9 (0.9)
923 (86.7)
133 (12.5)

8 (0.8)
716 (67.2)
219 (20.6)
122 (11.5)

14 (1.3)
918 (86.2)
133 (12.5)

8 (0.8)
774 (72.7)
170 (16.0)
113 (10.6)

15 (1.4)
968 (90.1)
82 (7.7)

5 (0.5)
774 (72.7)
177 (16.6)
109 (10.2)

16 (1.5)
987 (92.7)
62 (5.8)

6 (0.6)
823 (77.3)
129 (12.1)
107 (10.1)

12 (1.1)
995 (93.4)
58 (5.5)

5 (0.5)
812 (76.2)
158 (14.8)
90 (8.5)

11 (1.0)
981 (92.1)
73 (6.9)
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Table 6.8: Anticipated discrimination* reported on the Intersectional Discrimination Index
among participants in the United States (n=1577)
Median
(IQR)

Mean
(SD)

[Min,
Max]

Missing
(n)

1 (0-2)

1.3 (1.2)

[0,4]

0

1 (0-3)

1.5 (1.3)

[0,4]

3

I might have trouble getting an apartment or
house.
I worry about being treated unfairly by a
teacher, supervisor, or employer.
I may be denied a bank account, loan, or
mortgage.
I worry about being harassed or stopped by
police or security.
People might try to attack me physically.

1 (0-2)

1.4 (1.2)

[0,4]

3

1 (0-3)

1.6 (1.3)

[0,4]

3

1 (0-2)

1.3 (1.2)

[0,4]

7

1 (0-3)

1.5 (1.3)

[0,4]

4

1 (0-2)

1.5 (1.3)

[0,4]

7

I expect to be pointed at, called names, or
harassed when in public.
I fear that I will have a hard time finding
friendship or romance.
Mean score (range= 0-4)a

1 (0-2)

1.3 (1.3)

[0,4]

7

1 (0-2)

1.3 (1.3)

[0,4]

4

1.3 (0.6-2.1)

1.4 (1.0)

[0,4]

1

Because of who I am….
A doctor or nurse, or other health care provider
might treat me poorly.
I might have trouble finding or keeping a job.

*0=strongly disagree, 4=strongly agree; higher scores equal stronger agreement
a

For participants who completed at least 80% of items.
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Table 6.9: Enacted discrimination reported on the Intersectional Discrimination Index among participants in the United States
(n=1577)

Day-to-day discrimination, lifetime
(range=0-18)
Day-to-day discrimination, past-year
(range=0-36)
Major discrimination, lifetime
(range=0-26)
Major discrimination, past-year
(range=0-13)

Frequency score*
Median (IQR)
[Min, Max]
7 (1-14)
[0, 18]
1 (0-8)
[0, 36]
2 (0-5)
[0, 26]
0 (0-1)
[0, 13]

*Total scores computed for those who completed at least 80% of items.

Proportion reporting
any
n (%)

Missing
n (%)

1248 (79.1)

6 (0.4)

853 (54.1)

6 (0.4)

985 (62.5)

7 (0.4)

434 (27.5)

20 (1.3)
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Table 6.10: Frequency of day-to-day discrimination reported on the Intersectional Discrimination Index among participants in
the United States (n=1577)

Treated poorly or unfairly by a healthcare provider
Treated poorly or unfairly by a teacher or professor
Treated poorly or unfairly by a supervisor or employer
Treated poorly or unfairly by a coworker or classmate
Treated poorly or unfairly by a customer service
representative
Treated poorly or unfairly by police, border, security
officer
Treated poorly or unfairly by a transportation provider
Treated poorly or unfairly by a landlord
Treated poorly or unfairly by a relative or friend
Heard, saw, or read others joking or laughing about you
(or people like you)
Treated as if unfriendly, unhelpful, or rude
Called names or heard/saw identity used as an insult
Treated as if others are afraid of you
Stared or pointed at in public
Told that you should think, act, or look more like others
Heard that you or people like you don’t belong
Asked inappropriate, offensive, or overly personal
questions
Treated as if you are less smart or capable than others

Never
n (%)

Lifetime
only
n (%)

Many
times in
past year
n (%)
79 (5.0)
51 (3.2)
101 (6.4)
111 (7.0)
106 (6.7)

Missing
n (%)

303 (19.2)
373 (23.7)
477 (30.3)
530 (33.6)
420 (26.6)

Once or
twice in
past year
n (%)
156 (9.9)
150 (9.5)
187 (11.9)
177 (11.2)
255 (16.2)

1039 (65.9)
999 (63.4)
810 (51.4)
757 (48.0)
786 (49.8)
996 (63.2)

308 (19.6)

181 (11.5)

86 (5.5)

6 (0.4)

1155 (73.2)
1126 (71.4)
874 (55.4)
635 (40.3)

222 (14.1)
263 (16.7)
394 (25.0)
480 (30.4)

134 (8.5)
123 (7.8)
185 (11.7)
270 (17.1)

63 (4.0)
63 (4.0)
122 (7.7)
185 (11.7)

3 (0.2)
2 (0.1)
2 (0.1)
7 (0.4)

792 (50.2)
761 (48.3)
964 (61.1)
917 (58.2)
919 (58.3)
905 (57.4)
800 (50.7)

364 (23.1)
433 (27.5)
306 (19.4)
319 (20.2)
341 (21.6)
345 (21.9)
402 (25.5)

277 (17.6)
228 (14.5)
187 (11.9)
184 (11.7)
210 (13.3)
172 (10.9)
219 (13.9)

137 (8.7)
149 (9.5)
115 (7.3)
149 (9.5)
100 (6.3)
145 (9.2)
148 (9.4)

7 (0.4)
6 (0.4)
5 (0.3)
8 (0.5)
7 (0.4)
10 (0.6)
8 (0.5)

797 (50.5)

403 (25.6)

227 (14.4)

144 (9.1)

6 (0.4)

0 (0.0)
4 (0.3)
2 (0.1)
2 (0.1)
10 (0.6)
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Table 6.11: Frequency of major discrimination events reported on the Intersectional
Discrimination Index among participants in the United States (n=1577)

Refused health care
Missing
No
Yes
Yes, more than once
Fired, dismissed, or turned down for a job postinterview
Missing
No
Yes
Yes, more than once
Evicted or denied housing
Missing
No
Yes
Yes, more than once
Unreasonably stopped, searched, or arrested by
police or security
Missing
No
Yes
Yes, more than once
Unreasonably suspended or expelled from school
Missing
No
Yes
Yes, more than once
Unable to open a bank account or get a loan
Missing
No
Yes
Yes, more than once

Lifetime
n (%)

Past year
n (%)

3 (0.2)
1369 (86.8)
148 (9.4)
57 (3.6)

11 (0.7)
1448 (91.8)
118 (7.5)

7 (0.4)
1090 (69.1)
298 (18.9)
182 (11.5)

18 (1.1)
1414 (89.7)
145 (9.2)

6 (0.4)
1341 (85.0)
165 (10.5)
65 (4.1)

15 (1.0)
1479 (93.8)
83 (5.3)

13 (0.8)
1177 (74.6)
233 (14.8)
154 (9.8)

20 (1.3)
1419 (90.0)
138 (8.8)

10 (0.6)
1416 (89.8)
111 (7.0)
40 (2.5)

19 (1.2)
1503 (95.3)
55 (3.5)

12 (0.8)
1360 (86.2)
136 (8.6)
69 (4.4)

18 (1.1)
1469 (93.2)
90 (5.7)
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Had to move to another city, state/province, or
country
Missing
No
Yes
Yes, more than once
Lost a close relationship
Missing
No
Yes
Yes, more than once
Repeatedly harassed at work, school, home, or when
accessing services
Missing
No
Yes
Yes, more than once
Threatened with violence
Missing
No
Yes
Yes, more than once
Physically assaulted
Missing
No
Yes
Yes, more than once
Sexually assaulted
Missing
No
Yes
Yes, more than once
Property stolen, vandalized, or damaged
Missing
No
Yes
Yes, more than once

Lifetime
n (%)

Past year
n (%)

13 (0.8)
1364 (86.5)
141 (8.9)
59 (3.7)

20 (1.3)
1478 (93.7)
79 (5.0)

8 (0.5)
1137 (72.1)
226 (14.3)
206 (13.1)

22 (1.4)
1405 (89.1)
150 (9.5)

7 (0.4)
1156 (73.3)
260 (16.5)
154 (9.8)

13 (0.8)
1406 (89.2)
158 (10.0)

13 (0.8)
1242 (78.8)
187 (11.9)
135 (8.6)

26 (1.7)
1458 (92.5)
93 (5.9)

9 (0.6)
1238 (78.5)
176 (11.2)
154 (9.8)

20 (1.3)
1479 (93.8)
78 (5.0)

4 (0.3)
1293 (82.0)
150 (9.5)
130 (8.2)

11 (0.7)
1481 (93.9)
85 (5.4)

10 (0.6)
1180 (74.8)
253 (16.0)
134 (8.5)

24 (1.5)
1442 (91.4)
111 (7.0)
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6.3.4 Attributions
Among those who had a score greater than 0 on the day-to-day and/or major discrimination
measure across both countries (n=2254), attributions for discrimination are described in Table
6.12. Overall, ethnicity (58.2%), race (55.0%), and gender (48.2%) were the most common
attributions provided. As expected, ethnicity, race, and citizenship or country of origin were
more common attributions among non-white versus white respondents (all p<0.001). LGBT
respondents were more likely to attribute discrimination to sexual orientation or transgender
status (both p<0.001) than non-LGBT respondents. They were also significantly more likely to
attribute discrimination to age, income, mental health or substance use, disability, or weight.
Table 6.12: Attributions among those reporting any lifetime discrimination

Age
Gender
Transgender/ gender
non-conforming
Sexual orientation
Citizenship or
country of origin
Income
Education
Mental health or
substance use
Disability
Race
Ethnicity
Religion
Language
Weight

Overall
(n=2254)
n (%)
870 (38.6)
1087 (48.2)

White
(n=292)
n (%)
114 (39.0)
144 (49.3)

Non-white
(n=1962)
n (%)
756 (38.5)
943 (48.1)

LGBT
(n=395)
n (%)
175 (44.3)*
238 (60.3)**

Non-LGBT
(n=1853)
n (%)
693 (37.4)
847 (45.7)

297 (13.2)

37 (12.7)

260 (13.3)

120 (30.4)**

177 (9.6)

463 (20.5)

63 (21.6)

400 (20.4)

267 (67.6)**

196 (10.6)

888 (39.4)

68 (23.3)**

820 (41.8)

161 (40.8)

726 (39.2)

848 (37.6)
717 (31.8)

111 (38.0)
83 (28.4)

737 (37.6)
634 (32.3)

168 (42.5)*
124 (31.4)

679 (36.6)
591 (31.9)

463 (20.5)

67 (23.0)

396 (20.2)

134 (33.9)**

329 (17.8)

420 (18.6)
1240 (55.0)
1312 (58.2)
754 (33.5)
815 (36.2)
782 (34.7)

59 (20.2)
65 (22.3)**
85 (29.1)**
90 (30.8)
93 (31.9)
116 (39.7)

361 (18.4)
1175 (59.9)
1227 (62.5)
664 (33.8)
722 (36.8)
666 (33.9)

101 (25.6)**
227 (57.5)
241 (61.0)
137 (34.7)
155 (39.2)
187 (47.3)**

319 (17.2)
1011 (54.6)
1068 (57.6)
614 (33.1)
657 (35.5)
594 (32.0)

*= p<0.05, compared to cell to the right. **= p<0.001, compared to cell to the right.

For the full sample, other attributions written in included those related to appearance or dress
(n=28), height (n=15), family structure or relationship status (n=10), veteran status (n=4),
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criminal record (n=3), or having an interracial relationship or family (n=4). Occasionally, writein attributions suggested a broader interpretation of the phrase “because of who I am” than
intended, including political or moral views (n=10), “just because” or similar responses (n=11),
or the respondent’s intelligence or attractiveness (n=7).

6.3.5 Known groups comparisons
Median frequencies for all InDI components were significantly higher among Indigenous or
racialized individuals, as compared to white individuals, including anticipated discrimination
(1.4 vs. 1.0, p<0.001), past-year day-to-day discrimination (2.0 vs. 0, p<0.001), lifetime day-today discrimination (8.0 vs. 4.0, p<0.001), past-year major discrimination (0 [IQR=0-1] vs. 0
[IQR=0-0], p=0.018) and lifetime major discrimination (2.0 vs. 1.0 p=0.004). Similarly, LGBT
individuals had significantly higher frequencies for all discrimination types as compared to
cisgender heterosexual individuals (all p<0.001), including anticipated discrimination (1.9 vs.
1.2), past-year day-to-day discrimination (3.5 vs. 1.0), lifetime day-to-day discrimination (11.0
vs. 7.0), past-year major discrimination (0 [IQR=0-2] vs. 0 [IQR=0-1]) and lifetime major
discrimination (4.0 vs. 2.0).

6.3.6 Associations with health outcomes
Of 2572 participants who provided complete data on health conditions, 37.9% (n=1001) were
classified as having a negative mental health or health behaviour outcome based on meeting at
least one of the following criteria: severe psychological distress (17.0%, n=437), current
smoking (22.4%, n=577), or hazardous drinking (16.6%, n=428). As shown in Table 6.13,
greater anticipated, day-to-day (lifetime and past year), and major (lifetime and past-year)
discrimination were each positively associated with negative mental health or health behaviour
outcomes after controlling for age, income quartile, and childhood abuse. Results of models
stratified by race/ethnicity and LGBT minority statuses did not differ appreciably for day-to-day
or major discrimination (not shown). However, when stratified by race/ethnicity, anticipated
discrimination was significantly associated with health outcomes among Indigenous or racialized
respondents (n=2197; AOR for 1-unit change=1.68, 95% CI: 1.52, 1.86), but not white
respondents (n=373; AOR=1.26, 95% CI: 0.98, 1.63).
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Table 6.13: Logistic regression of composite mental and behavioural health outcomea on
InDI components

Anticipated discrimination, current
(range=0-4)
[n=2570]
Day-to-day discrimination, lifetime
(range=0-18) [n=2564]
Day-to-day discrimination, past-year
(range=0-36) [n=2564]
Major discrimination, lifetime
(range=0-26) [n=2566]
Major discrimination, past-year
(range=0-13) [n=2545]
a One

ORb for 1-unit
change (95% CI)

AORc for 1-unit
change
(95% CI)

1.86 (1.70, 2.03)*

1.58 (1.44, 1.73)*

1.12 (1.11, 1.14)*

1.10 (1.08, 1.11)*

1.11 (1.09, 1.12)*

1.08 (1.07, 1.10)*

1.17 (1.14, 1.19)*

1.14 (1.11, 1.16)*

1.62 (1.51, 1.74)*

1.46 (1.36, 1.56)*

or more of: severe psychological distress, current smoking, hazardous alcohol use.

b

OR=odds ratio.

c

AOR=adjusted odds ratio; adjusted for age, income quartile, and childhood physical or sexual abuse.

*p<0.0001

6.3.7 Correlation and agreement with Williams measures
Frequency scores on the InDI and Williams everyday/day-to-day discrimination components
(both completed at follow-up) were strongly positively correlated (Spearman’s r=0.83, 95% CI:
0.77, 0.87). When categorized into low, moderate, or high discrimination based on tertiles,
agreement between the day-to-day discrimination measures was moderate (weighted
kappa=0.61, 95% CI: 0.51, 0.71). Twenty-three participants were classified as experiencing
more day-to-day discrimination on the Williams scale as compared to the InDI, and 23 were
classified higher on the InDI. For major discrimination, correlation between the two measures
was also high (Spearman’s r=0.76, 95% CI: 0.69, 0.82), while agreement was moderate
(weighted kappa=0.56, 95% CI: 0.46, 0.66). Twenty participants were classified as reporting
greater major discrimination on the Williams measure as compared to the InDI, while 33
participants reported greater major discrimination on the InDI.
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6.3.8 Test-retest reliability
Adjusting for the number of days between baseline and follow-up survey completion (mean=43,
range=21 to 63), the intra-class correlation coefficient (ICC) for test-retest reliability of
anticipated discrimination (n=150) was 0.72 (95% CI: 0.63, 0.79). ICCs for lifetime day-to-day
and major discrimination frequencies (n=149) were 0.78 (95% CI: 0.71, 0.83) and 0.72 (0.63,
0.79) respectively.

6.4

Discussion

6.4.1 Prevalence of discrimination
We developed and evaluated the Intersectional Discrimination Index, which includes measures
of anticipated, day-to-day, and major discrimination for use in intersectional analyses of
discrimination and health. Our attribution-free scale of anticipated discrimination is novel, and
thus comparisons to existing measures were not possible. Moreover, given intentional
oversampling of racial/ethnic and sexual/gender minorities and lack of weighting to reflect
population demographics, prevalence estimates should not be over-interpreted. However, we
note that the proportion of United States respondents reporting lifetime day-to-day or major
discrimination (79.1% and 62.5%, respectively) are broadly comparable to the results of a 2015
survey weighted to reflect the U.S. population, in which 68% reported lifetime everyday and
47% reported lifetime major discrimination on a modified version of the Williams discrimination
measures.64 Similarly, between-country unadjusted prevalence differences in our sample may
reflect sociodemographic differences (e.g., the younger average age of Canadian respondents.
However, the higher prevalence of discrimination reported by Canadians (87.8% lifetime day-today discrimination, 70.8% lifetime major discrimination) warrant further investigation.

6.4.2 Anticipated discrimination
After removing two positively-worded items that may have been tapping a different construct
(anticipation of positive treatment versus the absence of anticipated discrimination), we found
support for use of the InDI Anticipated Discrimination measure as a unidimensional scale, with a
similar structure in both Canada and the United States. We also found evidence of construct
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validity. As hypothesized, anticipated discrimination scores were higher among racial/ethnic and
sexual/gender minority groups. Anticipated discrimination was associated with negative mental
and behavioural health outcomes within the full sample, and among racial/ethnic and
sexual/gender minorities, but not among white respondents as a group. Future research could
explore the possibility that anticipated discrimination has a stronger impact on health within
groups that experience a higher level of enacted (day-to-day or major) discrimination.

6.4.3 Day-to-day and major discrimination
Known groups comparisons and associations with mental and behavioural health outcomes
provided evidence of construct validity for both enacted discrimination components of the InDI.
Both forms of discrimination were reported significantly more often by Indigenous or racialized
and LGBT persons, versus white and non-LGBT individuals. Consistent with expectations,
lifetime and past-year reports of both discrimination types were associated with higher odds of
severe psychological distress, smoking, or hazardous drinking among the full sample, and when
stratified by racial/ethnic and sexual/gender minority statuses.
Among the 150 follow-up survey participants, correlation and agreement with the measures
developed by Williams et al.28 were high, particularly for day-to-day/everyday discrimination. In
developing the InDI, we aimed to ground discrimination reports in more concrete domains or
events than previous measures, while also covering a broader range of discrimination types. For
day-to-day discrimination, it does not appear that the InDI had broader coverage: the number of
respondents who were in a higher tertile of the response distribution for the Williams measure as
compared to the InDI was equal to the number who were in a higher tertile for the InDI. In
contrast, the InDI appeared to tap more major discrimination events than the Williams index.
Our ability to draw conclusions about the relative performance and content validity of the two
instrument sets is limited by the small follow-up survey sample.

6.4.4 Test re-test validity
Test re-test reliabilities for anticipated, lifetime day-to-day, and lifetime major discrimination
were high (ICC=0.72-0.78); while not directly comparable, these coefficients are higher than the
test-retest correlations reported for the Experiences of Discrimination measure by Krieger et al.27
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While ICCs were adjusted for the number of days between baseline and follow-up, all
participants completed follow-up at least three weeks after baseline. Thus, these estimates should
be taken as lower bounds of test-retest reliability.

6.4.5 Strengths and Limitations
The development and validation of the InDI had several strengths, as well as limitations, that
should be noted. To our knowledge, the InDI is the first set of discrimination measures
developed explicitly to assess the phenomenon across all types or bases of discrimination, taking
an intersectional approach that does not require respondents to indicate which social status(es) or
position(s) they believe to have been targeted for discrimination. This evaluation benefited from
a large binational sample, including neighbouring countries that share important similarities
(e.g., sociodemographic heterogeneity) as well as differences (e.g., immigration policies and
patterns 65) that may impact the nature and measurement of discrimination.
Establishing construct validity requires a theoretical and empirical basis for hypotheses (e.g.,
regarding expected variation in discrimination prevalence and health associations). Therefore,
these analyses were not structured to evaluate the performance of the measures intersectionally
(e.g., across groups cross-stratified by multiple sociodemographic variables), nor among specific
ethno-racial groups or minority populations that have been understudied in the discrimination
and health literature (e.g., people with disabilities). Considering this preliminary evidence of the
validity and reliability of the InDI, we plan to conduct further, exploratory analyses to
investigate its measurement properties across additional axes of social status and position,
including interactions of multiple non-dominant social statuses.
Based on concerns about recall of day-to-day discrimination over the long-term, as well as the
expected low frequencies of past year major discrimination, frequency response options for the
two components were not aligned. The approximate number of discrimination events (one versus
two or more) was measured over the past year for day-to-day discrimination, and over the
lifetime for major discrimination. Nevertheless, examination of the item frequencies for lifetime
versus past-year day-to-day discrimination suggests some degree of telescoping, with high
proportions of those indicating lifetime discrimination also indicating past-year discrimination.
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However, this may also reflect the chronic nature of day-to-day discrimination, as a phenomenon
that often reoccurs with regularity among members of minority groups.42 An optimal timeframe
for measuring discrimination cannot be identified from existing research, as most measures
include a single (or unspecified) timeframe, and because the relevant timeframe will vary by type
of discrimination (e.g., cumulative, lagged, or immediate effects) and health outcome (e.g.,
latency period).24 The InDI could be used to further investigate the temporal relationships
between discrimination and health, responding to calls for better integration of life course
frameworks within the field.66 Investigators using the InDI may opt to adapt the response scales
presented here to fit their research questions and study designs.
Finally, the InDI and these analyses are subject to similar limitations as all research on selfreported, perceived discrimination. For instance, reporting of discrimination may be influenced
by personality traits, response styles, or current mental health status. The current study did not
examine personality traits or response styles. However, evidence to date indicates that
associations between reported discrimination and health outcomes persist after control for
personality traits or styles (particularly social desirability), and longitudinally when
discrimination is measured prior to health outcomes.18 Further, the construct validity of social
desirability scales as measures of response style (versus adaptive impression management) has
been questioned.67

6.4.6 Conclusion and next steps
In conclusion, the InDI measures of anticipated, day-to-day, and major discrimination show great
promise for use in intersectional discrimination research in population health, and potentially in
other fields (e.g., for social science research interested in monitoring the prevalence of
discrimination over time). In this bi-national validity and reliability study, the InDI measures
demonstrated strong construct validity and test-retest reliability. The InDI is substantively novel
in several respects, including a wider range of manifestations of discrimination than extant
measures developed from models of racism, and using the stem “because of who you are” in lieu
of attributions to specific bases of discrimination.
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To support investigators in selecting discrimination measures, future research should evaluate the
unique contribution of the InDI as compared to scales currently in common use, particularly
those initially developed to measure racism in the United States but more recently adapted for
studies of multiple discrimination types. We have not recommended the use of an overall InDI
summary score because the appropriate weights to assign to each component are unknown.
However, future research could also consider the potential for combined scores with empiricallyderived weights. To provide guidance on applications of the InDI, we are preparing a companion
paper that uses the InDI measures in combination with data on socio-demographic characteristics
and targetable attributes (e.g., visibility of stigmatized statuses) to conduct intersectional
analyses of the impacts of discrimination on specific health outcomes.
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7

Chapter 7: Integrated Discussion

7.1

Introduction

This thesis sought to examine the impacts of discrimination on health risk behaviours in
Ontario’s transgender population, and to develop and evaluate the validity of an intersectional
index of discrimination for population health research. Specifically, Chapters 2-5 explored
relationships between self-reported discrimination— alongside other potential determinants of
transgender health—and HIV-related sexual risk behaviour, heavy episodic drinking, and illicit
drug use among transgender Ontarians. These chapters drew on data from the Trans PULSE
Project, a Canadian Institutes of Health Research-funded community-based research project
which surveyed 433 trans Ontarians in 2009-2010, using respondent-driven sampling. Chapter 6
described the development of the Intersectional Discrimination Index, and provided initial
evidence of the index’s reliability and validity in a bi-national sample of 2642 Canadians and
Americans. This chapter will review key findings and their implications for health and social
service delivery, and future research.

7.2

Summary of Key Findings

7.2.1 HIV-related sexual risk among transgender Ontarians
7.2.1.1

Transfeminine persons

In many settings, transfeminine persons who have sex with men are the population most heavily
impacted by HIV,1 and risk for HIV has been correlated with experiences of discrimination2-4 as
well as social and medical gender transition.5 Chapter 2 adds to the limited evidence base
regarding HIV and other sexually transmitted infection risk in broader transfeminine populations,
particularly outside the United States.6-8 Uniquely, this chapter also considered whether similar
factors might predict both HIV sexual risk and sexual inactivity. Sexual inactivity was
approximately twice as common in this population: of those who had ever had sex, 40.8% (95%
CI: 28.9, 52.6) reported no past-year sex partners while 20.9% (95% CI: 11.7, 30.2) were at high
HIV/STI-related risk. This contrasts with previous studies of transfeminine persons, which have
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often been designed explicitly to address HIV-related sexual risk, and thus have recruited highly
sexually active samples.1
Among sexually-experienced transfeminine persons overall, anti-transgender discrimination and
violence were not independently associated with HIV/STI sexual risk or inactivity, nor were
indicators of social exclusion (e.g., lack of social or parental support). Rather, a gender transition
factor—having completed genital surgery—was associated with lower odds of both outcomes,
relative to low-risk sex.
In a sensitivity analysis employing a restricted definition of HIV-related sexual risk excluding
insertive vaginal intercourse, results were more comparable to the extant literature, with lower
incomes9,10 and experiences of transphobia2-4 being positively associated with sexual risk. This
suggests that impacts of discrimination and social exclusion on trans people’s sexual health are
context-dependent. In the U.S. context, one study postulated that differential exposure to early
trauma and abuse among transfeminine persons attracted to men (who generally “come out” and
transition at younger ages) may shape their later HIV risk and susceptibility to effects of
discrimination and violence in adulthood.11

7.2.1.2

Transmasculine persons

Relative to their transfeminine counterparts, the sexual health of transmasculine persons has been
greatly understudied.12 Two recent reviews of the literature on transgender men’s sexual health
noted that research to date has relied on very small convenience samples, and— related to small
samples—analytic studies to identify contributors to sexual risk behaviour are lacking.13,14
Considering the limited potential for sexual transmission of HIV between transmasculine persons
and cisgender female partners, Chapter 3 focused on HIV-related sexual risk among
transmasculine persons who identified as sexual minorities (e.g., gay, bisexual, queer), and/or
who reported sex with men in the past year (T-GBMSM).
In this group, discrimination and social exclusion were not associated with sexual risk. Factors
most strongly related to HIV risk among cisgender men who have sex with men— childhood
sexual abuse,15,16 depression,17 and stimulant use18—were predictive instead. In addition,
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contrary to findings among transfeminine Ontarians, gender transition was related to higher
sexual risk, and in this case, it was social rather than medical transition that had an impact.

7.2.2 Substance use among transgender Ontarians
Chapters 4 and 5 drew on Trans PULSE and Canadian Community Health Survey data to
identify predictors of heavy episodic drinking and illicit drug use among trans Ontarians, and
disparities in relation to the overall provincial population.

7.2.2.1

Heavy episodic drinking

As described in Chapter 4, the past-year prevalence of heavy episodic drinking (HED) at least
monthly was higher among trans persons than expected based on the Ontario population,
standardized to the trans age distribution. When stratified by gender spectrum, disparities were
particularly pronounced for transmasculine persons, who had the highest estimated prevalence
(42.2%). Neither discrimination nor gender transition were associated with heavy episodic
drinking. In multivariable analyses, transmasculine gender spectrum and engagement in sex
work were the only predictors of greater HED. The latter finding is consistent with high levels of
substance use in studies of sex workers,19 however, as employment in sex work was relatively
uncommon in this population (2.2%), it is unlikely to represent an important contributor to the
large disparities identified.

7.2.2.2

Illicit drug use

Past-year prevalences of both cocaine and amphetamine use were higher among trans Ontarians
than in the age-standardized Ontario population. By gender spectrum, differences were less
pronounced than for HED, and varied by substance. Within the trans population, only one gender
spectrum difference in past-year drug use was detected (transfeminine persons were more likely
to use crack cocaine). Correlations with past-year use of illicit drugs (associated with higher risk
of harm to users) within the trans population were complex. Gender transition was not associated
in bivariable or multivariable models. Both anti-transgender violence and underhousing (an
indicator of social exclusion) were associated with increased drug use, while transphobia scale
scores were not. Contrary to expectations of our minority social stress approach, social support
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was positively associated with drug use. Further, when current sex work was added to the
multivariable model, violence and underhousing were no longer significant predictors of drug
use, suggesting mediation and/or confounding. This should be cautiously interpreted given the
small number of sex workers in the sample.

7.2.3 Implications for understanding impacts of gender affirmation on transgender health
behaviours
Guided by minority stress and gender affirmation frameworks, the exploratory analyses in
Chapters 2-4 considered the relationships between health behaviours and anti-transgender
discrimination (transphobia) and violence, as well as gender transition, among trans Ontarians.
This section reflects on the implications of all four chapters for understanding the role of gender
spectrum and transition on HIV-related sexual risk and substance use. The following section
(7.2.4) reflects on implications related to discrimination and health risk behaviours.
Transmasculine persons were significantly more likely than transfeminine persons to report
heavy episodic drinking monthly or more, but the prevalences of very frequent (weekly or more)
HED and of illicit drug use did not vary by gender spectrum. While psychopharmacologic and
neuroendocrine research indicates that cisgender females are more susceptible to substance use
initiation, dependence, and addiction,20 substance misuse remains heavily concentrated in
cisgender males.21,22 However, the disparity in substance use between cisgender men and women
has been declining across recent birth cohorts, and there is no plausible biological (sex-based)
explanation for this narrowing gap.22 Rather, both cisgender population data and the current
study indicate that social gender is a salient determinant of substance use behaviour. Studies of
transgender populations offer a more direct way to disentangle natal sex and gender (i.e.,
biological versus social) effects, which are largely confounded in cisgender populations. As
discussed in Chapter 5, results in this thesis lend further support to the importance of gender
identity (as opposed to natal sex) in shaping patterns of substance use. While hormonal transition
might alter sex-linked patterns of substance use, were biological sex a more salient determinant
of substance use, we would expect to see higher prevalence of HED and illicit drug use among
transfeminine persons; this is particularly true considering that less than half were using hormone
therapy, and most had transitioned within the previous few years.23
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As postulated by gender affirmation approaches to health risk behaviours among transfeminine
persons,24,25 it is plausible that some transmasculine persons engage in drinking behaviours
associated with masculinity as part of affirming gender identity. Qualitative research on the
motivations underlying health risk behaviours among transmasculine persons is needed to
contextualize findings of this thesis.
Gender spectrum differences in HIV-related sexual risk behaviour cannot be directly compared,
given the different subpopulations studied: all sexually-experienced transfeminine persons versus
T-GBMSM. In the former group, approximately 1 in 5 had at least one high-risk sexual
encounter in the past year, in the latter group, 1 in 10 did so. While this implies that
transfeminine persons are more likely to engage in HIV-related sexual risk, it is important to
recall that the outcome was defined to include vaginal or anal intercourse to ejaculation (with a
“flesh” penis). Therefore, transfeminine persons had more ways to engage in HIV risk behaviour
than did T-GBMSM (because ~99% could not be the insertive partner in intercourse we defined
as high-risk). Finally, a comprehensive evaluation of gender spectrum differences in HIV risk
behaviour would need to consider the actual HIV/STI risk associated with reported behaviour,
particularly partner characteristics, on which data were not collected.
With respect to social and medical gender transition, no impact on substance use was evident.
The relationship between transition and sexual risk behaviour varied by gender spectrum. Having
genital surgery predicted better sexual health outcomes among transfeminine persons (higher
odds of low-risk sex versus risky sex or inactivity). The negative association with sexual
inactivity may reflect reduced gender dysphoria as well as enhanced access to sexual partners,
considering the difficulties transfeminine individuals can face in finding respectful partners.8
Genital surgery was associated with a 92% reduction in the estimated odds of HIV-related sexual
risk, while feminizing hormone use was not significantly related. This is consistent with the
expectation of the gender affirmation framework that those with access to external and internal
gender affirmation will be less inclined to seek affirmation through sexual interactions,
potentiating risk behaviour.24 It also suggests that genital surgery is particularly important in this
regard, which is not surprising given the social emphasis placed on genitalia in defining
womanhood.26
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Among transmasculine persons at the time of data collection, genital surgery was extremely
uncommon (~1%23; 4 of 227 transmasculine participants). In this group, social transition (but not
hormone therapy) was associated with higher HIV-related sexual risk. This, too, appears
consistent with the gender affirmation framework: T-GBMSM have reported that following
social transition, sexual activity with gay and bisexual cisgender men can be an important source
of gender affirmation for which they are sometimes willing to take health risks.27,28

7.2.4 Implications for understanding impacts of minority stress on transgender health
behaviours
As measured (with a scale including internalized, anticipated, and enacted stigma29), transphobia
was largely unassociated with the outcomes examined in this thesis, while anti-transgender
violence was correlated with illicit drug use only. This is in contrast to previous Trans PULSE
findings of associations between transphobia and both depressive symptomatology30,31 and
suicidality.32
This pattern of results could be interpreted to indicate that transphobia is not a key determinant
of health risk behaviours among trans Ontarians. Across populations, discrimination is more
consistently associated with psychological distress than with health behaviours.33,34 Yet,
alternative explanations remain to be explored. First, exposure to some degree of transphobia is
nearly ubiquitous among trans Ontarians: 98% reported at least one experience.29 Within-group
analyses cannot detect effects of invariant exposures35,36—in this case, to any discrimination.
Rather, these thesis analyses asked whether increasing exposure to transphobia predicted risky
health behaviours within the trans population. Schwartz and Meyer35 argue that social stress
theory proposes a larger model, in which group disadvantage negatively impacts health directly,
and mediated by discrimination-related stressors. An ideal test of this model would use betweengroups and mediational analyses “that can capture the workings of stress…[and] its differential
effect” (p. 1116). To evaluate the effects of discrimination on behavioural health disparities
identified in this thesis, such a complete test would require discrimination measures that work
across social groups (so that discrimination can be evaluated as a mediator of disparities).
Reisner et al. provide a model of such an approach in a paper focused on gender minority
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disparities in adolescent substance use,37 in which the hypothesized mediator (bullying) was a
discrimination-related stressor, but measured without attribution to specific social positions.
It may also be the case that various forms of transphobia are differentially related to mental
health versus health behaviour outcomes. The Trans PULSE transphobia scale included 11 items.
Of these, four might be considered major discrimination events following this thesis’ schema:
being physically assaulted, denied employment, having to move, or being harassed by police. As
such discrete events can be independent of one another, they should be measured
comprehensively (i.e., sampling from all domains) and analyzed as an index or checklist rather
than as a psychometric scale.38-40
Another three items could be classified as day-to-day discrimination experiences: being made
fun of, hearing that trans people are not normal, or being objectified or fetishized sexually. The
remaining four items reflect internalized and/or anticipated stigma: feeling that being trans
embarrassed one’s family, trying to “pass” as non-trans, worrying about growing old alone, and
fearing dying young. If, as the social stress and discrimination literatures suggest, categories of
discrimination stressors are differentially associated with health outcomes,41 combining them
into a single scale may obscure effects. In addition, these types of discrimination vary in terms of
duration and chronicity of exposure, and potentially in etiologic period (the lag between
exposure and consequent health outcome).38,42,43
At the same time, the distribution of risky health behaviours within trans populations may be
distributed unevenly based on multiple, intersecting forms of discrimination. Marcellin
investigated the interacting effects of racism and transphobia on HIV-related sexual risk in her
thesis.29,44 As previously discussed, this analysis was limited by the fact that the study employed
transphobia and racism scales with a number of overlapping items. Discrimination that trans
people may experience due to other social statuses or positions was not assessed. Nevertheless,
she found that transphobia did predict increased HIV-related risk behaviour, but only among
Indigenous or racialized trans persons who were exposed to high levels of racism as well.
Therefore, while we can provisionally conclude that discrimination is more strongly related to
internalizing mental health conditions than to health behaviours among trans Ontarians, further
research should employ more comprehensive and intersectional measures of discrimination to
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test this hypothesis. The Intersectional Discrimination Index developed as part of this thesis is a
candidate for such a measure.

7.2.5 Validity and reliability of the Intersectional Discrimination Index
As described in Chapter 6, the Intersectional Discrimination Index (InDI) was developed through
a literature review, construct map, and series of expert consultations to measure anticipated, dayto-day, and major discrimination related to any social status or position. In this thesis, initial
validity and reliability analyses were conducted with a focus on measurement properties among
racial/ethnic and sexual/gender minorities, groups for which the body of research on measuring
discrimination and its health consequences is more developed. Online survey panel members in
Canada and the United States (n=2642) completed socio-demographic questions, the InDI, and
measures of mental and behavioural health. No data quality or acceptability concerns were
identified: missing data did not exceed 1.7% for any variable, and all items took the full range of
possible values. In test-retest reliability analyses, the InDI components demonstrated strong
reliability in comparison to other discrimination measures in the literature,45 with intra-cluster
correlation coefficients between 0.72-0.78.
After removal of two positively worded items that may have tapped a different construct, factor
analyses of the Anticipated Discrimination InDI scale found support for two interpretable
factors: anticipated institutional (6 items) and anticipated interpersonal discrimination (3 items).
Due to a very high factor inter-correlation (0.93) and high item-total correlations for the full 9item scale, use of the overall scale score (rather than subscales) appears suitable.
Results of known-groups comparisons consistently supported the hypothesis that racial/ethnic
and sexual/gender minorities would report significantly higher levels of each discrimination type
relative to the respective majority group (white persons or cisgender heterosexuals). All but one
of the hypothesized associations between discrimination and health were detected, employing a
composite mental and behavioral health outcome (1 or more of psychological stress, smoking,
hazardous drinking). Specifically, in the full sample, day-to-day and major discrimination over
both the lifetime and the past year, as well as anticipated discrimination, were associated with
higher odds of reporting one or more of the negative health outcomes. The pattern of results did
not differ when stratified, except when examining anticipated discrimination stratified by
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race/ethnicity: among white respondents only, anticipated discrimination was not significantly
associated with health outcomes. Limited variation in anticipated discrimination, or limited
salience of anticipated discrimination for members of socially dominant groups, are potential
explanations for this finding.
Results of comparisons to the Williams Everyday and Major Discrimination items,46 however,
were less conclusive with respect to the potential incremental validity of the InDI; Spearman
correlations between the measures using a lifetime frame were high (0.76 and 0.83). When
agreement was assessed using tertiles to classify scores as low, moderate, or high, the level of
agreement was moderate. The InDI demonstrated a slight advantage only for major
discrimination, by tapping a wider range of discrimination experiences (and thus a greater
number of experiences).
Day-to-day discrimination frequencies may depend less on the specific instrument used, as the
experiences are less discrete and may be more likely to cluster, whether because of
characteristics associated with being targeted for discrimination, or with perceiving and
reporting. It is also possible that differences in coverage between the two sets of measures were
washed out by the combination of the wider scope implied by the Williams item stem (“unfair”
treatment without reference to social position) and the wider range of discrimination
manifestations queried by the InDI. These possibilities require further research, as the small
follow-up sample size (n=150) limited our ability to conduct more in-depth analyses to explore
the incremental validity of the InDI relative to the Williams measures. Priming may have also
contributed to the high correlation and agreement observed. While correlations were calculated
between scores for the InDI completed at baseline and the Williams measures completed at
follow-up, respondents also completed the InDI a second time (to estimate test-retest
reliability) immediately preceding the Williams measures.

7.2.6 Implications for measuring discrimination in population health research
The development of the InDI was initially motivated by practical and conceptual problems we
encountered in investigating the impacts of discrimination using Trans PULSE Project data.
Building on common approaches in the discrimination and health literature, the Trans PULSE
survey included two discrimination measures—one for racism, and another for transphobia.
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While the research team was interested in assessing other forms of discrimination, they decided
that adding yet another scale would not be feasible in the context of a survey that was already 87
pages long.
From an intersectional perspective, requiring participants to disaggregate experiences of
discrimination into those based on race/ethnicity and those based on trans status was
problematic.47,48 Considering this challenge, and that fact that the two scales included a number
of parallel items (e.g., being turned down for a job, objectified sexually, harassed by police), it is
likely that they were “double-counting” some experiences. In addition, as discussed in section
7.2.4, the scales collapsed multiple dimensions of discrimination (day-to-day, major, anticipated,
and internalized) that may have differential impacts on health (e.g., for depression versus heavy
drinking) and etiologic periods.
The Introduction to this thesis showed that these motivating problems are not unique to Trans
PULSE, but are common in studies wherein multiple dimensions of discrimination, and/or
multiple bases of discrimination are of interest. Despite increasing attention to both
discrimination33,34 and intersectionality49,50 in population health research, there have been few
attempts to develop universal instruments to measure discrimination, and little conceptual debate
about the promises and pitfalls of such attempts.51 The InDI was intended to fill this gap by
explicitly measuring enacted (day-to-day and major) and anticipated discrimination based on
social position or status—versus generic “unfair treatment” — irrespective of attribution. To this
end, the item stems ask respondents to report experienced based on “who you are”, defined as:
“…both how you describe yourself and how others might describe you. For example, your skin
colour, ancestry, nationality, religion, gender, sexuality, age, weight, disability or mental health
issue, and income.”
Although we were concerned that this inclusive stem could encourage reporting of generic (nondiscriminatory) mistreatment, results indicate that almost all respondents interpreted the wording
as intended. To evaluate this possibility, an overall attribution question was asked of all those
who reported any discrimination. Only 28 respondents (1.1%) wrote-in an attribution that falls
outside of our definition of social discrimination (e.g., mistreatment based on personality).
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Beyond the question stem, a central feasibility question for the InDI was whether the same item
sets could meaningfully tap discrimination experiences across population groups defined by
intersecting social positions along lines of race, ethnicity, class, immigration status, gender,
sexuality, and so on. In developing the InDI, we drew on conceptual models of the functions and
manifestations of stigma and discrimination52,53 and strove to select a representative set of items.
This thesis focused on evaluating performance across race, ethnicity, sexuality, and gender
identity, finding evidence that the measure performed well among both racial/ethnic and
sexual/gender minority groups.
In summary, the analyses described in Chapter 6 provide preliminary evidence that the
Intersectional Discrimination Index can resolve the challenges to intersectional population health
research on discrimination that motivated its development. Questions remain concerning
incremental validity relative to existing discrimination measures, and the measures’ validity
across the full range of non-dominant social statuses and positions. Using the dataset collected
for this thesis, we will be able to investigate the latter, drawing on information collected
pertaining to social status and position, as well as targetable attributes (e.g., visible membership
in a religious minority group, perceived gender non-conformity).

7.2.7 Implications for prevention and health services
Findings of Chapters 2-5 have important implications for providers of health and social services
to trans individuals and communities. First, service providers should take note of the
heterogeneity of health behaviour risk within trans communities. The disproportionate burden of
HIV and substance use risks among trans people—including disparities demonstrated in this
thesis— should be recognized and responded to. However, we estimated that over the previous
year, 79% of sexually-experienced transfeminine Ontarians and 90% of T-GBMSM were at low
or no risk of sexually-transmitted HIV, while 67% of trans Ontarians did not drink heavily on a
regular basis and 88% did not use drugs associated with a high risk of harm to themselves.
Hence, trans people constitute a “vulnerable” population rather than an “at-risk” population;
Frohlich and Potvin define the former as a group “at risk of risks” due to social-structural
conditions, while the latter comprise those individuals at highest risk of a specific health
outcome.54 Of course, most-at-risk subgroups exist within any vulnerable population; one task of
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this thesis was to identify such groups in Ontario’s trans population. Since the 1985 publication
of Geoffrey Rose’s seminal contribution,55 a lively debate has been taking place in the public and
population health literature regarding the relative merits of disease prevention efforts focused on
the whole population versus on “high-risk” groups.54,56-58 Neither is necessarily the correct
approach; rather, over the longer-term, macrostructural conditions and ubiquitous exposures
must be addressed to shift the population distribution of health while, at the same time,
implementing interventions to prevent morbidity and mortality in those at highest immediate
risk.57
Applying this framework to interventions within the trans population, it becomes apparent that
supra-individual interventions are required to shift the entire distribution of health in trans
populations, considering the ubiquity of some degree of social exclusion and the high burden of
mental health conditions in particular.30-32 However, in the shorter-term, services should
prioritize prevention of HIV infection and substance use-related harms among the minority of
trans persons who are currently at-risk. This is particularly the case when delivering services that
are most appropriate for people already at some risk; for example, a blanket HIV testing
campaign for transfeminine communities may not be an appropriate use of resources when half
of the population is not sexually active. Universal approaches can also contribute to stigma by
labelling entire vulnerable populations as at-risk. Moreover, such universal approaches risk
worsening inequalities because they rely on individual agency, which is most challenged among
those at higher risk due to social-structural conditions.54 For example, for trans sex workers (who
we found to be at elevated risk of potentially hazardous substance use), efforts to promote access
to substance use services in the trans population at large may be less useful than targeted services
which address the specific barriers they face.59,60
In addition to considering the appropriate balance of overall trans population versus high-risk
prevention strategies, service providers should recognize heterogeneity of trans populations with
respect to gender spectrum and processes of social and medical gender affirmation, and take an
individualized approach to prevention, avoiding assumptions. Contrary to the assumption that
transfeminine persons are primarily impacted by substance use,19 we found that any past-year use
of illicit drugs did not vary by gender spectrum, while heavy drinking was concentrated among
transmasculine persons.
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Providers should be alert to potential changes in health behaviours related to various facets of
gender affirmation: social and medical, as well as forms not evaluated in the Trans PULSE study
(e.g., psychological self-affirmation of gender identity61). Among transfeminine persons, genital
surgery was associated with lower prevalence of sexual risk and inactivity. While this association
warrants further study, particularly longitudinally, these potential benefits may be considered in
decision-making processes related to individual treatment plans and health system policies
regarding access to surgery. Providers should also note that gender affirmation, while potentially
health-promoting overall, can also be associated with health risks (e.g., HIV risk behaviour
among T-GBMSM).
To address sexual health, physicians and other health care providers who interact with trans
patients should ensure to take complete sexual histories and to inquire about changes in sexual
behaviour and related risks, following cultural competence guidelines.62 For transfeminine
persons, the majority of whom were at HIV/STI risk due to insertive genital sex (i.e., with
cisgender women or transmasculine persons), sexually transmitted infections screening should be
considered irrespective of apparent HIV risk. Of course, sexual health extends beyond the
avoidance of disease, encompassing sexual well-being and pleasure. Primary care providers have
a role to play in screening and counselling for problems patients may have with achieving
desired sexual intimacy,63 and our results suggest that such attention is particularly indicated for
transfeminine individuals. Similarly, brief screening for problematic alcohol use is an evidencebased primary care intervention64 that should be implemented in trans patient care, considering
the heavy burden of binge drinking documented in Chapter 4.
Beyond primary care settings, the results of this thesis have implications for specialized HIV
prevention and substance use treatment services. Related to HIV prevention among T-GBMSM,
in previous studies, a preference for accessing services for gay and bisexual men has been
expressed.29 In this study, key determinants of HIV risk among cisgender gay and bisexual men
were also associated with such risk among T-GBMSM, lending support to the feasibility of these
preferences. Given the small size of the population, inclusion within such existing services (e.g.,
those delivered by AIDS Service Organizations across Ontario) may also be more efficient. It is
likely that T-GBMSM who are primarily attracted to men and who are living in their felt gender
(particularly if they identify as men) will be most comfortable accessing such services; these
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groups were also those found to be at elevated risk of HIV in this study. Service-side barriers to
inclusion (e.g., lack of inclusive policies or provider practices), however, may limit the ability of
T-GBMSM to take advantage of prevention programming.65 Results described in Chapters 4 and
5 indicate need for substance use prevention and treatment for trans sex workers. Flexible,
mobile or street-based outreach programs with peer involvement have shown effectiveness for
linking marginalized sex workers with substance use treatment in other settings.60

7.2.8 Implications for future research
At present, information on transgender status is not collected in any Statistics Canada surveys,
including the Canadian Community Health Survey (CCHS), the primary source of data on the
health status of Canadians. Given this, we evaluated trans-cisgender disparities in substance use
by comparing respondent-driven sampling survey data from Trans PULSE to CCHS data,
standardized to the trans population age distribution. While RDS data are theoretically
generalizable to the networked target population, this generalizability rests on assumptions that
may not be met in practice.66 Measurement and survey mode differences are further threats to the
validity of our estimated prevalence differences. Ultimately, better understanding of the health of
the trans population in Canada, and disparities with cisgender Canadians, will require inclusion
of measures to assess sex assigned at birth and gender identity and/or lived gender in population
health surveys.67 In the United States, some population-based surveys and surveillance systems
have begun collecting and reporting data on trans status, and the results are confirming some
disparities hypothesized based on convenience and respondent-driven sampling data, while
challenging others.68-70
To consider the impact of discrimination as a predictor of poor health outcomes within the trans
population, future research should employ measures of discrimination that disaggregate its
various dimensions, which may have different antecedents, and consequences for health. To
consider discrimination as a potential mediator of disparities with cisgender populations, surveys
which include both cisgender and trans populations (including but not limited to populationbased surveys) will need to include cross-group discrimination measures, such as the InDI.
The results of this thesis also raise the intriguing possibility that discrimination is a less salient
predictor of trans health risk behaviours in Canada, as compared to the United States. In a recent

177

24-country survey of public opinion on transgender issues, Canada had the third-highest score in
support of trans rights, while the United States ranked 8th. In 2012, gender identity and
expression were added as protected grounds under the Ontario Human Rights Code. As of March
2017, such protections formally exist in nine provinces and one territory, with legislation
pending in The Yukon, New Brunswick, and federally.71 While Trans PULSE study data predate
these legal changes, these advances nonetheless reflect a social climate that is more favorable to
trans people, as compared to the United States, where the right of trans people to use the
washroom that aligns with their gender identity continues to be a contentious subject of public
policy debate and legal struggle.72 In the United States, “structural stigma”, including negative
public opinion as well as laws and policies that marginalize sexual and gender minorities, has
been associated with poor health outcomes among sexual and gender minority adults and
adolescents.73-75 Thankfully, variation in legal protections based on gender identity, expression,
and sexuality within Canada is likely insufficient for such multi-level analyses. However, crossnational research would offer novel opportunities to examine relationships between trans human
rights policy and legislation, experiences of discrimination, and health outcomes.
The development and validation of the Intersectional Discrimination Index also raises several
intriguing questions for future research. In addition to assessing incremental validity against the
Williams Everyday and Major Discrimination46 measures in larger samples, comparisons could
be made with other measures that have been used to evaluate discrimination across groups, such
as Krieger’s Experiences of Discrimination scale.45 Further, while this thesis provided initial
evidence of English-language validity and reliability in Canada and the United States, validation
of translated versions (particularly French and Spanish) and validation or adaptation for other
country contexts would increase the InDI’s utility for comparative research and multilingual
population health surveys. Also, while measuring discrimination for its own sake is important
(e.g., to monitor trends in discrimination), we developed the InDI with the intent to study the
effects of discrimination on mental and behavioural health, and their roles as mediators of health
inequalities. Thus, we are preparing a companion paper to Chapter 6 which will demonstrate the
use of the InDI for such analyses, with an intersectional analytic approach.
Finally, the unadjusted descriptive results in Chapter 6 indicate that reports of discrimination
were higher among Canadian respondents, contrary to expectations. This may be an artifact of
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demographic differences, particularly the younger median age of Canadian participants. The data
collected as part of this thesis can also be used to determine whether cross-national differences
are artefactual, or robust to adjustment for demographic differences. If self-reported
discrimination is indeed more prevalent among Canadians than among demographically-similar
Americans, this would not necessarily conflict with the observation that Canada appears to offer
a more hospitable social environment for trans persons and other minority groups. Rather,
Canadians may perceive more discrimination precisely because a more hospitable climate
contributes to a greater expectation of fair treatment, and higher sensitivity to violations of this
expectation. A higher prevalence of perceived discrimination also need not translate into a
stronger relationship between discrimination and health outcomes. Temporal changes in
discrimination also warrant investigation, as the current political climate in the United States has
been associated with concerns about persistent and rising discrimination across multiple bases
(e.g., race, gender, religion)76 and increases in hate-motivated violence.77 These unfolding events
make evident the timeliness and urgency of research on discrimination and health.

7.3
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Appendices
Appendix A: Trans PULSE Project Survey

PLEASE NOTE:
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This copy of the survey is for informational use only. Please do not fill out and submit this
copy of the survey.
To collect information from surveys, Trans PULSE is using a method called "respondent-driven
sampling." This strategy requires that once completed, people that have been invited to
participate pass the survey along to other people they know and who are eligible to complete
it also. You should only fill out and submit the survey if you have been approached to do so.
The reason for this is that this method allows us to produce more accurate statistics.
Following this, the information produced from this method of collection will be considered
more reliable by policymakers and other stakeholders.

Fo

rI

Please feel free to read over this copy of the survey. If you have any questions or comments,
do not hesitate to contact us at
or email us at
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Provincial Survey
2009

Introduction
Thank you so much for taking the time to answer the questions in this survey. The results will go a long way to
help promote equality for trans communities in Ontario and beyond. We greatly appreciate your contribution.
This survey will eventually be completed by 1000 trans-identified people and people of trans experience across
Ontario. We've chosen particular kinds of questions to make sure that the results are useful to trans
communities, meaningful to us, and able to affect our lives for the better.

Why is this survey important?
This survey is important because it is driven and owned by community members who want to improve our
quality of life. It's essential to be able to have every voice heard and to have the real experiences of what it is
like to be trans or to transition in Ontario in order for services to change and to understand how the health of
our community is affected by the problems and challenges thrown our way.

Where did the questions on this survey come from?
Some of the questions in this survey were designed by members of our communities, and other questions come
from existing surveys so we can compare our results to theirs. This will enhance the success of our study in
creating change and improving things for us.
We know that some of the questions on the survey may seem very straightforward and basic. What's really
unique about this survey is that we've written many questions that relate to our real lives. For example, the
supports in our lives, how we feel about ourselves, the health issues that concern us, and our experiences with
services. Understanding these issues can help us promote change for trans communities. This survey is also
important because trans people across Ontario told us these issues were meaningful.

What will come of the results of this survey?
The survey itself is not the final step of our project. Once we've collected the surveys from you and analysed the
information, we will be talking to 60 to 80 trans people in more detail to help us understand our results. Input
from trans people is so important to make sure results are interpreted from our perspective. We will ensure that
the results of this study do not sit on a shelf somewhere, but rather are put into action to improve our health
and well-being.
We realize that this survey is long, but we appreciate the time you are taking to fill it out. Please feel free to
save it and come back to it at a later time. Also, if you have more to say on any of the topics we cover, there is
space at the end of the survey for you to tell us your thoughts.

A note on the following term:
“trans, trans-identified or trans experience” - these phrases are used in different places in the survey and
in the articles and information created by the Trans PULSE Project more generally. Identities and labels are
important parts of our lives and how we think about ourselves. At the same time, it's difficult to use a single term
to cover all people who are trans, transgendered, cross-dressers, transsexual, genderqueer, or those who have
transitioned and identify simply as `women' or `men.' So, we've decided to use these phrases as a means of
including all trans people, with an understanding that some people may not always identify as trans at all times
and stages in their life.
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A. One question (or three) before you begin…
This study uses new ways to reach more trans people than traditional surveys that are given out at
doctors' offices or at clubs or support groups. We want to know how well our method works. We
would like to know whether or not you might have completed the survey in one of these other places,
if we'd done this differently.

A1. If you were asked to complete this survey at your doctor's or therapist's office, would you have done it?

Yes
Likely yes
Likely not
No
A2. If you were asked to complete this survey at a trans or LGBT community event, would you have
done it?
Yes
Likely yes
Likely not
No
A3. In the past 12 months, have you … (Please check all that apply)

Been a client of a psychiatrist or psychologist who sees many trans clients
Been a patient of a doctor or clinic where many trans patients go
Attended a trans support group
Gone to trans-specific nights at a bar or club
Been a member of a LGBT student group
Gone to an event at a LGBT community centre
Been a member of a LGBT religious group
Been a client at a gender-identity clinic
None of the above
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B. About You
These first questions are meant to give you a chance to tell us some basic information about yourself.

B1. How old are you?
Years old

B2. What was your assigned sex at birth?
Male
Female
B3. Have you been diagnosed with a medically-recognized intersex condition?
Yes
No
Unsure
B4. Which of the following describes your present gender identity? (Please check all that apply)
Boy or Man
Girl or Woman
FTM
MTF
Trans Boy or Trans Man
Trans Girl or Trans Woman
Feel like a girl sometimes
Feel like a boy sometimes
T Girl
She-male
Two-spirit
Intersex
Crossdresser
Genderqueer
Bi-gender
Other, please specify:
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B5. Which of the following reflect your ethno-racial background? (Please check all that apply)
Aboriginal (First Nations, Métis or Inuit)
Latin American (e.g. Argentina, Mexico, Nicaragua)
East Asian (e.g. China, Japan, Korea, Taiwan)
Indo-Caribbean (e.g. Guyanese with origins in India)
South Asian (e.g. India, Sri Lanka, Pakistan)
Middle Eastern (e.g. Egypt, Iran, Israel, Saudi Arabia)
South East Asian (e.g. Vietnam, Malaysia, Philippines)
White Canadian or White American
White European (e.g. England, Greece, Sweden, Russia)
Black Canadian or African-American
Black African (e.g. Ghana, Kenya, Somalia)
Other, please specify:
B6. How do you identify your own ethno-racial background?
Please specify:

B7. Are you perceived or treated as a person of colour?
Yes
No
B8. What is your first language?
Please specify:

B9. What languages are most often spoken in your home?
First language:
Second language:
Third language:

B10. What country were you born in?
Canada
Other, please specify:
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B11. How long have you been living in Canada?
Years

B12.

Months

Are you...?
First Nations
Métis
Inuit
None of the above

B13. What is your status in Canada?
Canadian Citizen
Permanent resident/landed
Refugee
Refugee Claimant / PRRA / Judicial Review
Work permit / temporary work papers
Visitor permit
Student permit
Undocumented / Non-status / Without papers
I don't know
Other, please specify:

B14. Are you currently enrolled in elementary school, middle school, high school, college, trade school, or
university?
Yes, full-time
Yes, part-time
No
B15.

At this point, what level of education have you completed (in Canada or any other country)?
Did not graduate from high school
High school graduate
Some college or trade school
College or trade school graduate
Some university
University - bachelor's degree
University - graduate or professional degree
I don't know
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B16. When you were a child, what was the religious or faith practice of your family? (Please check all that
apply)
Aboriginal Spirituality
Agnostic
Anglican
Atheist
Bahá'í
Buddhist
Catholic
Hindu
Jewish
Mennonite
Amish
Islamic
Protestant Christian
Sikh
Unitarian
No religion
Other, please specify:

B17. How religious or faith-based was your upbringing?

1
not at all

2
a bit

3
somewhat
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B18. What is your current religious or faith practice? (Please check all that apply)
Aboriginal Spirituality
Agnostic
Anglican
Atheist
Bahá'í
Buddhist
Catholic
Hindu
Jewish
Mennonite
Amish
Islamic
Protestant Christian
Sikh
Unitarian
No religion
Other, please specify:

B19. Right now, how religious or spiritual are you?
1
not at all

2
a bit

3
somewhat

4
fairly

B20. What are the first three digits of your postal code?

The first three digits of my postal code are:
I don't know my postal code
I don't have a postal code, as I don't have a home right now
I don't have a postal code, as I am in the military
I don't have a postal code, as I am in the prison system
B21.

Do you live on a reserve?
Yes
No
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B22. How do you currently identify? (Please check all that apply)
Bisexual
Gay
Lesbian
Asexual
Pansexual
Queer
Straight or heterosexual
Two-Spirit
Not sure or questioning
Other, please specify:
B23. Are you attracted to…? (Please check all that apply)
Trans men
Non-trans men
Trans women
Non-trans women
Genderqueer or bigendered people
None of the above
Other, please specify:

Although a lot of health costs are covered by health insurance, there is still a relationship between our
health and our incomes. Please know that, like all other information you have provided, these answers
will be kept confidential.
B24. What is your best estimate of the total income, before taxes and deductions, of all household
members from all sources in the past 12 months?
Less than $5,000.00
$5,000 to less than $10,000
$10,000 to less than $15,000
$15,000 to less than $30,000
$30,000 to less than $40,000
$40,000 to less than $50,000
$50,000 to less than $60,000
$60,000 to less than $80,000
$80,000 to less than $100,000
$100,000 or more
I don't know
I'd rather not say
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B25. Including yourself, how many people were being supported on this household income? Please include
everyone who is being supported, including those who may live outside of Canada.

Number of people

We recognize that, as a community, we work in all types of fields. When we talk about work and
income, we are talking about all types of income-generating activity, both formal and informal
employment. This includes not only jobs, but income earned through activities ranging from public
speaking to sex work to child care.
B26. From which of the following sources did your household receive any income in the past 12
months? (Please check all that apply)
Wages and salaries
Income from self-employment
Dividends and interest (e.g. on bonds, savings)
Employment Insurance (E.I.)
Worker's compensation
Benefits from Canada or Quebec Pension Plan
Retirement pensions, superannuation and annuities
Old Age Security and Guaranteed Income Supplement
Child Tax Benefit
Provincial or municipal social assistance or welfare (including Ontario Works or Ontario Disability
Support Program-ODSP)
Child support
Alimony
None
Other (e.g. rental income, scholarships, parental support), please specify:

Will Rowe
Will Rowe is a member of the provincial Community Engagement Team which guides the Trans PULSE Project.
Will is a former lesbian feminist turned tranny poststructuralist. He has been active for over 20 years within
queer communities of Guelph, K-W, Toronto and Hamilton where he has resided for the past five years. He will
be attending MAC in the fall of '08 to complete his MSW. Will currently co-facilitates Hamilton's trans peer
support group and HIFY's Rainbow Youth Drop-in. He is a step-parent of two daughters and the grandparent of
four grandsons. Will enjoys spending time at home with his partner (and their dog) gardening, completing
home renovations and reading critical theory.
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B27. What is your best estimate of your total personal income, before taxes and other deductions,
from all sources in the past 12 months?
Less than $5,000.00
$5,000 to less than $10,000
$10,000 to less than $15,000
$15,000 to less than $30,000
$30,000 to less than $40,000
$40,000 to less than $50,000
$50,000 to less than $60,000
$60,000 to less than $80,000
$80,000 to less than $100,000
$100,000 or more
I don't know
I'd rather not say
B28. If you have socially or medically transitioned and are living in your felt gender, what is your best estimate
of the highest annual personal income you earned, before taxes and other deductions, from all sources
before you transitioned?
Less than $5,000.00
$5,000 to less than $10,000
$10,000 to less than $15,000
$15,000 to less than $30,000
$30,000 to less than $40,000
$40,000 to less than $50,000
$50,000 to less than $60,000
$60,000 to less than $80,000
$80,000 to less than $100,000
$100,000 or more
I don't know
I'd rather not say
Not applicable, I have not transitioned
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B29. Are you currently living with any of the following? (Please check all that apply)
Labelled with an intellectual disability
Learning disability
Autism, Aspergers or neuro-diverse spectrum
Mental health disability (including depression)
As a survivor of the psychiatric system
Blind, low vision or visual impairment
Communication disability (use of augmentative or alternative communication)
Physical or mobility disability
Chronic pain
Chronic illness
None of the above
B30. Are you?
Deaf
Deafened
Hard of hearing
None of the above
B31. What is your current relationship status?
Single and not dating
Single and dating
In a monogamous relationship
In a non-monogamous (open) relationship
In a polyamorous (multiple people) relationship
B32. What is your legal marital status right now?
Never married
Separated
Divorced
Widowed
Living common-law
Married
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B33. About how old were you when you first became aware that your own sense of your gender did not match
your body or physical appearance?
Years old

B34. Are you currently living in your felt gender?
Yes, full-time
Yes, part-time
No
B35. If yes, at what age did you begin living in your felt gender?
Years old
Not applicable
B36. In your day-to-day life, do you use a different name or pronoun from the one that you were given at birth,
one that better reflects your gender identity?
Yes
No
B37. Have you asked any of the following people to call you by a different name or pronoun, one which reflects
your gender identity?
Have done

Plan to do

My parent(s)
My sibling(s)
My spouse(s) or partner(s)
My child(ren)
My extended family
My roommates
My trans friends
My non-trans friends
My church/temple/mosque
My cultural community
My co-workers
My employer
My supervisor/boss
My teachers
My school
My classmates
Page 13 of 87
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B38. Have you legally changed your name to reflect your current gender identity?
Yes (skip to question B40)
No
B39.

If No, do you want to?
Yes
No

B40. For the following forms of legal identification, are you listed as “male” or “female?”
Male

Female

I don't have
this/
not relevant

Driver's license
Ontario Birth certificate
OHIP card (health card)
Non-Ontario birth certificate
Canadian passport
Other (non-Canadian) passport
Certificate of Indian status card
Canadian citizenship card
Canadian permanent resident card
Canadian armed forces card
“Bring your ID” Card/age of majority card

B41. Do your academic transcripts accurately reflect your current name and gender identity?
Yes
No
Not applicable
B42. Can you get letters of reference (for jobs, school, etc.) that accurately reflect your current name and
gender identity?
Yes
No
Not applicable
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B43. Which of the following applies to your current situation regarding hormones and/or surgery?
I have medically transitioned (hormones and/or surgery)
I am in the process of medically transitioning
I am planning to transition, but have not begun
I am not planning to medically transition
The concept of "transitioning" does not apply to me
I am not sure whether I am going to medically transition
B44. If you started or completed a medical transition, how old were you when you began?
Years old
Not applicable
B45. Why is changing your body important to you? (Please check all that apply)
For my self-esteem
For my mental well-being
For my safety
For employment reasons
To be comfortable in my own body
My work depends directly on my body presentation
It's not important to me
Other, please specify:

Nael Bhanji
Nael is a half East-Indian, half Arab, queer, transguy who has spent most of his life in Kenya and now resides in Toronto,
Ontario. A graduate student at the Women and Gender Studies Institute at the University of Toronto, he is passionate about
queer, transgender, post-colonial and diasporic theory. When not in nerd-mode, he is also partial to crosswords, safaris, film
festivals, soccer, basketball and warm socks. Nael is a member of the provincial Community Engagement Team which guides
the Trans PULSE Project.
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C. Overall Health Care
In the next few sections, we would like to learn about your experiences with finding competent and respectful
health care and social services.
This first care-related section deals with overall health care.

C1. Do you have Ontario Health Insurance Program (OHIP) coverage?
Yes
No
C2. The following four questions refer to health care broadly, not just trans-related care.

Excellent

Good

Fair

Poor

Overall, how would you rate the availability of health
care services in Ontario?
Overall, how would you rate the quality of the health
care services available in Ontario?
Overall, how would you rate the availability of health
care services in your community?
Overall, how would you rate the quality of the health
care services available in your community?

C3. During the past 12 months, was there ever a time when you felt that you needed health care but didn't
receive it?

Yes
No
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We know this next section takes more time than others in the survey, but we appreciate your effort in
answering these important questions.
C4. For each type of service listed in Column 1, please indicate if you have needed the service in the past 12
months. If you did not need it, please go on to the next line (i.e. next service).
If you check Yes for any service(s) in Column 2, please indicate whether you were able to obtain this service in
Column 3. If you check No, please indicate the reason(s) you were unable to obtain this service in Column 4 by
choosing from the options in the list.
Column 1:
Service

Column 2

Column 3

Column 4

In the past 12 If yes, were you able Use the list of options on page 20 to indicate the top
months, have
to obtain this service? reason(s) you were unable to obtain this service
you needed this
service?
Addictions services

YesJ

Yes

No

J

#1

No
#2
#3
Emergency services

YesJ

Yes

No

J

#1

No
#2
#3
General health care
services

YesJ

Yes

No

J

#1

No
#2
#3
Sexual health care

YesJ

Yes

No

J

#1

No
#2
#3
Trans-related
hormonal therapy

Yes J

Yes

No

J

#1

No
#2
#3
Trans-related
surgery of any kind

YesJ

Yes

No

J

#1

No
#2
#3
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Column 1:
Service

Column 2

Column 3

Column 4

In the past 12 If yes, were you able Use the list of options on page 20 to indicate the top
months, have
to obtain this service? reason(s) you were unable to obtain this service
you needed this
service?
Trans-related
electrolysis

YesJ

Yes

No

J

#1

No
#2
#3
Trans-related
speech therapy

YesJ

Yes

No

J

#1

No
#2
#3
HIV or sexuallytransmitted
infections testing

YesJ

Yes

No

J

#1

No
#2
#3

Sexual health
information

YesJ

Yes

No

J

#1

No
#2
#3
Pap smears

YesJ

Yes

No

J

#1

No
#2
#3
Breast exams

YesJ

Yes

No

J

#1

No
#2
#3
Mammograms

YesJ

Yes

No

J

#1

No
#2
#3
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Column 1:
Service

Column 2

Column 3

Column 4

In the past 12 If yes, were you able Use the list of options on page 20 to indicate the top
months, have
to obtain this service? reason(s) you were unable to obtain this service
you needed this
service?
Prostate exams

Yes

J

Yes

No

J

#1

No
#2
#3
Fertility Services

Yes

J

Yes

No

J

#1

No
#2
#3
AIDS service
organizations

Yes

J

Yes

No

J

#1

No
#2
#3
Shelter and hostel

Yes

J

Yes

No

J

#1

No
#2
#3
Sexual assault
centres

Yes

J

Yes

No

J

#1

No
#2
#3
Mental health care
services for
reasons other than
being trans

Yes

J

Yes

No

J

#1

No
#2
#3

Trans-related
mental health
services

Yes

J

Yes

No

J

#1

No
#2
#3
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Column 1:
Service

Column 2

Column 3

Column 4

In the past 12 If yes, were you able Use the list below to indicate the
months, have
to obtain this service? reason(s) you were unable to obtain this service
you needed this
service?
Adoption services

Yes

J

Yes

No

J

#1

No
#2
#3

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.

I don't know if this service is available in my area
The service is not available in my area
I didn't meet the requirements
The service or program was full
The waiting time was too long
I don't have coverage for this service
I cannot afford to pay for it
I was denied approval for this service
The staff are insensitive or hostile to trans people
Other patients or clients might be insensitive or hostile to me
I have difficulties accepting my own trans status
There were not appropriate bathrooms
This service did not accommodate my disability
There were language problems
I was afraid my immigration status would be revealed
I found these services to be culturally insensitive
The service provider might be racist
I have pre-existing mental health conditions
I have pre-existing physical health concerns
I haven't gotten around to it
I didn't know where to go
I had problems with transportation
I was not able to find child care
I had personal or family responsibilities
I dislike doctors or am afraid of them
There was too much stigma around this service
There is too much stigma because I'm a sex worker
I didn't want my HIV+ status to be revealed
Other (please specify):
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C5. Do you trust in doctor-patient confidentiality when it comes to receiving trans-related care?
Completely
Mostly
Not much
Not at all

C6. While living in Ontario, what is the furthest distance you have ever traveled for trans-related physical or
mental health care?
Within my city, town or township
To another city or town in Ontario. How far away by car?

Hours

Minutes

To another province. Please specify:
To another country. Please specify:
I have never received trans-related health care.
C7. How far did you travel to get to your most recent appointment for trans-related physical or mental health
care?
Within my city, town or township
To another city or town in Ontario. How far away by car?

Hours

Minutes

To another province. Please specify:
To another country. Please specify:
I have never received trans-related health care.

Liz James
Liz James is a 2-Spirited Transsexual Warrior Born in Toronto. A graduate from the school of Hard Knox.
Having once been a Prostitute, Bank robber, Heroin/Cocaine addict, and thus ending up in Federal Prison for
5 years. Fast forwarding to the present day: Raven has discovered her First Nation 2-Spirit heritage.
Obtained Sex re-assignment surgery, and turned over a new leaf. She has returned to school in order to
better help her community. Liz is a member of the provincial Community Engagement Team which guides
the Trans PULSE Project.
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D. Emergency Care
D1. Have you ever avoided going to the emergency room when you needed care because you are trans?
Yes
No
I have never needed emergency care
D2. Have you ever used emergency room services presenting in your felt gender?
Yes
No (skip to Section E)
D3. For each of the following, has an emergency care provider ever…? (Please check all that apply)
Refused to see you or ended care because you were trans
Used hurtful or insulting language about trans identity or experience
Refused to discuss or address trans-related health concerns
Told you that you were not really trans
Discouraged you from exploring your gender
Told you they don't know enough about trans-related care to provide it
Belittled or ridiculed you for being trans
Thought the gender listed on your ID or forms was a mistake
Refused to examine parts of your body because you're trans
None of the above
D4. Have you ever had to educate an emergency care provider regarding your needs as a trans person?
Yes, provided a lot of education
Yes, provided some education
Yes, provided a little education
No
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E. Family Medicine
E1. Do you have a regular family doctor?
Yes (skip to Question E2)
No
E1a. If no, have you ever tried to get a family doctor and not been able to?
Yes (skip to Question E5)
No (skip to Question E5)
E2. Does your current family doctor know about your trans identity or experience?
Yes
No
I'm not sure
E3. How comfortable are you discussing your trans status and trans-specific health care needs with your
family doctor? (Please check only ONE response)
Very uncomfortable
Uncomfortable
Comfortable
Very comfortable
E4. How knowledgeable is your family doctor about trans-specific health care needs? (Please check only ONE
response)
Not at all knowledgeable
Somewhat knowledgeable
Knowledgeable
Very knowledgeable
E5. How comfortable would you be discussing your trans status and/or trans-related health care needs with
a doctor you did not know? (Please check only ONE response)
Very uncomfortable
Uncomfortable
Comfortable
Very comfortable
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E6. Do you use walk-in clinics as your primary source of health care?
Yes
No
E7. If yes, how comfortable are you discussing your trans status and/or trans-related health care needs with a
doctor at a walk in clinic? (Please check only ONE response)
Very uncomfortable
Uncomfortable
Comfortable
Very comfortable
E8. For each of the following, has a family doctor ever…? (Please check all that apply)
Refused to see you or ended care because you were trans
Used hurtful or insulting language about trans identity or experience
Refused to discuss or address trans-related health concerns
Told you that you were not really trans
Discouraged you from exploring your gender
Told you they don't know enough about trans-related care to provide it
Belittled or ridiculed you for being trans
Thought the gender listed on your ID or forms was a mistake
Refused to examine parts of your body because you're trans
None of the above
Not applicable, I have never used this service
E9. Have you ever had to educate a family doctor regarding your needs as a trans person?
Yes, provided a lot of education
Yes, provided some education
Yes, provided a little education
No

Tyson Purdy-Smith
Tyson Purdy-Smith is a member of the provincial Community Engagement Team which guides the Trans
PULSE Project. Tyson is a 21-year-old transman from Halifax, Nova Scotia. He has been a singer all his life
and an amateur actor since he was 13. He lives in an attic decorated with Les Miserables memorabilia and
black-and-white abstract art. He likes poofy white shirts and multicoloured hand-knit socks. He really likes
it when people who've read his bio-blurb offer to buy him bubble tea.
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E10. For each of the following, has a walk in clinic doctor ever…? (Please check all that apply)
Refused to see you or ended care because you were trans
Used hurtful or insulting language about trans identity or experience
Refused to discuss or address trans-related health concerns
Told you that you were not really trans
Discouraged you from exploring your gender
Told you they don't know enough about trans-related care to provide it
Belittled or ridiculed you for being trans
Thought the gender listed on your ID or forms was a mistake
Refused to examine parts of your body because you're trans
None of the above
Not applicable, I have never used this service
E11. Have you ever had to educate a walk-in clinic doctor regarding your needs as a trans person?
Yes, provided a lot of education
Yes, provided some education
Yes, provided a little education
No
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F. General Mental Health Care
People use mental health care services for a variety of reasons. This section asks only about
experiences in seeking mental health care for reasons other than your gender identity. Section G will
ask about mental health care related to gender identity or transition.
F1. Have you ever used mental health care services for reasons other than being trans, while presenting in
your felt gender?
Yes
No (skip to Section G)
F2. I received mental health care for the following: (Please check all that apply)
Depression
Anxiety disorders (panic attacks, post traumatic stress disorder)
Addictions
Bipolar disorder
Schizophrenia
Borderline personality disorder
Stress
Anger management
Grieving or bereavement
Eating disorders
Relationship issues
Suicidal thoughts
Couples/Relationship counselling
Dissociative identity disorders (e.g. multiple personality disorder)
Other, please specify:

F3. Who did you see or talk to? (Please check all that apply)
Family doctor or general practitioner
Psychiatrist
Psychologist
Nurse
Social worker or counsellor
Aboriginal Elder
Religious or spiritual leader
Support group
Other, please specify:
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F4. For each of the following, when seeing a mental health provider for reasons other than being trans, has a
mental health provider ever…? (Please check all that apply)
Refused to see you or ended care because you were trans
Used hurtful or insulting language about trans identity or experience
Refused to discuss or address trans-related health concerns
Told you that you were not really trans
Discouraged you from exploring your gender
Told you they don't know enough about trans-related care to provide it
Belittled or ridiculed you for being trans
Thought the gender listed on your ID or forms was a mistake
None of the above
F5. When seeing a mental health provider for reasons other than being trans, have you ever had to educate
that mental health provider regarding your needs as a trans person?
Yes, provided a lot of education
Yes, provided some education
Yes, provided a little education
No
F6. In the past 12 months, have you used mental health care services for reasons other than being trans?
Yes
No (skip to Section G)
F7. Whom did you see or talk to in the past 12 months? (Please check all that apply)
Family doctor or general practitioner
Psychiatrist
Psychologist
Nurse
Social worker or counsellor
Aboriginal Elder
Religious or spiritual leader
Support group
Other, please specify:
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F8. In the last 12 months, how satisfied were you with your experience(s) with mental health care providers?
Very satisfied
Satisfied
Neither satisfied nor dissatisfied
Dissatisfied
Very dissatisfied

Caleb Nault
Caleb is a white, 24 year old, queer-identified trans guy who is currently completing his MA in Sociology at
York University. He is a member of the provincial Community Engagement Team which guides the Trans
PULSE Project. Caleb comes from a family of truck drivers and loves to travel (by bike during the summer,
and grudgingly by transit in the winter). His current research interests include the negotiation of trans
subjectivity and the autobiographical imperative, social determinants of health for trans people, theorizing
the body, autoethnographic research methods, and anti-psychiatry, madness, and whiteness studies. He
currently lives in Parkdale with his amazing partner, Megan, and their cat, Chandler.
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G. Trans-related Mental Health Care
G1. Have you ever used mental health services related to your trans identity or experience?
Yes
No (Skip to Section H)

G2. Whom did you see or talk to? (Please check all that apply)
Family doctor or general practitioner
Psychiatrist
Psychologist
Nurse
Social worker or counsellor
Aboriginal Elder
Religious or spiritual leader
Support group
Other, please specify:

G3. At what age did you first see a mental health care provider to discuss your trans identity or experience?

Years old
G4.

Thinking back to your overall experiences discussing your needs as a trans person with a mental health
care provider, how satisfied were you with your experience?
Very satisfied
Satisfied
Equally satisfied and dissatisfied
Dissatisfied
Very dissatisfied
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G5. Thinking back to your most recent experience discussing your needs as a trans person with a mental health
care provider, how satisfied were you with your experience?
Very satisfied
Satisfied
Equally satisfied and dissatisfied
Dissatisfied
Very dissatisfied
G6. For each of the following, when you used mental health care services related to your trans identity, has a
mental health care provider ever…? (Please check all that apply)
Refused to see you or ended care because you were trans
Used hurtful or insulting language about trans identity or experience
Refused to discuss or address trans-related health concerns
Told you that you were not really trans
Discouraged you from exploring your gender
Told you they don't know enough about trans-related care to provide it
Belittled or ridiculed you for being trans
Thought the gender listed on your ID or forms was a mistake
None of the above
G7. When using mental health care services related to your trans identity, have you ever had to educate your
mental health provider regarding your needs as a trans person?
Yes, provided a lot of education
Yes, provided some education
Yes, provided a little education
No

G8. In the past 12 months, have you used mental health care services related to your trans identity or
experience?
Yes
No (skip to Section H)
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G9. Whom did you see or talk to in the past 12 months? (Please check all that apply)
Family doctor or general practitioner
Psychiatrist
Psychologist
Nurse
Social worker or counsellor
Aboriginal Elder
Religious or spiritual leader
Support group
Other, please specify:

Matt Lundie
Matt is an Ottawa-area FTM who has been involved in the Ottawa queer communities for the past 10
years and is a member of the GBQ Trans Mens' Working Group. Currently a public servant working in
an unrelated field, Matt's experience includes facilitating workshops for various community-driven
initiatives, volunteering for the Ottawa Men's Survey, OASIS (a drop-in centre for street active and atrisk people), the Ottawa Police Liaison Committee, and the GLBT Cultural Competence Project.
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H. HIV and Sexually Transmitted Infections
H1. In your lifetime, have you been diagnosed with any of the following? (Please check all that apply)
Gonorrhoea (the clap)
Chlamydia
Genital herpes
Syphilis
HPV (Genital or anal warts)
Abnormal Pap test (cervical HPV)
Hepatitis B
Hepatitis C
I have not been diagnosed with any of these
I'd rather not say

H2. In the past 12 months, have you been diagnosed with any of the following? (Please check all that apply)
Gonorrhoea (the clap)
Chlamydia
Genital Herpes
Syphilis
HPV (Genital or anal warts)
Abnormal Pap test (cervical HPV)
Hepatitis B
Hepatitis C
I have not been diagnosed with any of these
I'd rather not say
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H3. Have you ever not gotten tested, or delayed getting tested for HIV for any of these reasons? (Please check
all that apply)
It was not important to me to get tested
I hadn't had sex recently, so I didn't believe I needed to get tested
I always had safer sex, so I didn't believe I needed to get tested
I felt healthy, so I didn't believe I needed to get tested
I didn't know where to get anonymous testing
I didn't want my partner to know I got tested
I didn't want other people to know I got tested
I was afraid I might be HIV positive
The HIV testing staff are/have been hostile or insensitive to me
I don't believe I'm at risk
I didn't want my insurance company to know my HIV status
I always used clean needles so I didn't believe I needed to get tested
I have delayed getting tested, or not gotten tested for other reasons (please specify):

H4. Have you ever had an HIV test?
Yes
No (skip to Question H6)
H5. When was your most recent HIV test?
Less than 6 months ago
6 months to less than 1 year ago

Evana Ortigoza

1 to less than 2 years ago

My name is Evana Ortigoza. I was
born in Maracaibo, Venezuela on
January 28 1965. My family sent me
away at the age of 12 to Spain and I
studied a marketing degree and
Ballet from the University of
Barcelona. When I came to Canada
in 1994 I danced with the National
Ballet of Canada for 4 years. I am
currently an Outreach Worker at The
519 Community Centre working with
trans women who are working in the
sex-trade in downtown Toronto. I
also help to coordinate the weekly
Meal Trans Drop-In for low-income
trans people. I am forever grateful
for the opportunity to work with
other trans people and to improve
my own life. Evana is a member of
the
provincial
Community
Engagement Team which guides the
Trans PULSE Project.

2 or more years ago
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H6. Why have you gone to get an HIV test? (Please check all that apply)
Someone suggested I should be tested
I felt I had unsafe sex
I had sex with someone who I knew was HIV positive
I had sex with someone who I suspected was HIV positive
I shared needles or drug-using equipment
I thought I might have been exposed at work
I just wanted to find out if I was infected or not
It was part of a routine medical check-up, or for hospitalization or surgical procedure
I was feeling sick
I had been sexually assaulted
I had to for life insurance coverage
I had to for immigration
I was concerned I could give HIV to someone
No particular reason
Don't know
Some other reason (please specify):
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I. HIV-Related Care
I1. Are you….?
HIV Positive
HIV Negative (skip to Section J)
I don't know (skip to Section J)
I would rather not say (skip to Section J)
I2. When did you find out that you are HIV positive?
Year

Month

I3. Of the following options, which best describes the way you most likely became HIV positive? (Please check
only ONE response)
I don't know
Unprotected sex
Broken condom or other failed barrier
Sharing needles or other drug-using equipment
Sharing needles while injecting hormones or silicone
Received tainted blood product
Sexually assaulted or raped
Needle stick as a health care worker
Tattoo or piercing
Born with HIV
Other, please specify:

I4. Do you currently have a doctor who regularly treats you for your HIV-related needs?
Yes
No
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I5. For each of the following, has the doctor(s) who provides your HIV care ever…? (Please check all that apply)

Refused to see you or ended care because you were trans
Used hurtful or insulting language about trans identity or experience
Refused to discuss or address trans-related health concerns
Told you that you were not really trans
Discouraged you from exploring your gender
Told you they don't know enough about trans-related care to provide it
Belittled or ridiculed you for being trans
Thought the gender listed on your ID or forms was a mistake
Refused to examine parts of your body because you're trans
None of the above
I have never seen a doctor for HIV-related needs

I6.

Have you ever had to educate the doctor who provides your HIV care regarding your needs as a trans
person?
Yes, provided a lot of education
Yes, provided some education
Yes, provided a little education
No

I7. Are you currently taking any medications to treat HIV/AIDS?
Yes
No (skip to Section J)

I8. Are you currently taking trans-related hormones with your HIV medications?
Yes
No (skip to Section J)

I9. Does the doctor who prescribed your HIV medications know you also take hormones?
Yes
No
I don't know
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I10. Did the doctor discuss any possible interactions between the hormones and the HIV medications, or the
effects of HIV on hormonal levels in your body?
Yes
No
I don't recall

Catherine Purdie
Catherine refers to herself as a "grass roots, low key influencer" and takes advantage of every opportunity to
participate in speaking events to educate the public that transgender people have a lot to offer society.
Before retiring in October 2007 she worked in senior management at a financial institution where she
developed a strong background in technology and senior management, and took pride in developing many
other leaders and leading large projects. She now spends her time actively involved in several GLBT and
non-GLBT organizations in the Ottawa area and pursuing her hobby of writing and photography. Catherine is
a member of the Trans PULSE's provincial Community Engagement Team.
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J. Gender-Related Hormones
J1. What is your primary source of information regarding hormones?
Family
Friends
Internet / Websites
Trans community people and organizations
Doctor (GP, Specialist)
Medical Journals
Other(s), please specify:

J2. Do you feel you have enough information about hormones for gender transition or gender confirmation?
Yes
No
Not Sure
I do not need information on hormones

J3.

Do you have prescription drug coverage of any kind?
Yes, through the province (Ontario Drug Benefits or Trillium Drug Program)
Yes, through employer- or school-provided insurance
Yes, through parent's insurance
Yes, through private insurance I have purchased
Yes, through having Aboriginal status
Yes, through the military
Yes, through the federal prison system
No

J4. Whether or not you are now taking them, do you have prescription drug coverage for hormones?
Yes
No
Not sure
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J5. Have you ever tried to get a prescription for hormones and not been able to?
Yes
No
I have never tried to get a prescription for hormones

J6. Have you ever taken hormones for trans-related reasons?
Yes (skip to Question J7)
No

J6a. If you have never taken hormones, which best describes your situation?
Not planning on taking hormones
Still deciding if taking hormones is right for me
Can't find a doctor to prescribe hormones
Other, please specify:

If you have never taken any hormones, please skip to Section K

Devi McCallion
Devi is an enthused seventeen year old transwoman who's modest, yet lustrous personality doesn't
particularly shine through the medium of a short bio written in third person. When she's not pretending to be
the type of person to regularly use the world lustrous, Devi dedicates time to local peer outreach groups and
fussily contributes to her ever-growing song writing catalogue. After years spent particularly muted as a
home-schooled youth in a small town, she's doing her best to make up for lost time by propelling herself
deeply into what she believes to be a more responsible level of social activism.
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J7. In the following table, please specify whether you have ever taken any of the listed hormones, the
year you started taking each type of hormone(s), and the total amount of time you have been on each
hormone, excluding any breaks.
Column 1
Hormones

Progesterone

Column 2

Column 3

Column 4

Have you
ever taken
the hormone
(s) listed in
Column 1?

If you check `yes' for
any hormone in
Column 2, please state
the year you first
started taking the
hormone(s)

If you check `yes' for any
hormone in Column 2, please
state the total amount of time
you've been on the
hormone(s), excluding any
breaks

YesJ

Year

Years

Months

Year

Years

Months

Year

Years

Months

Year

Years

Months

Year

Years

Months

Year

Years

Months

Year

Years

Months

No
YesJ

Estrogen

No

Testosterone blockers/ anti-androgens

YesJ
No

Testosterone

YesJ
No

Puberty blockers

YesJ
No

Other, please specify:

YesJ
No

Other, please specify:

YesJ
No

J8. From which source(s) have you ever received your hormones? (Please check all that apply)
Family doctor or GP
Specialist (e.g. endocrinologist)
Internet pharmacy
Friend or relative
Street/strangers
Herbals or supplements
Veterinary sources
Other(s), please specify:
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J9. Do you currently take hormones?
Yes, under medical supervision
Yes, without medical supervision
No (skip to Section K)

J10. Which hormone(s) are you currently taking? (Please check all that apply)
Progesterone
Estrogen
Anti-androgens / Testosterone blockers
Testosterone
Puberty blockers
Other(s), please specify:

J11. From which source(s) do you currently get your hormones? (Please check all that apply)
Family doctor or GP
Specialist (e.g. endocrinologist)
Internet pharmacy
Friend or relative
Street/strangers
Herbals or supplements
Veterinary sources
Other(s), please specify:

J12. Have you ever received blood tests to monitor the effect of hormones on your body?
Yes, I receive regular blood tests
Yes, but not regularly
No
I'm not sure whether blood tests were done

J13. Do you take hormones by injection?
Yes
No (skip to Section K)
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J14. Where do you get your syringes or needles? (Check all that apply)
Pharmacy
Doctor's office
Friends
Needle exchange
Street
Other(s), please specify:

J15. Have you ever been in a situation where you had to use a needle or syringe to inject your hormones that
had been used before by someone else?
Yes
No
Don't know

J16. Do you think you have enough knowledge about how to safely inject hormones?
Yes
No
Don't know
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K. Surgery and Body Modifications
K1. For each of the following procedures, please indicate which applies to you:
Don't
want/need

Considering

Want

Orchiectomy (removal of testicles)
Vaginoplasty (SRS/GRS; making a
vagina)
Hysterectomy (removal of uterus)
Oophorectomy (removal of ovaries)

Metaoidioplasty (releasing the
clitoris)
Urethral lengthening
Testicular Implants (creating
testicles)
Phalloplasty (making a penis)
Breast Augmentation (making
breasts bigger)
Breast Reduction (making breasts
smaller)
Mastectomy or Chest Reconstruction
(`top surgery')
Facial Surgeries (feminization/
masculinization)
Vocal Chord Surgery (making voice
higher)
Facial Hair Removal (laser or
electrolysis)
Adams Apple Shave
Hair Transplants
Other, please specify:
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K2. How much money have you spent out-of-pocket on hormones, silicone and any of the above procedures?
None
$1 to less than $1,000
$1,000 to less than $2,500
$2,500 to less than $5,000
$5,000 to less than $10,000
$10,000 to less than $20,000
$20,000 to less than $50,000
$50,000 to less than $100,000
$100,000 or more
K3. Have you ever performed any of the above procedures on yourself?
Yes
No
K3a. If so, please tell us what you did:

K4. Have you ever injected silicone?
Yes
No (skip to Section L)
K5. In the past 12 months, how many times have you injected silicone?
None
1
2
3
4
5
More than 5 times
K6. Have you ever been in a situation where you had to use a needle or syringe to inject silicone that had been
used before by someone else?
Yes
No
Don't know
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L. Making Money
L1. Do you currently have any of the following assets? (Please check all that apply)
Retirement savings (RRSPs, RIFs, or pension from employer)
GICs, stocks, or mutual funds outside of RRSPs
Home you own
Rental property (residential or commercial)
Car that is owned outright
None of the above
Other assets, please specify:

L2. Do you currently have any of the following debts? (Please check all that apply)
Credit card debt
Line of credit
Mortgage
Loan debt (e.g. car loan, medical loan, student loan)
None of the above
Other, please specify:

L3. Has being trans affected your credit history?
Yes, for the better
Yes, for the worse
No

Michelle Le-Claire
Michelle is a trans-activist who is actively involved in fighting for Trans Human Rights. She is the Executive
elected as Commissioner of Advocacy and Equity on the Board of Directors Executive Committee for the
Students' Association of George Brown College. It is there that she is earning her SSW diploma as a full
time student, and has intentions to further her education through attaining her MSW degree. She also cofacilitates Trans Youth Toronto at The 519, is part of THRIVE!-TS/TG Housing and Employment Program at
the Fred Victor Centre, a Programming Committee Member for Egale's Gender Variance Conference, and
volunteers for many other not-for-profit organizations. Her key interests are fighting oppression and
advocating for trans communities, in particularly, gender variant and/or trans youth. Michelle is a member
of Trans PULSE's provincial Community Engagement Team, helping to guide the Project.

Page 45 of 87

231
L4. Which of the following describes your employment situation? (Check all that apply)
Employed in a permanent full-time position (35 hours or more per week)
Employed in a permanent part-time position (less than 35 hours per week)
Employed on contract full-time (35 hours or more per week as a temporary or casual worker)
Employed on contract part-time (less than 35 hours per week as a temporary or casual worker)
Self-employed full-time (35 hours or more per week)
Self-employed part-time (less than 35 hours per week)
On leave from work
Not employed (not a student, retired, or disabled)
Student
Retired
Receiving disability (ODSP)
Receiving Employment Insurance (EI)
Receiving General Social Assistance (welfare or workfare)

L5. About how many hours a week do you usually work at your job or business? If you usually work extra hours,
paid or unpaid, please include these hours.
Hours

L6. How many jobs do you currently have?
Number of jobs

L7. How long have you been in your current job (if you work multiple jobs, respond based on the longest job you
currently have)?

Months

Years
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L8. What type of paid work do you do right now (Check all that apply)?
No paid work
Accounting/Finance/Insurance/Banking
Administrative/Clerical
Aesthetics/Hair/Make-up
Agriculture, Forestry, & Fishing
Arts, Entertainment, and Media
Automotive/Motor Vehicle
Building Construction/Skilled Trades
Business
Computer Services/Hardware/Software
Consulting Services
Counselling
Creative/Design
Customer Support/Client Care
Drug Trade
Editorial/Writing
Education/Training
Electronics
Engineering
Escort work
Food Services/Hospitality/Travel/Tourism
Government and Policy
Healthcare/medicine
Legal services/law
Manufacturing
Military
Nonprofit
Personal Care and Service
Printing/Editing/Writing
Research/academia
Retail/Sales
Science/biotechnology
Sex Work
Sports and Recreation/Fitness
Other, please specify:
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L9. How satisfied are you with your job or main activity?
Very satisfied
Satisfied
Neither satisfied nor dissatisfied
Dissatisfied
Very dissatisfied
L10. Right now, do you work in the field/job you would like to be working in?
Yes (skip to Question L11)
No
L10a. Why are you not working in the field/job you would like to be working in? (Please check all
that apply)
There are no jobs available in my field
Do not have necessary education/training
Education/training earned in another country is not recognized as equivalent in Canada
Fear of discrimination for being trans
Previous experiences of discrimination for being trans
Employers do not accommodate my disability
Disability
Other, please specify:

L10b. What is the one main reason why you are not working in the field/job you would like to be
working in?
There are no jobs available in my field
Do not have necessary education/training
Education/training earned in another country is not recognized as equivalent in Canada
Fear of discrimination for being trans
Previous experiences of discrimination for being trans
Other forms of discrimination
Employers do not accommodate my disability
Other, please specify:
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L11. Have you ever done sex work or exchanged sex for money or other resources (e.g. shelter, drugs, food)?
Yes
No (skip to Question L12)
L11a. If yes, what were your reasons for doing so? (Please check all that apply)
It paid well
It was necessary to pay for living expenses
It was necessary to pay for transition-related expenses (e.g. surgery, hormones)
To be part of a community
To affirm my gender identity
It made me feel attractive
None of the above
L11b. How would you describe your experience with sex work?
Entirely positive
Mostly positive
An equal mix of positive and negative
Mostly negative
Entirely negative
L12. When applying for a job, have you ever not provided references from a previous job because of your trans
identity or experience?
Yes
No
L13. Have you ever declined a job offer due to a lack of a trans-positive work environment?
Yes
No
L14.

Do you believe you've ever been turned down for a job because you are trans?
Yes
No
Unsure
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L15. If you medically and/or socially transitioned in the workplace, how often were your employers and
coworkers accepting during this period of time?
Always
Very frequently
Occasionally
About half the time
Rarely
Very rarely
Never

L16. Have you ever been fired, constructively dismissed, or laid off because of your trans identity or gender
expression?
Yes
No
Not sure
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L17.

Please rank your monthly expenses from most important to least important, with 1 being the most
important.
Designate all items that are not expenses for you because you don't have them or they are paid by
someone else as not applicable ("NA"):

Rent or home payment
Groceries
Hormones
Other prescription drugs
Alcohol and/or recreational drugs
Saving for surgery
Transportation-related expenses
Hair removal
Saving money for education
Paying off money borrowed for education (student loan)
Paying off money borrowed for surgery or other gender-related medical care
Paying off other debt
Clothing
Vacation
Entertainment
Providing for my children
Sending money home to family
Saving money for retirement
Saving money for other purposes
Legal expenses
Counselling
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M. Living and Eating
M1. Which of the following statements best describes the food eaten in your household in the past 12 months? (Choose ONE)
You and your household always had enough of the kinds of food you wanted to eat
You and your household had enough to eat, but not always the kinds of food you wanted
Sometimes you and your household did not have enough to eat
Often you and your household didn't have enough to eat
Don't know
M2. Was that often true, sometimes true, or never true in the past 12 months?
Often true
Sometimes true
Never true
Don't know
M3. Which best describes your current housing situation?
I own a house
I rent a house
I own an apartment or condo
I rent an apartment or condo
I live in housing on a Reserve
I live on a Metis Settlement
I live in an Inuit Hamlet
I live in subsidized or public housing
I live in a group home
I live in a long-term care facility
I live with my parents or family
I live in a seniors home or retirement home
I live in a boarding school
I live in a student residence
I live in a self-contained room in a motel or boarding house
I couch-surf or stay at a friend's house
I am squatting
I live on the street
I live in a rehabilitation facility
I live in military housing
I live in a prison
Other, please specify:
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M4. In the past 5 years, how many different places have you lived?
Number of places

M5. How long have you been in your current dwelling?
Years

Months

M6. Have you ever moved to a different city or town for your own safety because you were trans?
Yes
No

M7. Have you ever moved to a different city or town to be closer to trans-related services you needed?
Yes
No

M8. Have you ever been asked or told to leave your parent's or other guardian's house (where you were
living) for being trans?
Yes
No
I was not out as trans while living with parents/family

M9. Have you ever been asked or told to leave your home by your spouse or partner (who you were living with)
for being trans?
Yes
No
I have never been out as trans while living with a partner or spouse

M10. Has being trans affected your rental history?
Yes, for the better
Yes, for the worse
No
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M11. Considering your income, how difficult is it for you to meet your monthly housing-related costs? Housing
costs include rent, mortgage, property taxes and utilities only.
Very difficult
Fairly difficult
A little difficult
Not difficult at all
I don't know
I'd rather not say
M12. Have you ever lost housing or a housing opportunity due to your trans status or gender expression?
Yes
No
Unsure
M13.

Are you worried that you will lose your housing because of your trans status or gender expression?
Yes
No

M14. Have you ever accessed a shelter as a trans person?
Yes
No (skip to Question M15)
M14a. As a trans person, did you feel safe at the shelter?
Yes
No
M14b. At the shelter, did you experience hostility or verbal harassment because of your trans status
or gender expression?
Yes
No
M14c. At the shelter, did you experience physical harassment or violence because of your trans
status or gender expression?
Yes
No
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M15. Have you ever been refused access to a shelter because of your trans status or gender expression?
Yes
No
I have never attempted to access a shelter

M16. Have you avoided accessing a shelter due to transphobia?
Yes
No
I have never attempted to access a shelter

These next few questions are about your history of homelessness. By homeless we mean that you
don't have a fixed, regular, and adequate night-time residence or you stay in a shelter, welfare hotel,
transitional program or any place not usually used for sleeping, such as streets, cars, movie theatres,
abandoned buildings, etc. People living in jail are not considered homeless.
M17. Based on the above definition, have you ever been homeless while presenting in your felt gender?
Yes
No (skip to Question M20)

M18. Are you currently homeless?
Yes
No

M19. Thinking about your most recent or current episode of homelessness, where did you sleep or where are
you sleeping?
In a shelter
Outside on the street
In a motel or hotel
Outside in parks
With a friend or friends
In a car
With a family member
Other, please specify:
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M20. Have you ever spent any time in a jail, presenting as your felt gender?
Yes, both federal and provincial
Yes, federal
Yes, provincial
No (skip to Section N)
M20a. Were you in a jail appropriate to your felt gender?
Yes
No
Some of the time
M20b. As a trans person, did you usually feel safe in jail?
Yes
No
M20c. In jail, did you experience hostility or verbal harassment in jail because of your trans status or
gender expression?

Yes
No
M20d. In jail, did you experience physical harassment or violence because of your trans status or
gender expression?
Yes
No

M21. In the past twelve months, have you spent any time in a jail?
Yes, both federal and provincial
Yes, federal
Yes, provincial
No
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N. Your Life Experiences
Next are some questions about the support that is available to you.
N1. About how many close friends and close relatives do you have, that is, people you feel at ease with and
can talk to about what is on your mind?
Number of close friends

N2. How often is each of the following kinds of support available to you if you need it:
None of
the time
Someone to help you if you were confined to bed?
Someone you can count on to listen to you when you
need to talk?
Someone to give you advice about a crisis?
Someone to take you to the doctor if you needed it?
Someone who shows you love and affection?
Someone to have a good time with?
Someone to give you information in order to help you
understand a situation?
Someone to confide in or talk to about yourself or your
problems?
Someone who hugs you?
Someone to get together with for relaxation?
Someone to prepare your meals if you were unable to
do it yourself?
Someone whose advice you really want?
Someone to do things with to help you get your mind
off things?
Someone to help with daily chores if you were sick?
Someone to share your most private worries and fears
with?
Someone to turn to for suggestions about how to deal
with a personal problem?
Someone to do something enjoyable with?
Someone who understands your problems?
Someone to love you and make you feel wanted?
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N3. How often do people you encounter perceive you as a person of colour?
Always
Very frequently
Occasionally
About half the time
Rarely
Very rarely
Never

N4. For each of the following, please indicate how often you've had this experience.
Never
1. As you were growing up, how often were made fun of or called
names because of your race or ethnicity?
2. As you were growing up, how often were you hit or beaten up
because of your race or ethnicity?
3. As an adult, how often were you made fun of or called names
because of your race or ethnicity?
4. How often were you treated rudely or unfairly because of your
race or ethnicity?
5. How often have you experienced some form of police harassment
because of your race or ethnicity?
6. How often have you been turned down for a job because of your
race or ethnicity?
7. How often have been uncomfortable in trans spaces because of
your race or ethnicity?
8. How often have had difficulty finding lovers because of your race
or ethnicity?
9. How often have you been objectified sexually because of your
race or ethnicity?
10. In sexual relationships, how often do you find that partners pay
more attention to your race or ethnicity than to who you are as a
person?

N5. How accepting of ethno-racial diversity is the trans community?
Completely accepting
Mostly accepting
Somewhat accepting
Slightly accepting
Not at all accepting
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N6. How accepting of gender diversity is your ethno-racial community?
Completely accepting
Mostly accepting
Somewhat accepting
Slightly accepting
Not at all accepting

N7. How often do people you encounter know you are trans without being told so?
Always
Very frequently
Occasionally
About half the time
Rarely
Very rarely
Never

N8. In general, do you want people to know you're trans without being told?
Yes
No
Don't care

Never

N9.
How often have you been made fun of or called names for being trans?
How often have you been hit or beaten up for being trans?
How often have you heard that trans people are not normal?
How often have you been objectified or fetishized sexually because
you're trans?
How often have you felt that being trans hurt and embarrassed your
family?
How often have you had to try to pass as non-trans to be accepted?
How often do you suspect you have been turned down for a job
because of your trans identity?
How often have you had to move away from your family or friends
because you're trans?
How often have you experienced some form of police harassment for
being trans?
How often do you worry about growing old alone?
How often do you fear you will die young?
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Questions N10 to N15 are intended for those who have begun social transition or re living in their felt
gender. If this does not apply to you, please skip to Question N16.

N10. In general, how supportive of your gender identity or expression are the following people? (Please
check one for each)
Not at all
supportive

Not very
supportive

Somewhat
supportive

Very
supportive

Not
applicable

My parent(s)
My sibling(s)
My spouse(s) or partner(s)
My child(ren)
My extended family
My roommates
My trans friends
My non-trans friends
My church/temple/mosque
My cultural community
My co-workers
My employer
My supervisor/boss
My teachers
My school
My classmates

N11. Since starting your transition and/or coming out as trans, has the number of people you would call
"close friends"…?
Increased a lot
Increased somewhat
Stayed about the same
Decreased somewhat
Decreased a lot

N12. Since transitioning or identifying as trans, has your quality of life...? (please check only one)
Gotten a lot better
Gotten somewhat better
Stayed the same
Gotten somewhat worse
Gotten a lot worse
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N13. Have you ever experienced the following because you're trans or because of your gender expression?
(Please check all that apply)
Silent harassment (e.g. being stared at, being whispered about)
Verbal harassment
Physical intimidation and threats
Physical violence (e.g. being hit, kicked or punched)
Sexual harassment (e.g. cat calling, being propositioned)
Sexual assault (e.g. unwanted sexual touching or sexual activity)
N14. If you experienced physical violence and/or sexual assaults, did you report the incident to the police?
Yes
No
I have never experienced physical violence and/or sexual assaults

N15. Have you ever avoided any of the following situations because of a fear of being harassed, being read as
trans, or being outed? (please check all that apply)
Public transit
Grocery store or pharmacy
Malls or clothing stores
Schools
Travelling abroad
Clubs or social groups
Gyms
Church/synagogue/temple or other religious institution
Public washrooms

Treanor Mahood-Greer
Treanor has many life experiences:
per was a pig farmer, a prospector
and now a social worker with a
master's degree. Per is also an artist
and an activist who maintains hir
self-efficacy and balance by having
JOHN WAYNE and Johnny Cash in hir
life. Per attempts to help people
understand gender theory through a
trans-spiritual lens, by bringing
together per's experiences from
working in the bush, per's love of art
and nature, and spirituality, and hir
transgendered status. Per wants to
create
praxis,
which
becomes
informed action not just dialogue in
order to make a difference in this
gendered world. Treanor is a
member
of
the
Community
Engagement Team which guides the
Trans PULSE Project.

Public spaces (e.g. parks)
Restaurants or bars
Cultural or community centres
None of the above
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If you have begun or completed a transition or come out as your felt gender, skip to N21.
N16.

If you have not transitioned or come out, how supportive of your gender identity or expression do
you expect the following people will be? (Please check one for each)
Not at all
Not very Somewhat
Very
Not
supportive supportive supportive supportive applicable
My parent(s)
My sibling(s)
My spouse(s) or partner(s)
My child(ren)
My extended family
My roommates
My trans friends
My non-trans friends
My church/temple/mosque
My cultural community
My co-workers
My employer
My supervisor/boss
My teachers
My school
My classmates

N17.

After you begin your transition or come out as trans, do you expect the number of people you would
call "close friends" to…?
Increase a lot
Increase somewhat
Stay about the same
Decrease somewhat
Decrease a lot

N18. After you begin your transition or come out as trans, do you expect your quality of life will…?
Get a lot better
Get somewhat better
Stay the same
Get somewhat worse
Get a lot worse
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N19. Do you expect that you will experience the following because you're trans or because of your gender
expression? (Check all that apply)
Silent harassment (e.g. being stared at, being whispered about)
Verbal harassment
Physical intimidation and threats
Physical violence (e.g. being hit, kicked or punched)
Sexual harassment (e.g. cat calling, being propositioned)
Sexual assault (e.g. unwanted sexual touching or sexual activity)

N20. Do you expect that you will avoid any of the following situations because of a fear of being harassed,
being read as trans, or being outed? (please check all that apply)
Public transit
Grocery store or pharmacy
Malls or clothing stores
Schools
Travelling abroad
Clubs or social groups
Gyms
Church/synagogue/temple or other religious institution
Public washrooms
Public spaces (e.g. parks)
Restaurants or bars
Cultural or community centres
None of the above

N21. Do you personally know of other trans people who have experienced the following because they're trans or
because of their gender expression? (please check all that apply)
Silent harassment (e.g. being stared at, being whispered about)
Verbal harassment
Physical intimidation and threats
Physical violence (e.g. being hit, kicked or punched)
Sexual harassment (e.g. cat calling, being propositioned)
Sexual assault (e.g. unwanted sexual touching or sexual activity)
Committed suicide
Been killed
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N22. How would you describe your sense of belonging to your local community?
Very strong
Somewhat strong
Somewhat weak
Very weak

N23. How important is having a strong `trans community' to you?
Very important
Somewhat important
Neutral
Not too important
Not important at all

N24. Are you a member of any voluntary organizations or associations?
Trans or LGBT
Organization

Other
organization

No

School groups
Religious social groups
Community centers
Support groups
Ethnic or cultural associations
Social, civic or fraternal clubs
Other groups

N25. How often did you participate in meetings or activities of these groups in the past 12 months? (If you
belong to many, just think of the ones in which you are most active)
At least once a week
At least once a month
At least 3 or 4 times a year
At least once a year
Not at all
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The following questions relate to the sensitive issues of childhood sexual, physical and emotional
abuse. If you need to speak to someone immediately regarding your childhood experiences, please
contact the Abuse Victim Hotline at 1-877-448-8678.
These next questions are about experiences before age 16. If you've had any such experiences, they
may be difficult to discuss and we appreciate your willingness to answer these questions.

N26. Before age 16, did you ever experience something sexual that you did not want, that felt inappropriate,
or was at any time perceived as hurtful? Unwanted sexual experiences could include such things as
watching someone having sex, touching someone or having them touch you sexually, or some other
type of sexual activity including oral, anal, or vaginal intercourse or mutual masturbation.
Yes
No (skip to Question N27)
Don't know (skip to Question N27)
I'd rather not answer (skip to Question N27)
N26a. In the above experience(s), what was the relationship of the person(s) to you?

N26b. How old were you the first time this happened?
Years old

N27. Before age 16, were you ever pushed, grabbed, shoved, kicked, punched or physically attacked in some
other way?
Yes
No (skip to Question N28)
Don't know (skip to Question N28)
I'd rather not answer (skip to Question N28)
N27a. In the above experience(s), what was the relationship of the person(s) to you?

N27b. How old were you the first time this happened to you?
Years old

Page 65 of 87

251
N28. Before age 16, were you shamed, belittled, humiliated, or emotionally manipulated?
Yes
No (skip to Section O)
Don't know (skip to Section O)
I'd rather not say (skip to Section O)
N28a. In the above experience(s), what was the relationship of the person(s) to you?

N28b. How old were you the first time this happened to you?
Years old

Adrian Edgar
Adrian is a transguy in med school with a background in cross-cultural health, ethics, and Native studies.
He does a lot of health activism but enjoys 'Peace through Health' and queer/trans health advocacy the
most. Adrian worked on the Transgender Health Program's trans health survey in Vancouver last summer,
and volunteered with Camp Ten Oaks for queer kids and kids with queer families the two summers before
that. He is strongly committed to increasing community-based health services for Aboriginal people and
Nations, and people in conflict with the law. Adrian is going to be a palliative care doctor and will work to
increase understanding and respect for the needs and dignity of trans people at the end of their lives.
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O. Parenting
O1. Would you like to have or adopt a child in the future?
Yes
No
Undecided/Unsure
O2. Before medically transitioning, did your health care provider discuss the possibility of retaining sperm, eggs, or fertilized
embryos for future fertility treatments?
Yes
No
This does not apply to me

O3. Are you a parent, whatever this means to you?
Yes
No (skip to Section P)

O4. Which of the following describe your relationship to your children? (Check all that apply)
I am a step parent
I am a biological parent
I am an adoptive parent
I am a foster parent
I am an intentional non-biological parent
I am partnered with a biological parent of the child(ren)
I am partnered with a step parent of the child(ren)
I am partnered with an adoptive parent of the child(ren)
I am partnered with a foster parent of the child(ren)
I am partnered with an intentional non-biological parent of the child(ren)
Other, please specify:

O5. Which of the following describes the legal custody status of your children?
I have sole custody
I have shared custody
I am an access parent
I am a supervised access parent
I have no legal access to my children
My children are adults
Other, please specify:
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O6. Have you ever lost or had custody reduced due to being trans?
Yes, lost custody
Yes, had custody reduced
No
O7. How satisfied are you with your current custody arrangement?
Completely satisfied
Mostly satisfied
Mostly dissatisfied
Completely dissatisfied
O8. Do you see your children less due to being trans?
Yes
No
Unsure
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P. Sexual Activity and Sexual Health
In this section, we'd like to ask you questions about sex, specifically, who you're having sex with, what types of
sex you're having, if any, and how you feel about your sex life and sexuality. We understand that these can be
sensitive topics but we wanted to include these questions because sex and relationships can be important parts
of our lives and can have a big impact on how we feel about ourselves.
We're asking you to please recall your sexual experiences over the last year and your lifetime. By “sex partners,”
please include everyone you've had sexual contact with, even once, including anal, oral, or genital sex.

P1. Over your lifetime, how many sex partners have you had?
Number of people
I have not yet had sex (skip to Section Q)
P2. In your lifetime, who have your sex partners been? (Please check all that apply)
Trans men
Non-trans men
Trans women
Non-trans women
Genderqueer persons
Unknown
Other, please specify:

P3. In the past 12 months, how many sex partners have you had?
Number of people
I have not had sex in the past 12 months
P4. In the past 12 months, who have your partners been? (Please check all that apply)
Trans men
Non-trans men
Trans women
Non-trans women
Genderqueer persons
Unknown
Other, please specify:
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We all have different ways we talk about our bodies, and different words to refer to our tender parts. The
following questions ask about your sexual experiences in the past 12 months. We will use this information
responsibly. Whatever you're doing, we hope you're having a good time!
Since we cannot make assumptions about body parts, we won't. As a result, questions ask specifically
about body parts, fluids and behaviours. If you are unwilling to share this information, please skip to
Question P11.

P5. In the past 12 months, have you received oral sex from anyone?
Yes
No (skip to Question P6)
P5a. In the past 12 months, while receiving oral sex, how often did your partner(s) get your sex fluids
or menstrual blood in their mouth(s)?
Every time
Most times
About half the time
Less than half the time
Never
P5b. Who was your partner(s) in this activity? (Please check all that apply)
Spouse/long-term lover
Regular sex partner
One time or occasional sex partner
Regular partner who I pay (cash, drugs, shelter) for sex
Regular partner who pays me (cash, drugs, shelter) for sex
One time or occasional partner who I pay (cash, drugs, shelter) for sex
One time or occasional partner who pays me (cash, drugs, shelter) for sex

P6. In the past 12 months, have you given anyone oral sex?
Yes
No (skip to Question P7)
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P6a. In the past 12 months, while performing oral sex, how often did you get sex fluids or menstrual
blood in your mouth?
Every time
Most times
About half the time
Less than half the time
Never
P6b. Who was your partner(s) in this activity? (check all that apply)
Spouse/long-term lover
Regular sex partner
One time or occasional sex partner
Regular partner who I pay (cash, drugs, shelter) for sex
Regular partner who pays me (cash, drugs, shelter) for sex
One time or occasional partner who I pay (cash, drugs, shelter) for sex
One time or occasional partner who pays me (cash, drugs, shelter) for sex

P7. In the past 12 months, have you been the receptive partner in anal sex?
Yes
No (skip to Question P8)
P7a. Which of the following did your partner(s) use for penetration? (Check all that apply)
Flesh genitals
Silicone or latex
Fingers or hands
P7b. In the past 12 months, while receiving anal sex, how often did your partner(s) ejaculate inside
you (without a condom)?

Every time
Most times
About half the time
Less than half the time
Never
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P7c. Who was your partner(s) in this activity? (Check all that apply)
Spouse/long-term lover
Regular sex partner
One time or occasional sex partner
Regular partner who I pay (cash, drugs, shelter) for sex
Regular partner who pays me (cash, drugs, shelter) for sex
One time or occasional partner who I pay (cash, drugs, shelter) for sex
One time or occasional partner who pays me (cash, drugs, shelter) for sex

P8.

In the past 12 months, have you been the insertive partner in anal sex?
Yes
No (skip to Question P9)
P8a. Which of the following did you use for penetration? (check all that apply)
Flesh genitals
Silicone or latex
Fingers or hands
P8b. In the past 12 months, as the insertive partner in anal sex, how often did you ejaculate inside
your partner's ass (without a condom)?
Every time
Most times
About half the time
Less than half the time
Never
P8c. Who was your partner(s) in this activity? (please check all that apply)
Spouse/long-term lover
Regular sex partner
One time or occasional sex partner
Regular partner who I pay (cash, drugs, shelter) for sex
Regular partner who pays me (cash, drugs, shelter) for sex
One time or occasional partner who I pay (cash, drugs, shelter) for sex
One time or occasional partner who pays me (cash, drugs, shelter) for sex
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P9. In the past 12 months, have you been the receptive partner in genital sex (i.e. vaginal or front hole sex)?
Yes
No (skip to Question P10)
P9a. Which of the following did your partner(s) use for penetration? (check all that apply)
Flesh genitals
Silicone or latex
Fingers or hands
P9b. In the past 12 months, while being the receptive partner in genital sex, how often did your partner
ejaculate inside you (without a condom)?
Every time
Most times
About half the time
Less than half the time
Never
P9c. Who was your partner(s) in this activity? (please check all that apply)
Spouse/long-term lover
Regular sex partner
One time or occasional sex partner
Regular partner who I pay (cash, drugs, shelter) for sex
Regular partner who pays me (cash, drugs, shelter) for sex
One time or occasional partner who I pay (cash, drugs, shelter) for sex
One time or occasional partner who pays me (cash, drugs, shelter) for sex

P10. In the past 12 months, have you been the insertive partner in genital sex (i.e. vaginal or front hole sex)?
Yes
No (skip to Question P11)
P10a. Which of the following did you use for penetration? (please check all that apply)
Flesh genitals
Silicone or latex
Fingers or hands
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P10b. In the past 12 months, while being the insertive partner in genital sex, how often did you ejaculate
inside your partner (without a condom)?
Every time
Most times
About half the time
Less than half the time
Never
P10c. Who was your partner(s) in this activity? (please check all that apply)
Spouse/long-term lover
Regular sex partner
One time or occasional sex partner
Regular partner who I pay (cash, drugs, shelter) for sex
Regular partner who pays me (cash, drugs, shelter) for sex
One time or occasional partner who I pay (cash, drugs, shelter) for sex
One time or occasional partner who pays me (cash, drugs, shelter) for sex

P11. In the past 12 months, have you ever had sex while drunk or high?
Yes
No

P12. Do you have a spouse or long term sexual partner?
Yes
No (skip to Question P13)
P12a. How often do you and your spouse or long-term sexual partner use condoms or other protective
barriers (dental dam, latex glove, plastic wrap) during sex that involves sex fluids? Check ONE
only:
Always
Most of the time
Sometimes
Rarely
Never
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P12b. Has your spouse or long-term sex partner been tested for HIV since their last risk activity?
Yes
No
I'm not sure
Not applicable
P12c. If your spouse or long-term sex partner has been tested for HIV, they are:
The same HIV status than I am
A different HIV status than I am
I don't know as I don't know what the results of their test were
I don't know as I haven't been tested
I don't want to say
Not applicable
P12d. Has your spouse or long-term sex partner been tested for other sexually transmitted infections
(such as gonorrhea and chlamydia) since their last risk activity?
Yes
No
I'm not sure
Not applicable
P13. When you think about using protection with a partner (for example, a condom, dental dam, glove, or plastic
wrap), how certain are you that you could use protection in the following scenarios? A `7' means that
you're absolutely certain you could do what the question asks; a `1' means you're absolutely certain that
you couldn't do what the question asks.
Not at all
Certain
1

I can ask a new partner to use a protective barrier
I can ask a partner I haven't been using protective barriers
with to start using them
I can refuse sex when I don't have a protective barrier
available
I can get a partner to use a protective barrier, even if I'm
drunk or high
I can get a partner to use a protective barrier, even if they
don't want to.
I can ask a partner who truly sees me as the gender I know
myself to be to use a protective barrier
I can ask a non-trans partner to use a protective barrier
I can ask a trans partner to use a protective barrier
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P14. Please read each item and decide to what extent it is characteristic of you. Give each item a rating of how
much it applies to you by using the following scale:
Not at all

Slightly

Somewhat

Moderately

Very

Not at all

Slightly

Somewhat

Moderately

Very

I feel anxious when I think about the sexual
aspects of my life.
I worry about the sexual aspects of my life.
Thinking about the sexual aspects of my life often
leaves me with an uneasy feeling.
I am satisfied with the status of my own sexual
fulfillment.
The sexual aspects of my life are personally
gratifying to me.
The sexual aspects of my life are satisfactory,
compared to most people's.
I am satisfied with the sexual aspects of my life.
I am satisfied with the way my sexual needs are
currently being met.
I am afraid of becoming sexually involved with
another person.
I have a fear of sexual relationships.
I am fearful of engaging in sexual activity.
I don't have much fear about engaging in sex.

P15. When I think about having sex, I worry…

That other people think my body is unattractive
That there are very few people who would want to
have sex with me
About my physical safety
About feeling ashamed about my body
That once I'm naked, people will not see me as
the gender I am
That people only want to have sex with me
because I'm trans
That I can't have the sex I want until I have
a(nother) surgery

P16. If you have transitioned or come out as trans, has the quality of your sex life changed?
Yes, for the better
Yes, for the worse
No, it has not changed
Not applicable
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Q. Emotional Well-being
Q1. In general, would you say your mental health is…?
Excellent
Very good
Good
Fair
Poor
I don't know

Q2. How satisfied are you with your life in general?
Very satisfied
Satisfied
Neither satisfied nor dissatisfied
Dissatisfied
Very dissatisfied
I don't know

Q3. Thinking about the amount of stress in your life, would you say that most days are…?
Not at all stressful
Not very stressful
A bit stressful
Quite a bit stressful
Extremely stressful
I don't know

Q4. Have you ever been diagnosed with any of the following:
Anxiety disorders (e.g. panic attacks, post-traumatic stress disorder)
Schizophrenia
Bipolar disorder
Major depression
Dissociative identity disorders (multiple personality disorder)
Borderline personality disorder
Other major mental health disorder, please specify:
None of the above
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Q5. Have you ever been diagnosed with any of the following:
Anorexia nervosa
Bulimia nervosa
Exercise bulimia
Binge eating disorder
None of the above

Q6. Below is a list of the ways you might have felt or behaved. Please tell us how often you have felt this way
during the past week.
During the past week

Rarely or
none of the
time
(less than
1 day)

1. I was bothered by things that usually don't bother me.
2. I did not feel like eating; my appetite was poor.
3. I felt that I could not shake off the blues even with help
from my family or friends.
4. I felt I was just as good as other people.
5. I had trouble keeping my mind on what I was doing.
6. I felt depressed.
7. I felt that everything I did was an effort.
8. I felt hopeful about the future.
9. I thought my life had been a failure.
10. I felt fearful.
11. My sleep was restless.
12. I was happy.
13. I talked less than usual.
14. I felt lonely.
15. People were unfriendly.
16. I enjoyed life.
17. I had crying spells.
18. I felt sad.
19. I felt that people dislike me.
20. I could not get “going.”
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Q7. How much do you agree with the following statements?
Strongly
Agree

Agree

Disagree

Strongly
Disagree

On the whole, I am satisfied with myself.
At times, I think I am no good at all.
I feel that I have a number of good qualities.
I am able to do things as well as most other people.
I feel I do not have much to be proud of.
I certainly feel useless at times.
I'm a person of worth, at least on an equal plane with others.
I wish I could have more respect for myself.
All in all, I am inclined to feel that I am a failure.
I take a positive attitude toward myself.

The following questions relate to the sensitive issue of suicide. If you need to
speak to someone immediately regarding suicide, please contact the National
Suicide Prevention Lifeline at 1-800-273-8255.

Q8. Have you ever seriously considered committing suicide or taking your own life?
Yes
No (skip to Section R)
Q8a. If yes, was this related to your being trans?
Yes
No
Q8b. If yes, has this happened in the past 12 months?
Yes
No

Q9. Have you ever attempted to commit suicide or tried taking your own life?
Yes
No (skip to Section R)
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Q9a. If yes, did this happen in the past 12 months?
Yes
No
Q9b. Did you see or talk to a health professional following your attempt to commit suicide?
Yes
No
Q9c. How old were you when you first attempted suicide or tried taking your own life?
Years Old

Mason McColl
Mason is a 22-year old
fluid
transmasculine
queer radical living in
Peterborough, who is
actively involved in
gender politics, antipoverty work and sexpositive
activism.
Mason works as a
community organizer,
group
builder
and
policy changer. He is
passionate
about
everything, specifically
kids,
education,
solidarity, and most of
all, his dog Lily.
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R. Cigarettes, Drugs and Alcohol
R1. In your lifetime, have you smoked a total of 100 or more cigarettes (about 4 packs)?
Yes
No (skip to Question R4)

R2. At the present time, do you smoke cigarettes daily, occasionally or not at all?
Daily
Occasionally
Not at all

R3. Over your life, how long have you smoked in total?
Years

Months

The next few questions ask about your alcohol consumption.
When we use the word `drink' it means:
- one (1) bottle or can of beer or a glass of draft
- one (1) glass of wine or a wine cooler
- one (1) drink or cocktail with 1 ½ ounces of liquor.

R4. During the past 12 months, have you had a drink of beer, wine, liquor or any other alcoholic beverage?
Yes
No (skip to Question R12)

R5. During the past 12 months, how often did you drink alcoholic beverages?
Never
Less than once a month
Once a month
2 to 3 times a month
Once a week
2 to 3 times a week
4 to 6 times a week
Every day
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R6. How often in the past 12 months have you had 5 or more drinks on one occasion?
Never
Less than once a month
Once a month
2 to 3 times a month
Once a week
More than once a week

R7. Have you ever felt you should cut down on your drinking?
Yes
No

R8. Have people annoyed you by criticising your drinking?
Yes
No

R9. Have you ever felt bad or guilty about your drinking?
Yes
No

R10. Have you ever had a drink first thing in the morning to steady your nerves or get rid of a hangover?
Yes
No

R11. Is your current drinking a problem for you?
Yes
Sometimes
No
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R12. In the past 12 months, which of the following have you used? (Please check all that apply)
Marijuana or hashish
Poppers or nitrites, including ampules
Crack
Cocaine
Crystal meth
Other amphetamine
PCP (angel dust)
Special K
GHB (G)
LSD (acid)
Opium
Heroin
Ecstasy
Prescription narcotics, other than for medical use (Percocet, Oxycontin)
Other, please specify:
None of the above

(skip to Section S)

R13. Is your current drug use a problem for you?
Yes
Sometimes
No
R14. Overall, has this experience of using drugs been:
Completely positive
Mostly positive
Equally positive and negative
Mostly negative
Completely negative
None of the above, it's neither positive nor negative
R15. In the past 12 months, have you ever injected drugs for reasons other than medical use?
Yes
No (skip to Section S)
R16. If yes, in the past 12 months, have you ever been in a situation where you had to use needles or drugusing equipment that someone had used before?
Yes
No
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S. General Health Concerns
Research on trans people has rarely been concerned with our general health. We'd like to ask you
some questions about your health overall, to help us better understand our communities' health
issues.
S1. To start, in general, would you say your health is…?
Excellent
Very good
Good
Fair
Poor
I don't know
S2. Compared to one year ago, how would you say your health is now?
Much better now
Somewhat better now
About the same
Somewhat worse now
Much worse now
I don't know
S3. Are you usually pain-free or physically comfortable?
Yes (skip to Question S6)
No
I don't know
S4. How would you describe the usual intensity of your pain or discomfort?
Mild
Moderate
Severe
I don't know
S5. How many activities does your pain or discomfort prevent?
None
A few
Some
Most
I don't know
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S6.

Have you been diagnosed with the following health conditions? If yes, please include the year of
diagnosis.
Yes

Year of diagnosis:

Yes

Allergies

Testicular cancer

Asthma

Thyroid condition

Breast cancer

Uterine cancer

Cervical cancer

Vaginal cancer

Chronic fatigue syndrome

Venous thrombosis (blood
clot in the leg)

Diabetes
Elevated liver enzymes
Elevated prolactin levels
Endometrial cancer
Endometrial hyperplasia
Fibromyalgia
Gall stones
Heart attack
High blood pressure
High cholesterol
Pulmonary embolism
(blood clot in the lung)
Osteoporosis
Ovarian cancer
Penile cancer
Polycystic ovary syndrome
Prostate cancer
Sleep apnea (stopped
breathing during sleep)
Stroke
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T. Strategies for Information and Action
What is the best way to make the results of this study available to trans communities (for example, posters or
pamphlets)?

What types of actions do you think we should undertake using the results of this study?

What sort of education or policy changes would you like to see as a result of this study?

Now that you've finished the survey, is there anything else you'd like to let us know?
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Appendix B: The Intersectional Discrimination Index (InDI)
These questions are about experiences related to who you are. This includes both how you describe yourself and
how others might describe you. For example, your skin colour, ancestry, nationality, religion, gender, sexuality, age,
weight, disability or mental health issue, and income.

Strongly
disagree
1.

Because of who I am, a doctor or nurse,
or other health care provider might treat
me poorly.

2.

Because of who I am, I might have
trouble finding or keeping a job.

3.

Because of who I am, I might have
trouble getting an apartment or house

4.

I am confident that I will be treated with
as much respect as my peers.*
I worry about being treated unfairly by a
teacher, supervisor, or employer.
I may be denied a bank account, loan, or
mortgage because of who I am.
I feel safe in my neighbourhood.*

5.
6.
7.

Disagree

8.

I worry about being harassed or stopped
by police or security.
9. Because of who I am, people might try
to attack me physically.
10. I expect to be pointed at, called names,
or harassed when in public.
11. I fear that I will have a hard time finding
friendship or romance because of who I
am.
* Deleted from final version of InDI based on results of factor analyses.

Neither
agree nor
disagree

Agree

Strongly
agree
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Because of who you are, have you…
Never

1.

5.

Been treated poorly or unfairly by a
a. ….Health care provider
b. …Teacher or professor
c. …Supervisor or employer
d. …Coworker or classmate
e. …Sales clerk, receptionist, or other
customer service representative
f. …Police officer, border guard,
security officer
g. Transportation provider (e.g., bus or
taxi driver)
h. …Landlord
i. …Relative or friend
Heard, saw, or read others joking or laughing
about you (or people like you)
Been treated as if you are unfriendly,
unhelpful, or rude
Been called names or heard/saw your identity
used as an insult
Been treated as if others are afraid of you

6.

Been stared or pointed at in public

2.
3.
4.

Yes, but not in Yes, once or twice
the past year in the past year

Yes, many
times in the
past year

7.

Been told that you should think, act, or look
more like others
8. Heard that you or people like you don’t
belong
9. Asked inappropriate, offensive, or overly
personal questions
10. Been treated as if you are less smart or
capable than others
As a reminder, we are interested in experiences related to who you are. This includes both how you describe
yourself and how others might describe you. For example, your skin colour, ancestry, nationality, religion, gender,
sexuality, age, weight, disability or mental health issue, and income.
11. Because of who you are, has a health care provider ever refused you care?
Never
Once
More than once
11b. [If once or more] Has this happened to you in the past 12 months?

Yes

No

12. Because of who you are, have you ever been fired or dismissed from a job, or been turned down for a job that you
interviewed for?
Never
Once
More than once
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12b. [If once or more] Has this happened to you in the past 12 months?

Yes

No

Yes

No

13. Because of who you are, have you ever been evicted or denied housing?
Never
Once
More than once
13b. [If once or more] Has this happened to you in the past 12 months?

14. Because of who you are, have you ever been unreasonably stopped and questioned, searched, or arrested by police
or security?
Never
Once
More than once
14b. [If once or more] Has this happened to you in the past 12 months?

Yes

No

15. Because of who you are, have you ever been unreasonably expelled or suspended from school?
Never
Once
More than once
15b. [If once or more] Has this happened to you in the past 12 months?

Yes

No

16. Because of who you are, have you ever been unable to open a bank account, cash a cheque, or get a loan?
Never
Once
More than once
16b. [If once or more] Has this happened to you in the past 12 months?

Yes

No

17. Because of who you are, have you ever had to move to another neighbourhood, town, city, state, province, or
country?
Never
Once
More than once
17b. [If once or more] Has this happened to you in the past 12 months?

Yes

No

18. Because of who you are, have you ever lost a close relationship (e.g., with a family member, friend, or partner)?
Never
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Once
More than once
18b. [If once or more] Has this happened to you in the past 12 months?

Yes

No

19. Because of who you are, have you ever been repeatedly harassed at work or school, where you live, or when
accessing services?
No
Yes—in one place
Yes—in more than one place
19b. [If yes] Has this happened to you in the past 12 months?

Yes

No

20. Because of who you are, have you ever been threatened with a physical or sexual attack?
Never
Once
More than once
20b. [If once or more] Has this happened to you in the past 12 months?

Yes

No

21. Because of who you are, have you ever been physically attacked (e.g., spit on, had objects thrown at you, hit,
punched, pushed or grabbed, beaten)?
Never
Once
More than once
21b. [If once or more] Has this happened to you in the past 12 months?

Yes

No

22. Because of who you are, have you ever been made to engage in sexual activity, or been touched in a sexual way,
that you didn’t want?
Never
Once
More than once
22b. [If once or more] Has this happened to you in the past 12 months?

Yes

No

23. Because of who you are, have you ever had someone take, damage, or vandalize your property?
Never
Once
More than once
23b. [If once or more] Has this happened to you in the past 12 months?

Yes

No
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Appendix C: Understanding Social Experiences and Health Baseline Survey

IFOLLOW - IFOLLOW - SHOW ALL
The following questions will determine whether or not you are eligible to participate in the survey. If you choose to
skip any of these questions, you will not be able to participate.

AGENUM - AGENUM
How old are you?
jQuery(function() { jQuery('&#160; years old').insertAfter(jQuery('#AGENUM')); }); .questionarea { marginbottom: -5px; } .questiontitle{ display : none; }

Q2 - Q2 - ASK ALL
What country do you live in?

Canada (1)
United States (2)
Other (96)
Q5CAN - Q5CAN - ASK IF Q2=1(Canada)
Which one or more of the following best describes your racial, ethnic, and cultural background?

White (1)
Aboriginal or Indigenous (First Nations, Métis, or Inuit) (2)
East Asian (Chinese, Japanese, Korean) (3)
South Asian (for example, East Indian, Pakistani, Sri Lankan) (4)
Southeast Asian (for example, Filipino, Thai, Indonesian, Vietnamese) (5)
Black or African Canadian (6)
Latin American (7)
Middle Eastern (for example, Egyptian, Iranian, Lebanese) (8)
Q5US - Q5US - ASK IF Q2=2(USA)
Which one or more of the following best describes your racial, ethnic, and cultural background?

White (1)
Hispanic or Latino/a (2)
Black or African American (3)
American Indian or Alaska Native (4)
East Asian (Chinese, Japanese, Korean) (5)
South Asian (for example, Asian Indian, Pakistani, Sri Lankan) (6)
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Southeast Asian (for example, Filipino, Thai, Indonesian, Vietnamese) (7)
Native Hawaiian or Pacific Islander (8)
Middle Eastern (for example, Egyptian, Iranian, Lebanese) (9)
Q74 - Q74 - ASK ALL
Do you consider yourself lesbian, gay, bisexual, or transgender, or a similar identity?

Yes (1)
No (2)

Q9Q19 - Q9Q19 - ASK ALL
These questions are about experiences related to who you are. This includes both how you describe yourself and
how others might describe you. For example, your skin ^f('Q2').any('1')?"colour":"color"^, ancestry, nationality,
religion, gender, sexuality, age, weight, disability or mental health issue, and income.
Strongly
disagree (1)

Disagree
(2)

Neither agree
nor disagree (3)

Agree
(4)

Strongly
agree (5)

Because of who I am, a doctor or nurse, or
other health care provider might treat me
poorly. (1)
Because of who I am, I might have trouble
finding or keeping a job. (2)
Because of who I am, I might have trouble
getting an apartment or house (3)
I am confident that I will be treated with as
much respect as my peers. (4)
I worry about being treated unfairly by a
teacher, supervisor, or employer. (5)
I may be denied a bank account, loan, or
mortgage because of who I am. (6)
I feel safe in my neighbourhood. (7)
I worry about being harassed or stopped by
police or security. (8)
Because of who I am, people might try to
attack me physically. (9)
I expect to be pointed at, called names, or
harassed when in public. (10)
I fear that I will have a hard time finding
friendship or romance because of who I am.
(11)
Q20 - Q20 - ASK ALL
Because of who you are, have you...

Never
(1)
Been treated poorly or unfairly by a health care
provider (20a)

Yes, but not in
the past year
(2)

Yes, once or
twice in the past
year (3)

Yes, many times
in the past year
(4)
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Never
(1)

Yes, but not in
the past year
(2)

Yes, once or
twice in the past
year (3)

Yes, many times
in the past year
(4)

Been treated poorly or unfairly by a teacher or
professor (20b)
Been treated poorly or unfairly by a supervisor
or employer (20c)
Been treated poorly or unfairly by a coworker or
classmate (20d)
Been treated poorly or unfairly by a sales clerk,
receptionist, or other customer service
representative (20e)
Been treated poorly or unfairly by a police
officer, border guard, security officer (20f)
Been treated poorly or unfairly by a
transportation provider (e.g., bus or taxi driver)
(20g)
Been treated poorly or unfairly by a landlord
(20h)
Been treated poorly or unfairly by a relative or
friend (20i)
Q21Q29 - Q21Q29 - ASK ALL
Because of who you are, have you...
Never
(1)

Yes, but not in
the past year (2)

Yes, once or twice
in the past year (3)

Yes, many times
in the past year (4)

&nbsp; (b)
Heard, saw, or read others joking or
laughing about you (or people like you)
(21)
Been treated as if you are unfriendly,
unhelpful, or rude (22)
Been called names or heard/saw your
identity used as an insult (23)
Been treated as if others are afraid of you
(24)
Been stared or pointed at in public (25)
Been told that you should think, act, or
look more like others (26)
Heard that you or people like you don’t
belong (27)
Asked inappropriate, offensive, or overly
personal questions (28)
Been treated as if you are less smart or
capable than others (29)

IQ30 - IQ30 - ASK ALL
As a reminder, we are interested in experiences related to who you are. This includes both how you describe
yourself and how others might describe you. For example, your skin ^f('Q2').any('1')?"colour":"color"^, ancestry,
nationality, religion, gender, sexuality, age, weight, disability or mental health issue, and income.
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Q30 - Q30 - ASK ALL
Because of who you are, has a health care provider ever refused you care?

Never (1)
Once (2)
More than once (3)
Q30B - Q30B - ASK IF Q30=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q30B .questiontitle { display:none; }
Yes (1)
No (2)
Q31 - Q31 - ASK ALL
Because of who you are, have you ever been fired or dismissed from a job, or been turned down for a job that you
interviewed for?

Never (1)
Once (2)
More than once (3)
Q31B - Q31B - ASK IF Q31=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q31B .questiontitle { display:none; }
Yes (1)
No (2)
Q32 - Q32 - ASK ALL
Because of who you are, have you ever been evicted or denied housing?

Never (1)
Once (2)
More than once (3)
Q32B - Q32B - ASK IF Q32=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q32B .questiontitle { display:none; }
Yes (1)
No (2)
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Q33 - Q33 - ASK ALL
Because of who you are, have you ever been unreasonably stopped and questioned, searched, or arrested by police
or security?

Never (1)
Once (2)
More than once (3)
Q33B - Q33B - ASK IF Q33=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q33B .questiontitle { display:none; }
Yes (1)
No (2)
Q34 - Q34 - ASK ALL
Because of who you are, have you ever been unreasonably expelled or suspended from school?

Never (1)
Once (2)
More than once (3)
Q34B - Q34B - ASK IF Q34=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q34B .questiontitle { display:none; }
Yes (1)
No (2)
Q35 - Q35 - ASK ALL
Because of who you are, have you ever been unable to open a bank account, cash a
^f('Q2').any('1')?"cheque":"check"^, or get a loan?

Never (1)
Once (2)
More than once (3)
Q35B - Q35B - ASK IF Q35=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q35B .questiontitle { display:none; }
Yes (1)
No (2)
Q36 - Q36 - ASK ALL
Because of who you are, have you ever had to move to another neighbourhood, town, city, state, province, or
country?
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Never (1)
Once (2)
More than once (3)
Q36B - Q36B - ASK IF Q36=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q36B .questiontitle { display:none; }
Yes (1)
No (2)
Q37 - Q37 - ASK ALL
Because of who you are, have you ever lost a close relationship (e.g., with a family member, friend, or partner)?

Never (1)
Once (2)
More than once (3)
Q37B - Q37B - ASK IF Q37=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q37B .questiontitle { display:none; }
Yes (1)
No (2)
Q38 - Q38 - ASK ALL
Because of who you are, have you ever been repeatedly harassed at work or school, where you live, or when
accessing services?

No (1)
Yes — in one place (2)
Yes — in more than one place (3)
Q38B - Q38B - ASK IF Q38=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q38B .questiontitle { display:none; }
Yes (1)
No (2)
Q39 - Q39 - ASK ALL
Because of who you are, have you ever been threatened with a physical or sexual attack?

Never (1)
Once (2)
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More than once (3)
Q39B - Q39B - ASK IF Q39=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q39B .questiontitle { display:none; }
Yes (1)
No (2)
Q40 - Q40 - ASK ALL
Because of who you are, have you ever been physically attacked (e.g., spit on, had objects thrown at you, hit,
punched, pushed or grabbed, beaten)?

Never (1)
Once (2)
More than once (3)
Q40B - Q40B - ASK IF Q40=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q40B .questiontitle { display:none; }
Yes (1)
No (2)
Q41 - Q41 - ASK ALL
Because of who you are, have you ever been made to engage in sexual activity, or been touched in a sexual way, that
you didn’t want?

Never (1)
Once (2)
More than once (3)
Q41B - Q41B - ASK IF Q41=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q41B .questiontitle { display:none; }
Yes (1)
No (2)
Q42 - Q42 - ASK ALL
Because of who you are, have you ever had someone take, damage, or vandalize your property?

Never (1)
Once (2)
More than once (3)
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Q42B - Q42B - ASK IF Q42=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q42B .questiontitle { display:none; }
Yes (1)
No (2)
Q43 - Q43 - If >NEVER to any of 20-42
Thinking of all of the times that you have been treated unfairly or poorly because of who you are, how often do you
think each of the following was a reason why others treated you this way?
Never a
reason
(1)
Your age (1)
Your gender (2)
Your transgender or gender non-conforming status (3)
Your sexual orientation (being gay, lesbian, bisexual, or
straight) (4)
Your citizenship status or country of origin (5)
Your income (6)
Your level of education (7)
Your mental health issue or substance use disorder (8)
Your physical disability (9)
Your race (skin ^f('Q2').any('1')?"colour":"color"^) (10)
Your ethnicity (cultural background or ancestry) (11)
Your religion (12)
Your language (e.g., accent, how you speak
English^f('Q2').any('1') ? " or French" : ""^, other
language spoken) (13)
Your weight (14)
Another reason, please specify (96)____________
PROV - PROV - ASK IF Q2=1(CANADA)
What PROVINCE/TERRITORY do you live in?

British Columbia (BC)
Alberta (AB)
Saskatchewan (SK)
Manitoba (MB)
Ontario (ON)
Quebec (QC)
New Brunswick (NB)
Nova Scotia (NS)
Prince Edward Island (PE)
Newfoundland (NF)
Northwest Territories (NT)
Yukon (YK)

Sometimes a
reason (2)

Always a
reason (3)

Not sure if
this was a
reason (4)
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Nunavut (NU)
USSTATE - USSTATE - ASK IF Q2=2(USA)
What STATE do you live in?

Alabama (1)
Alaska (2)
Arizona (3)
Arkansas (4)
California (5)
Colorado (6)
Connecticut (7)
Delaware (8)
District of Columbia (9)
Florida (10)
Georgia (11)
Hawaii (12)
Idaho (13)
Illinois (14)
Indiana (15)
Iowa (16)
Kansas (17)
Kentucky (18)
Louisiana (19)
Maine (20)
Maryland (21)
Massachusetts (22)
Michigan (23)
Minnesota (24)
Mississippi (25)
Missouri (26)
Montana (27)
Nebraska (28)
Nevada (29)
New Hampshire (30)
New Jersey (31)
New Mexico (32)
New York (33)
North Carolina (34)
North Dakota (35)
Ohio (36)
Oklahoma (37)
Oregon (38)
Pennsylvania (39)
Rhode Island (40)
South Carolina (41)
South Dakota (42)
Tennessee (43)
Texas (44)

285

Utah (45)
Vermont (46)
Virginia (47)
Washington (48)
West Virginia (49)
Wisconsin (50)
Wyoming (51)
I prefer not to answer (99)
Q4 - Q4 - ASK ALL
What is the language you most often speak at home?

English (1)
French (2)
Other (96)
Q6CAN - Q6CAN - ASK IF Q2=1(Canada)
How do other people usually classify you in this country?
(Please choose one or two responses)
White (1)
Aboriginal or Indigenous to Canada (First Nations, Métis, or Inuit) (2)
East Asian (Chinese, Japanese, Korean) (3)
South Asian (for example, East Indian, Pakistani, Sri Lankan) (4)
Southeast Asian (for example, Filipino, Thai, Indonesian, Vietnamese) (5)
Black or African Canadian (6)
Latin American (7)
Middle Eastern (for example, Egyptian, Iranian, Lebanese) (8)
Not sure (98)
Q44CAN - Q44CAN - ASK IF Q2=1(Canada)
Which of the following best describes you?

Born a citizen of CANADA (1)
Immigrated to CANADA when I was 16 or younger (2)
Immigrated to CANADA when I was 17 or older (3)
Living temporarily in CANADA (4)
Q6US - Q6US - ASK IF Q2=2(USA)
How do other people usually classify you in this country?
(Please choose one or two responses)
White (1)
Hispanic or Latino/a (2)
Black or African American (3)
American Indian or Alaska Native (4)
East Asian (Chinese, Japanese, Korean) (5)
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South Asian (for example, Asian Indian, Pakistani, Sri Lankan) (6)
Southeast Asian (for example, Filipino, Thai, Indonesian, Vietnamese) (7)
Native Hawaiian or Pacific Islander (8)
Middle Eastern (for example, Egyptian, Iranian, Lebanese) (9)
Not sure (98)
Q44US - Q44US - ASK IF Q2=2(USA)
Which of the following best describes you?

Born a citizen of THE UNITED STATES (1)
Immigrated to THE UNITED STATES when I was 16 or younger (2)
Immigrated to THE UNITED STATES when I was 17 or older (3)
Living temporarily in THE UNITED STATES (4)
Q44BCAN - Q44BCAN - ASK IF Q44CAN = NOT born a citizen(2,3,4)
In total, how many years have you lived in CANADA?
jQuery(function() { jQuery('&#160;year(s)').insertAfter(jQuery('#Q44BCAN')); });

Q44BUS - Q44BUS - ASK IF Q44US = NOT born a citizen(2,3,4)
In total, how many years have you lived in THE UNITED STATES?
jQuery(function() { jQuery('&#160;year(s)').insertAfter(jQuery('#Q44BUS')); });

Q45 - Q45 - ASK ALL
How do you define yourself in terms of religion or spirituality?
(Please choose one)
Anglican (1)
Protestant Christian (2)
Catholic (3)
Other Christian (not Protestant, Anglican, or Catholic) (4)
Buddhist (5)
Hindu (6)
Jewish (7)
Muslim (8)
Sikh (9)
Agnostic (10)
Atheist (11)
None of the above (97)
Q46 - Q46 - ASK ALL
Do you wear clothing or accessories associated with your faith? (e.g., head covering, head scarf, face veil, turban,
jewellery with religious symbols)
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(Please choose one)
Yes — most of the time (1)
Yes — only for prayers, holidays, or special events (2)
No (3)
Q47 - Q47 - ASK ALL
Which of the following best describes where you currently live?

Urban or suburban (1)
Rural (2)
Q48 - Q48 - ASK ALL
What was your sex assigned at birth (e.g., on your birth certificate)?

Male (1)
Female (2)
Q49 - Q49 - ASK ALL
In what gender do you live your day-to-day life?

Male (1)
Female (2)
Sometimes male, sometimes female (3)
Non-binary, or something other than male or female (4)
Q7 - Q7 - ASK ALL
Which of the following best describes you?
(Please choose one)
Straight or heterosexual (1)
Bisexual (2)
Gay or lesbian (3)
Not sure (4)
Asexual (not sexually attracted to others) (5)
Q8 - Q8 - ASK ALL
How often have other people thought you were lesbian, gay, bisexual, or transgender? (Regardless of how you
identify)

Never (1)
Once or twice (2)
Sometimes (3)
Most of the time (4)
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Q50 - Q50 - ASK ALL
Do you have any of the following: Blindness or severe visual impairment
Deafness or hard of hearing
A long-lasting condition that substantially limits one or more basic physical activities, such as walking, climbing
stairs, or lifting
A long-lasting physical, mental, or emotional condition that increases the difficulty of learning, remembering,
concentrating, or interacting with others

Yes (1)
No (2)
Q51 - Q51 - ASK IF Q50=1(yes)
When you meet people for the first time, do they classify you as having a disability, mental health condition, or
chronic illness- without being told?

No, never (1)
Yes, some of the time (2)
Yes, most or all of the time (3)
Q52 - Q52 - ASK ALL
Has a doctor or other health care provider ever told you that you have a mental health disorder (e.g., bipolar
disorder, borderline personality disorder, schizophrenia), not including dysthymia, depression, or anxiety?

Yes (1)
No (2)
Q53 - Q53 - ASK ALL
What is the highest level of education you have completed?

Did not graduate from high school (1)
High school diploma (2)
Some ^f('Q2').any('1')?"":"community "^college or trade school (3)
^f('Q2').any('1')?"College ":"Community college "^or trade school diploma (4)
Some university (5)
University bachelor’s degree (6)
University graduate degree (7)
Q54 - Q54 - ASK ALL
In the past year, what was the main source of income for your household?

Employment (wages and salaries) (1)
Self-employment or small business (2)
Investments or savings (3)
Unemployment insurance or worker’s compensation (4)
Government retirement pension or Social Security for retirement (5)
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Retirement pension from employer (6)
Social assistance or disability benefits (7)
Student loans or scholarships (8)
I'd rather not say (99)
Q55 - Q55 - ASK ALL
What is your best estimate of the total income, before taxes and deductions, of all household members from all
sources in the past 12 months?

Less than $10,000 (1)
$10,000 to less than $15,000 (2)
$15,000 to less than $30,000 (3)
$30,000 to less than $40,000 (4)
$40,000 to less than $50,000 (5)
$50,000 to less than $60,000 (6)
$60,000 to less than $80,000 (7)
$80,000 to less than $100,000 (8)
$100,000 to less than $150,000 (9)
More than $150,000 (10)
I don't know (98)
I'd rather not say (99)
Q55B - Q55B - ASK ALL
Including yourself, how many adults and children living in the household were being supported on this income?

Q56 - Q56 - ASK ALL
Before age 16, did you ever experience something sexual that you did not want, that felt inappropriate, or was at any
time perceived as hurtful?

Yes (1)
No (2)
I don’t know (8)
I'd rather not say (9)
Q57 - Q57 - ASK ALL
Before age 16, were you ever pushed, grabbed, shoved, kicked, punched or physically attacked by an adult?

Yes (1)
No (2)
I don’t know (8)
I'd rather not say (9)
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Q58A - Q58A - ASK ALL
In your lifetime, have you smoked more than 100 cigarettes (about ^f('Q2').any('1')?"4":"5"^ packs)?

Yes (1)
No (2)
Q58B - Q58B - ASK IF Q58A=1(yes)
At the present time, how often do you smoke cigarettes?

Daily (1)
Occasionally (2)
Not at all (3)
Q59 - Q59 - ASK ALL
The following questions ask about how you have been feeling during the past 30 days. For each question, please
check the box that best describes how often you had this feeling.
During the past 30 days, about how often did you feel...
All of the
time (1)

Most of the
time (2)

Some of the
time (3)

A little of the
time (4)

...nervous (1)
...hopeless (2)
...restless or fidgety (3)
...so depressed that nothing could
cheer you up (4)
...that everything was an effort
(5)
...worthless (6)
Q60A - Q60A - ASK ALL
How often do you have a drink containing alcohol?

Never (1)
Monthly or less (2)
2 to 4 times a month (3)
2 to 3 times a week (4)
4 or more times a week (5)
Q60B - Q60B - ASK IF Q60A = NOT NEVER
How many drinks containing alcohol do you have on a typical day when you are drinking?

1 or 2 (1)
3 or 4 (2)
5 or 6 (3)

None of the
time (97)
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7, 8, or 9 (4)
10 or more (5)
Q60C - Q60C - ASK IF Q60A = NOT NEVER
How often do you have six or or more drinks on one occasion?

Never (1)
Less than monthly (2)
Monthly (3)
Weekly (4)
Daily or almost daily (5)
Q60D - Q60D - ASK IF (Q60A = NOT NEVER) AND (Q60B=2,3,4,5 OR Q60D=2,3,4,5)
How often during the last year have you found that you were not able to stop drinking once you had started?

Never (1)
Less than monthly (2)
Monthly (3)
Weekly (4)
Daily or almost daily (5)
Q60E - Q60E - ASK IF (Q60A = NOT NEVER) AND (Q60B=2,3,4,5 OR Q60D=2,3,4,5)
How often during the last year have you failed to do what was normally expected from you because of drinking?

Never (1)
Less than monthly (2)
Monthly (3)
Weekly (4)
Daily or almost daily (5)
Q60F - Q60F - ASK IF (Q60A = NOT NEVER) AND (Q60B=2,3,4,5 OR Q60D=2,3,4,5)
How often during the last year have you needed a first drink in the morning to get yourself going after a heavy
drinking session?

Never (1)
Less than monthly (2)
Monthly (3)
Weekly (4)
Daily or almost daily (5)
Q60G - Q60G - ASK IF (Q60A = NOT NEVER) AND (Q60B=2,3,4,5 OR Q60D=2,3,4,5)
How often during the last year have you had a feeling of guilt or remorse after drinking?

Never (1)
Less than monthly (2)
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Monthly (3)
Weekly (4)
Daily or almost daily (5)
Q60H - Q60H - ASK IF (Q60A = NOT NEVER) AND (Q60B=2,3,4,5 OR Q60D=2,3,4,5)
How often during the last year have you been unable to remember what happened the night before because you had
been drinking?

Never (1)
Less than monthly (2)
Monthly (3)
Weekly (4)
Daily or almost daily (5)
Q60I - Q60I - ASK ALL
Have you or someone else been injured as a result of your drinking?

No (1)
Yes, but not in the last year (2)
Yes, during the last year (3)
Q60J - Q60J - ASK ALL
Has a relative or friend or a doctor or another health worker been concerned about your drinking or suggested you
cut down?

No (1)
Yes, but not in the last year (2)
Yes, during the last year (3)
Q61A - Q61A - ASK ALL
The following items ask about anxiety and fear. For each item, please select the answer that best describes your
experience over the past week.
.questionarea {

margin-bottom: -10px; }
Never (1)

Rarely (2)

Occasionally (3)

Frequently (4)

Constantly (5)

How often do you feel anxious? (1)
Q61B - Q61B - ASK ALL

I never feel
anxious (1)
When you feel anxious, how intense or severe
is your anxiety? (1)

Mild
(2)

Moderate
(3)

Severe
(4)

Extreme
(5)
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Q61C - Q61C - ASK ALL

How often do you avoid situations, places,
objects, or activities because of anxiety or fear?
(1)

Never
(1)

Rarely
(2)

Occasionally
(3)

Frequently
(4)

All the
time (5)











Q61D - Q61D - ASK ALL

Not at
all (1)

Mild
(2)

Moderate
(3)

Severe
(4)

Extreme
(5)











How much does anxiety or fear interfere with your ability
to do the things you need to do at work, at school, or at
home? (1)
Q61E - Q61E - ASK ALL

How much does anxiety or fear interfere with your
social life and relationships? (1)
Q62 - Q62 - ASK ALL

Not at
all (1)

Mild
(2)

Moderate
(3)

Severe
(4)

Extreme
(5)
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Appendix D: Understanding Social Experiences and Health (InDI) Follow-up Survey

Q9Q19 - Q9Q19 - ASK ALL
These questions are about experiences related to who you are. This includes both how you describe yourself and
how others might describe you. For example, your skin ^f('Q2').any('1')?"colour":"color"^, ancestry, nationality,
religion, gender, sexuality, age, weight, disability or mental health issue, and income.
Strongly
disagree (1)

Disagree
(2)

Neither agree
nor disagree (3)

Agree
(4)

Strongly
agree (5)

Because of who I am, a doctor or nurse, or
other health care provider might treat me
poorly. (1)
Because of who I am, I might have trouble
finding or keeping a job. (2)
Because of who I am, I might have trouble
getting an apartment or house (3)
I am confident that I will be treated with as
much respect as my peers. (4)
I worry about being treated unfairly by a
teacher, supervisor, or employer. (5)
I may be denied a bank account, loan, or
mortgage because of who I am. (6)
I feel safe in my neighbourhood. (7)
I worry about being harassed or stopped by
police or security. (8)
Because of who I am, people might try to
attack me physically. (9)
I expect to be pointed at, called names, or
harassed when in public. (10)
I fear that I will have a hard time finding
friendship or romance because of who I am.
(11)
Q20 - Q20 - ASK ALL
Because of who you are, have you...

Never
(1)
Been treated poorly or unfairly by a health care
provider (20a)
Been treated poorly or unfairly by a teacher or
professor (20b)
Been treated poorly or unfairly by a supervisor
or employer (20c)
Been treated poorly or unfairly by a coworker or
classmate (20d)
Been treated poorly or unfairly by a sales clerk,
receptionist, or other customer service
representative (20e)

Yes, but not in
the past year
(2)

Yes, once or
twice in the past
year (3)

Yes, many times
in the past year
(4)
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Never
(1)

Yes, but not in
the past year
(2)

Yes, once or
twice in the past
year (3)

Yes, many times
in the past year
(4)

































Been treated poorly or unfairly by a police
officer, border guard, security officer (20f)
Been treated poorly or unfairly by a
transportation provider (e.g., bus or taxi driver)
(20g)
Been treated poorly or unfairly by a landlord
(20h)
Been treated poorly or unfairly by a relative or
friend (20i)
Q21Q29 - Q21Q29 - ASK ALL
Because of who you are, have you...

&nbsp; (b)
Heard, saw, or read others joking or
laughing about you (or people like you)
(21)
Been treated as if you are unfriendly,
unhelpful, or rude (22)
Been called names or heard/saw your
identity used as an insult (23)
Been treated as if others are afraid of you
(24)
Been stared or pointed at in public (25)
Been told that you should think, act, or
look more like others (26)
Heard that you or people like you don’t
belong (27)
Asked inappropriate, offensive, or overly
personal questions (28)
Been treated as if you are less smart or
capable than others (29)

Never
(1)

Yes, but not in
the past year (2)

Yes, once or twice
in the past year (3)

Yes, many times
in the past year (4)

















































































IQ30 - IQ30 - ASK ALL
As a reminder, we are interested in experiences related to who you are. This includes both how you describe
yourself and how others might describe you. For example, your skin ^f('Q2').any('1')?"colour":"color"^, ancestry,
nationality, religion, gender, sexuality, age, weight, disability or mental health issue, and income.

Q30 - Q30 - ASK ALL
Because of who you are, has a health care provider ever refused you care?

 Never (1)
 Once (2)
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 More than once (3)
Q30B - Q30B - ASK IF Q30=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q30B .questiontitle { display:none; }

 Yes (1)
 No (2)
Q31 - Q31 - ASK ALL
Because of who you are, have you ever been fired or dismissed from a job, or been turned down for a job that you
interviewed for?

 Never (1)
 Once (2)
 More than once (3)
Q31B - Q31B - ASK IF Q31=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q31B .questiontitle { display:none; }

 Yes (1)
 No (2)
Q32 - Q32 - ASK ALL
Because of who you are, have you ever been evicted or denied housing?

 Never (1)
 Once (2)
 More than once (3)
Q32B - Q32B - ASK IF Q32=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q32B .questiontitle { display:none; }

 Yes (1)
 No (2)
Q33 - Q33 - ASK ALL
Because of who you are, have you ever been unreasonably stopped and questioned, searched, or arrested by police
or security?

 Never (1)
 Once (2)
 More than once (3)
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Q33B - Q33B - ASK IF Q33=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q33B .questiontitle { display:none; }

 Yes (1)
 No (2)
Q34 - Q34 - ASK ALL
Because of who you are, have you ever been unreasonably expelled or suspended from school?

 Never (1)
 Once (2)
 More than once (3)
Q34B - Q34B - ASK IF Q34=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q34B .questiontitle { display:none; }

 Yes (1)
 No (2)
Q35 - Q35 - ASK ALL
Because of who you are, have you ever been unable to open a bank account, cash a
^f('Q2').any('1')?"cheque":"check"^, or get a loan?

 Never (1)
 Once (2)
 More than once (3)
Q35B - Q35B - ASK IF Q35=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q35B .questiontitle { display:none; }

 Yes (1)
 No (2)
Q36 - Q36 - ASK ALL
Because of who you are, have you ever had to move to another neighbourhood, town, city, state, province, or
country?

 Never (1)
 Once (2)
 More than once (3)
Q36B - Q36B - ASK IF Q36=2,3(once or more)
Has this happened to you in the past 12 months?
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#placeholder_Q36B .questiontitle { display:none; }

 Yes (1)
 No (2)
Q37 - Q37 - ASK ALL
Because of who you are, have you ever lost a close relationship (e.g., with a family member, friend, or partner)?

 Never (1)
 Once (2)
 More than once (3)
Q37B - Q37B - ASK IF Q37=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q37B .questiontitle { display:none; }

 Yes (1)
 No (2)
Q38 - Q38 - ASK ALL
Because of who you are, have you ever been repeatedly harassed at work or school, where you live, or when
accessing services?

 No (1)
 Yes — in one place (2)
 Yes — in more than one place (3)
Q38B - Q38B - ASK IF Q38=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q38B .questiontitle { display:none; }

 Yes (1)
 No (2)
Q39 - Q39 - ASK ALL
Because of who you are, have you ever been threatened with a physical or sexual attack?

 Never (1)
 Once (2)
 More than once (3)
Q39B - Q39B - ASK IF Q39=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q39B .questiontitle { display:none; }

 Yes (1)
 No (2)
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Q40 - Q40 - ASK ALL
Because of who you are, have you ever been physically attacked (e.g., spit on, had objects thrown at you, hit,
punched, pushed or grabbed, beaten)?

 Never (1)
 Once (2)
 More than once (3)
Q40B - Q40B - ASK IF Q40=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q40B .questiontitle { display:none; }

 Yes (1)
 No (2)
Q41 - Q41 - ASK ALL
Because of who you are, have you ever been made to engage in sexual activity, or been touched in a sexual way, that
you didn’t want?

 Never (1)
 Once (2)
 More than once (3)
Q41B - Q41B - ASK IF Q41=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q41B .questiontitle { display:none; }

 Yes (1)
 No (2)
Q42 - Q42 - ASK ALL
Because of who you are, have you ever had someone take, damage, or vandalize your property?

 Never (1)
 Once (2)
 More than once (3)
Q42B - Q42B - ASK IF Q42=2,3(once or more)
Has this happened to you in the past 12 months?
#placeholder_Q42B .questiontitle { display:none; }

 Yes (1)
 No (2)

300

Q43 - Q43 - If >NEVER to any of 20-42
Thinking of all of the times that you have been treated unfairly or poorly because of who you are, how often do you
think each of the following was a reason why others treated you this way?
jQuery(function() { jQuery('Your').appendTo(jQuery('#Q43_header0')); });

Age (1)
Gender (2)
Transgender or gender non-conforming status (3)
Sexual orientation (being gay, lesbian, bisexual, or
straight) (4)
Citizenship status or country of origin (5)
Income (6)
Level of education (7)
Mental health issue or substance use disorder (8)
Physical disability (9)
Race (skin ^f('Q2').any('1')?"colour":"color"^) (10)
Ethnicity (cultural background or ancestry) (11)
Religion (12)
Language (e.g., accent, how you speak
English^f('Q2').any('1') ? " or French" : ""^, other
language spoken) (13)
Weight (14)
Another reason, please specify (96)____________

Never a
reason
(1)

Sometimes a
reason (2)

Always a
reason (3)

Not sure if
this was a
reason (4)

















































































Q63 - Q63 - ASK ALL
We know that these questions may seem repetitive, but we appreciate your patience in filling them out.
In your day-to-day life, how often do any of the following things happen to you?

You are treated with less
courtesy than other people are.
(1)
You are treated with less
respect than other people are.
(2)
You receive poorer service than
other people at restaurants or
stores. (3)
People act as if they think you
are not smart. (4)
People act as if they are afraid
of you. (5)
People act as if they think you
are dishonest. (6)

Never
(1)

Less than
once a year
(2)

A few
times a
year (3)

A few times
a month (4)

At least
once a
week (5)

Almost
everyday (6)
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People act as if they’re better
than you are. (7)
You are called names or
insulted. (8)
You are threatened or harassed.
(9)

Never
(1)

Less than
once a year
(2)

A few
times a
year (3)

A few times
a month (4)

At least
once a
week (5)

Almost
everyday (6)





































Q64 - Q64 - ASK ALL
What do you think was the reason (or reasons) for these experiences? Your...
(check all that apply)

 Age (1)
 Gender (2)
 Transgender or gender non-conforming status (3)
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4)
 Citizenship status or country of origin (5)
 Income (6)
 Level of education (7)
 Mental health issue or substance use (8)
 Physical disability (9)
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10)
 Ethnicity (cultural background or ancestry) (11)
 Religion (12)
 Language (e.g., accent, how you speak English or French, other language spoken) (13)
 Weight (14)
 Another reason, please specify (96)____________
IEND - IEND
In the following questions, we are interested in the way other people have treated you or your beliefs about how
other people have treated you. Have any of the following ever happened to you:

Q65A - Q65A - ASK ALL
At any time in your life, have you ever been unfairly fired?

 Yes (1)
 No (2)
Q65B - Q65B - ASK IF Q65A=1(yes)
What do you think was the reason (or reasons) for this experience? Your...
(check all that apply) #placeholder_Q65B .questiontitle { display:none; }

 Age (1)
 Gender (2)
 Transgender or gender non-conforming status (3)
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4)
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 Citizenship status or country of origin (5)
 Income (6)
 Level of education (7)
 Mental health issue or substance use (8)
 Physical disability (9)
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10)
 Ethnicity (cultural background or ancestry) (11)
 Religion (12)
 Language (e.g., accent, how you speak English^f('Q2').any('1') ? " or French" : ""^, other language spoken) (13)
 Weight (14)
 Another reason, please specify (96)____________
Q66A - Q66A - ASK ALL
For unfair reasons, have you ever not been hired for a job?

 Yes (1)
 No (2)
Q66B - Q66B - ASK IF Q66A=1(yes)
What do you think was the reason (or reasons) for this experience? Your...
(check all that apply) #placeholder_Q66B .questiontitle { display:none; }

 Age (1)
 Gender (2)
 Transgender or gender non-conforming status (3)
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4)
 Citizenship status or country of origin (5)
 Income (6)
 Level of education (7)
 Mental health issue or substance use (8)
 Physical disability (9)
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10)
 Ethnicity (cultural background or ancestry) (11)
 Religion (12)
 Language (e.g., accent, how you speak English^f('Q2').any('1') ? " or French" : ""^, other language spoken) (13)
 Weight (14)
 Another reason, please specify (96)____________
Q67A - Q67A - ASK ALL
Have you ever been unfairly denied a promotion?

 Yes (1)
 No (2)
Q67B - Q67B - ASK IF Q67A=1(yes)
What do you think was the reason (or reasons) for this experience? Your...
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(check all that apply) #placeholder_Q67B .questiontitle { display:none; }

 Age (1)
 Gender (2)
 Transgender or gender non-conforming status (3)
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4)
 Citizenship status or country of origin (5)
 Income (6)
 Level of education (7)
 Mental health issue or substance use (8)
 Physical disability (9)
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10)
 Ethnicity (cultural background or ancestry) (11)
 Religion (12)
 Language (e.g., accent, how you speak English^f('Q2').any('1') ? " or French" : ""^, other language spoken) (13)
 Weight (14)
 Another reason, please specify (96)____________
Q68A - Q68A - ASK ALL
Have you ever been unfairly stopped, searched, questioned, physically threatened or abused by the police?

 Yes (1)
 No (2)
Q68B - Q68B - ASK IF Q68A=1(yes)
What do you think was the reason (or reasons) for this experience? Your...
(check all that apply) #placeholder_Q68B .questiontitle { display:none; }

 Age (1)
 Gender (2)
 Transgender or gender non-conforming status (3)
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4)
 Citizenship status or country of origin (5)
 Income (6)
 Level of education (7)
 Mental health issue or substance use (8)
 Physical disability (9)
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10)
 Ethnicity (cultural background or ancestry) (11)
 Religion (12)
 Language (e.g., accent, how you speak English^f('Q2').any('1') ? " or French" : ""^, other language spoken) (13)
 Weight (14)
 Another reason, please specify (96)____________
Q69A - Q69A - ASK ALL
Have you ever been unfairly discouraged by a teacher or advisor from continuing your education?

 Yes (1)
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 No (2)
Q69B - Q69B - ASK IF Q69A=1(yes)
What do you think was the reason (or reasons) for this experience? Your...
(check all that apply) #placeholder_Q69B .questiontitle { display:none; }

 Age (1)
 Gender (2)
 Transgender or gender non-conforming status (3)
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4)
 Citizenship status or country of origin (5)
 Income (6)
 Level of education (7)
 Mental health issue or substance use (8)
 Physical disability (9)
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10)
 Ethnicity (cultural background or ancestry) (11)
 Religion (12)
 Language (e.g., accent, how you speak English^f('Q2').any('1') ? " or French" : ""^, other language spoken) (13)
 Weight (14)
 Another reason, please specify (96)____________
Q70A - Q70A - ASK ALL
Have you ever been unfairly prevented from moving into a neighborhood because the landlord or a realtor refused to
sell or rent you a house or apartment?

 Yes (1)
 No (2)
Q70B - Q70B - ASK IF Q70A=1(yes)
What do you think was the reason (or reasons) for this experience? Your...
(check all that apply) #placeholder_Q70B .questiontitle { display:none; }

 Age (1)
 Gender (2)
 Transgender or gender non-conforming status (3)
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4)
 Citizenship status or country of origin (5)
 Income (6)
 Level of education (7)
 Mental health issue or substance use (8)
 Physical disability (9)
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10)
 Ethnicity (cultural background or ancestry) (11)
 Religion (12)
 Language (e.g., accent, how you speak English^f('Q2').any('1') ? " or French" : ""^, other language spoken) (13)
 Weight (14)
 Another reason, please specify (96)____________
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Q71A - Q71A - ASK ALL
Have you ever moved into a neighborhood where neighbors made life difficult for you or your family?

 Yes (1)
 No (2)
Q71B - Q71B - ASK IF Q71A=1(yes)
What do you think was the reason (or reasons) for this experience? Your...
(check all that apply) #placeholder_Q71B .questiontitle { display:none; }

 Age (1)
 Gender (2)
 Transgender or gender non-conforming status (3)
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4)
 Citizenship status or country of origin (5)
 Income (6)
 Level of education (7)
 Mental health issue or substance use (8)
 Physical disability (9)
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10)
 Ethnicity (cultural background or ancestry) (11)
 Religion (12)
 Language (e.g., accent, how you speak English^f('Q2').any('1') ? " or French" : ""^, other language spoken) (13)
 Weight (14)
 Another reason, please specify (96)____________
Q72A - Q72A - ASK ALL
Have you ever been unfairly denied a bank loan?

 Yes (1)
 No (2)
Q72B - Q72B - ASK IF Q72A=1(yes)
What do you think was the reason (or reasons) for this experience? Your...
(check all that apply) #placeholder_Q72B .questiontitle { display:none; }

 Age (1)
 Gender (2)
 Transgender or gender non-conforming status (3)
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4)
 Citizenship status or country of origin (5)
 Income (6)
 Level of education (7)
 Mental health issue or substance use (8)
 Physical disability (9)
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10)
 Ethnicity (cultural background or ancestry) (11)
 Religion (12)
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 Language (e.g., accent, how you speak English^f('Q2').any('1') ? " or French" : ""^, other language spoken) (13)
 Weight (14)
 Another reason, please specify (96)____________
Q73A - Q73A - ASK ALL
Have you ever received service from someone such as a plumber or car mechanic that was worse than what other
people get?

 Yes (1)
 No (2)
Q73B - Q73B - ASK IF Q73A=1(yes)
What do you think was the reason (or reasons) for this experience? Your...
(check all that apply) #placeholder_Q73B .questiontitle { display:none; }

 Age (1)
 Gender (2)
 Transgender or gender non-conforming status (3)
 Sexual orientation (being gay, lesbian, bisexual, or straight) (4)
 Citizenship status or country of origin (5)
 Income (6)
 Level of education (7)
 Mental health issue or substance use (8)
 Physical disability (9)
 Race (skin ^f('Q2').any('1')?"colour":"color"^) (10)
 Ethnicity (cultural background or ancestry) (11)
 Religion (12)
 Language (e.g., accent, how you speak English^f('Q2').any('1') ? " or French" : ""^, other language spoken) (13)
 Weight (14)
 Another reason, please specify (96)____________
MessComplete - MessComplete
Thank you, you have completed the survey.
^f('REDIRTXT')^

MessScreened - MessScreened
^f('REDIRTXT')^
^f('SMODE').any('3') ? "THIS LINE APPEARS ONLY IN TEST MODE: : " + f('INTCODE').value() : ""^
^f('SMODE').any('3') ? " - " + f('INTCODE').valueLabel() : ""^
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308

Appendix F: Letters of Invitation, Understanding Social Experiences and Health

Survey Code: AC14727_093_5FR.8524.77893
Survey Length: 40 minutes
Reward: $4 or 8 Air Miles
Dear $+FIRSTNAME+$ $+LASTNAME+$,
A new online survey is now available, Understanding Social Experiences and Health. It
will only take 40 minutes of your time and give you $6.50 or 13 Air Miles if you meet the
criteria to answer the survey. You have until CHOOSE CLOSING DATE to participate in
this survey. Please see the link for more information about this survey.

~ PARTICIPATE! ~
+ Get chances for our monthly draw

Remember that for every survey conducted, you get chances for our monthly draw in addition to earning
your rewards. The monthly draw includes: 2 prizes of $ 1,000 in cash, a prize of $ 100 in cash, a prize of
1,000 miles of Airmiles rewards and a prize of an iPad.

Can I answer this survey from a mobile device? Yes or No
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Thank you for your participation!
Questions or trouble with the survey? Call us at

or

If you are not able to open the link to complete the survey , please copy and paste the following link into your web browser :
https://legerweb.com/sid.asp?CODESURVEY=AC14727_093_5FR.8524.77893&L=FR&LMID=POR2012641461417216213

Unsubscribe | About Us | Privacy | Facebook | Twitter | Contact Us
© 2016 Legerweb.com. All Rights Reserved.
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Survey Code: AC14727_093_5FR.8524.77893
Survey Length: 15 minutes
Reward: $2 or 4 Air Miles
Dear $+FIRSTNAME+$ $+LASTNAME+$,
A new online survey is now available, Understanding Social Experiences and Health. It
will only take 15 minutes of your time and give you $2 or 4 Air Miles if you meet the
criteria to answer the survey. You have until CHOOSE CLOSING DATE to participate in
this survey. Please see the link for more information about this survey.

~ PARTICIPATE! ~
+ Get chances for our monthly draw
Remember that for every survey conducted, you get chances for our monthly draw in addition to earning
your rewards. The monthly draw includes: 2 prizes of $ 1,000 in cash, a prize of $ 100 in cash, a prize of
1,000 miles of Airmiles rewards and a prize of an iPad.

Can I answer this survey from a mobile device? Yes or No
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Thank you for your participation!
Questions or trouble with the survey? Call us at

or

If you are not able to open the link to complete the survey , please copy and paste the following link into your web browser :
https://legerweb.com/sid.asp?CODESURVEY=AC14727_093_5FR.8524.77893&L=FR&LMID=POR2012641461417216213

Unsubscribe | About Us | Privacy | Facebook | Twitter | Contact Us
© 2016 Legerweb.com. All Rights Reserved.
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Appendix G: Letters of Information and Consent, Understanding Social Experiences and Health

Study Title: Understanding Social Experiences and Health
Principal Investigator
Greta Bauer, Associate Professor
Epidemiology & Biostatistics
Schulich School of Medicine & Dentistry
Western University
London, Ontario, Canada

Invitation to Participate
You are being invited to participate in this research study about social discrimination (i.e., being treated
differently because of who you are) and health because you are a Legerweb member. You do not need
to have experienced social discrimination to participate.
Why is this study being done?
The purpose of this study is to develop better ways of asking people about how they are treated in
society, and to increase our understanding of how this treatment affects health.
How long will you be in this study?
The survey you are being asked to participate in today takes 30-40 minutes to complete. If you complete
today’s survey, you may be contacted in one to two weeks and invited to complete a 15-minute followup survey.
What are the study procedures?
If you are eligible and agree to participate, you will be asked to answer some survey questions about
who you are (demographics), experiences of unfair treatment related to who you are, and some aspects
of your current health.
What are the risks and harms of participating in this study?
There are no known or anticipated risks associated with participating in this study. It is possible that you
may be uncomfortable with some of the questions, or that they may cause distress by recalling difficult
memories or experiences. You are welcome to skip any questions you do not wish to answer. If you
need to speak with someone about your feelings after completing the survey, please visit
http://www.yourlifecounts.org/need-help/crisis-lines to find a distress line in your area.
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What are the benefits of participating in this study?
You may not directly benefit from participating in this study but information
gathered may provide benefits to society as a whole which include more knowledge about how unfair
treatment impacts health.
Can participants choose to leave the study?
If you decide to withdraw from the study (by exiting the webpage), the information that was collected
prior to you leaving the study may still be used. No new information will be collected without your
permission.
How will participant information be kept confidential?
All survey data collected will remain confidential. If the results are published, your name will not be
used. Contact or personal information that you have provided Legerweb will not be stored together with
other information you provide about yourself.
Representatives of The University of Western Ontario Non-Medical Research Ethics Board may require
access to your study-related records to monitor the conduct of the research. Data will be retained for
five years following the end of the study.
Are participants compensated to be in this study?
Yes. Legerweb will compensate you with $6.50 or 13 Air Miles for participating.
What are the rights of participants?
Your participation in this study is voluntary. You may decide not to be in this study. Even if you consent
to participate you have the right to not answer individual questions or to withdraw from the study at
any time. Your relationship with Legerweb will not be affected should you decide to withdraw from this
study. You do not waive any legal rights by consenting to this study.
Who do participants contact for questions?
If you have technical questions or questions about compensation, please contact Legerweb. For other
questions about this specific research study, please contact Ayden Scheim at
or
If you have any questions about your rights as a research participant or the conduct of this study, you
may contact The Office of Human Research Ethics
, email:
Consent
Completion of the survey is indication of your consent to participate.
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Study Title: Understanding Social Experiences and Health
Principal Investigator
Greta Bauer, Associate Professor
Epidemiology & Biostatistics
Schulich School of Medicine & Dentistry
Western University
London, Ontario, Canada

Invitation to Participate
You are being invited to participate in this follow-up survey about social discrimination (i.e., being
treated differently because of who you are) and health because in the past two weeks, you participated
in the initial survey for this research project. You do not need to have experienced social discrimination
to participate.
Why is this study being done?
The purpose of this study is to develop better ways of asking people about how they are treated in
society, and to increase our understanding of how this treatment affects health.
How long will you be in this study?
The survey you are being asked to participate in today takes about 15 minutes to complete.
What are the study procedures?
If you agree to participate, you will be asked to answer some survey questions about experiences of
unfair treatment related to who you are.
What are the risks and harms of participating in this study?
There are no known or anticipated risks associated with participating in this study. It is possible that you
may be uncomfortable with some of the questions, or that they may cause distress by recalling difficult
memories or experiences. You are welcome to skip any questions you do not wish to answer. If you
need to speak with someone about your feelings after completing the survey, please visit
http://www.yourlifecounts.org/need-help/crisis-lines to find a distress line in your area.
What are the benefits of participating in this study?
You may not directly benefit from participating in this study but information
gathered may provide benefits to society as a whole which include more knowledge about how unfair
treatment impacts health.
Can participants choose to leave the study?
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If you decide to withdraw from the study (by exiting the webpage), the information that was collected
prior to you leaving the study may still be used. No new information will be collected without your
permission.
How will participant information be kept confidential?
All survey data collected will remain confidential. If the results are published, your name will not be
used. Contact or personal information that you have provided Legerweb will not be stored together with
other information you provide about yourself.
Representatives of The University of Western Ontario Non-Medical Research Ethics Board may require
access to your study-related records to monitor the conduct of the research. Data will be retained for
five years following the end of the study.
Are participants compensated to be in this study?
Yes. Legerweb will compensate you with $2 or 4 Air Miles for participating.
What are the rights of participants?
Your participation in this study is voluntary. You may decide not to be in this study. Even if you consent
to participate you have the right to not answer individual questions or to withdraw from the study at
any time. Your relationship with Legerweb will not be affected should you decide to withdraw from this
study. You do not waive any legal rights by consenting to this study.
Who do participants contact for questions?
If you have technical questions or questions about compensation, please contact Legerweb. For other
questions about this specific research study, please contact Ayden Scheim at
or
If you have any questions about your rights as a research participant or the conduct of this study, you
may contact The Office of Human Research Ethics
email:
Consent
Completion of the survey is indication of your consent to participate.

316

Curriculum Vitae
Name

Ayden Scheim

Post-secondary
Education and
Degrees

University of Toronto
Toronto, Ontario, Canada
2007-2011 Hon. B.A.
The University of Western Ontario
London, Ontario, Canada
2011-2017 Ph.D.

Graduate Honours and Awards

Pierre Elliott Trudeau Foundation Scholarship, 2014-2017
Canadian Institutes of Health Research (CIHR) Vanier
Scholarship, 2014-2017
Western University Vice President of Research Support
Grant, 2014-2017
Schulich School of Medicine and Dentistry Dean’s MScPhD Transfer Award (partially declined), 2014-2017
CIHR Institute of Gender and Health Travel Award, 2014
CIHR HIV/AIDS Community-Based Research Master’s
Award, 2011-2013
Dr. Carol Buck Graduate Scholarship in Epidemiology,
2012
Universities Without Walls, CIHR Strategic Training
Fellowship in HIV/AIDS, 2011-2012
Ontario Graduate Scholarship (declined), 2011-2012 &
2014-2015

Related Work
Experience

Teaching Assistant
The University of Western Ontario
2013-2016

317

Consultant, IRGT: A Global Network of Trans Women
and HIV, Global Forum on MSM and HIV
2015-2018
Consultant/Trainer, Transgender Health
Rainbow Health Ontario
2015-2017
Grants
1. A community-based cohort study of HIV pre-exposure prophylaxis in Ontario (2017-2020).
PIs: Tan D, Lisk R. Role: Co-Investigator (1 of 22) Canadian Institutes of Health Research
HIV/AIDS Community-Based Research: $450,000.
2. Ontario Integrated Supervised Injection Site Feasibility Study (2015-2016). PIs: Kerr T,
Scheim AI, Marshall Z, Rourke S. CIHR Centre for REACH in HIV/AIDS: $89,150.
3. Trans Priorities Project: Cross-Country Trans Women and HIV Research Priority Setting
(2015-2017). PIs: Marshall Z, Scheim AI, Marshall Z, Butler Burke N, Leblanc G, Ortigoza
E, Persad Y. CIHR Centre for REACH in HIV/AIDS: $69,821.
4. Planning Trans PULSE Canada: A National Survey of Transgender Health (2015-2016). PIs:
Bauer GR, Scheim AI, Hammon R, Travers R. CIHR Planning and Dissemination Grant:
$9,972.
5. HIV Prevention for Gay and Bisexual Men: A Multisite Study and Development of New HIV
Prevention Interventions (2014-2019). PIs: Hart TA, Jollimore J, Cox J, Moore D, Grace D.
Role: Co-Investigator (1 of 26). CIHR Team Grant: Advancing Research to Improve Boys’
and Men’s Health: $1,500,000.
6. Improving Quantitative Research Methods in Gender, Sex and Population Health: Theory,
Evidence and Applications for Multi-dimensionality and Intersectionality (2013-2017). PI:
Bauer GR. Role: Co-Investigator (1 of 3). Canadian Institutes of Health Research Operating
Grant: $296,749.
7. Community-Based Research and Research Ethics: Creating Community Products to Promote
Ethical Research Practices with People who Use Drugs (2013-2015). PI: Margaret (Peggy)
Milson. Role: Co-Investigator (1 of 5). CIHR Social Research Centre in HIV Prevention:
$24,000.
8. Trans Men who have Sex with Men Sexual Health Study (2012-2014). PIs: Adam B, Scheim
AI, Marshall Z, Travers R, Ware S. Canadian Institutes of Health Research Operating Grant,
HIV/AIDS Community-Based Research: $99,552.

318

Journal Publications
1. Scheim AI, Zong X, Giblon R, Bauer GR. Disparities in access to family physicians among
transgender people in Ontario, Canada. International Journal of Transgenderism. Accepted,
16 April 2017.
2. Scheim AI, Bauer GR, Shokoohi M. (2017). Drug use among transgender people in Ontario,
Canada: Disparities and associations with social exclusion. Addictive Behaviors, 72: 151158.
3. Scheim AI, Rachlis B, Bardwell G, Mitra S, Kerr T. (2017). Public injecting among people
who inject drugs in a mid-sized Canadian city: A cross-sectional survey. CMAJ Open, 5:
e290-e294.
4. Scheim AI, Bauer GR, Travers R. (2017). HIV-related sexual risk among transgender men
who are gay, bisexual, or have sex with men. Journal of Acquired Immune Deficiency
Syndromes, 74: e89-e96.
5. Scheim AI, Travers R. (2016). Barriers and facilitators to HIV and sexually transmitted
infections testing for gay, bisexual, and other transgender men who have sex with men. AIDS
Care. Online ahead of print December 27.
6. Scheim AI, Bauer GR, Shokoohi M. (2016). Heavy episodic drinking among transgender
persons: Disparities and predictors. Drug and Alcohol Dependence, 167:156-162.
7. Poteat T, Scheim AI, Xavier J, Reisner SL, Baral S. (2016). Epidemiology of HIV and
related syndemics among transgender people in the US and globally. Journal of Acquired
Immune Deficiency Syndromes, 73 (Suppl 3):S210-219.
8. Scheim AI, Santos G-M, Arreola S, Makofane K, Do TD, Hebert P, Thomann M, Ayala G.
(2016). Inequities in access to HIV prevention services for transgender men: Results of a
global survey of men who have sex with men. Journal of the International AIDS Society, 19
(Suppl 2): 20779.
9. Souleymanov R, Kuzmanović D, Marshall Z, Scheim AI, Mikiki M, Worthington C, Millson
MP. (2016). The ethics of community-based research with people who use drugs: Results of
a scoping review. BMC Medical Ethics, 17:25.
10. Scheim AI, Bauer GR, Coleman T. (2016). Socio-demographic differences by survey mode
in a respondent-driven sampling study of transgender people in Ontario, Canada. LGBT
Health, 3(5): 391-395.
11. Gilbert M, Swenson L, Unger D, Scheim A, Grace D. (2016). Need for robust and inclusive
public health ethics review of the monitoring of HIV phylogenetic clusters for HIV
prevention. The Lancet HIV. 3(10): e641.

319

12. Bauer GR, Zong X, Scheim AI, Hammond R, Thind A. (2015). Factors impacting
transgender patients' discomfort with their family physicians: A respondent-driven sampling
survey. PLoS ONE, 10(12): e0145046-16.
13. Bauer GR, Scheim AI, Pyne J, Travers R, Hammond R. (2015). Intervenable factors
associated with suicide risk in transgender persons: A respondent-driven sampling study in
Ontario, Canada. BMC Public Health, 15:525.
14. Scheim AI, Bauer GR. (2015). Sex and gender diversity among transgender people in
Ontario, Canada: Results from a respondent-driven sampling survey. Journal of Sex
Research, 52(1):1-14.
15. Scheim AI, Arreola S, Do T, Makofane K, Santos GM, Thomann M, Wilson PA, Ayala G.
(2015). Potential for conceptual bias in studies of racial disparities in HIV infection. Journal
of Acquired Immune Deficiency Syndromes, 68(3):e42-e43.
16. Bauer GR, Scheim AI, Deutsch M, Massarella C. (2014). Reported emergency department
avoidance, utilization and experiences of transgender persons in Ontario, Canada: Results
from a respondent-driven sampling survey. Annals of Emergency Medicine, 63(6): 713-720.
17. Scheim AI, Jackson R, James E, Dopler S, Pyne J, Bauer GR. (2013). Barriers to well-being
for Aboriginal gender-diverse people: Results from the Trans PULSE Project in Ontario,
Canada. Journal of Ethnicity and Inequalities in Health and Social Care, 6(4): 108-120.
18. Marcellin RL, Bauer GR, Scheim AI. (2013). Intersecting impacts of transphobia and racism
on HIV risk among trans persons of colour in Ontario, Canada. Journal of Ethnicity and
Inequalities in Health and Social Care, 6(4): 97-107.
19. Bauer GR, Redman N, Bradley K, Scheim AI. (2013). Sexual health of trans men who are
gay, bisexual, or who have sex with men: Results from Ontario, Canada. International
Journal of Transgenderism, 14(2): 66-74.
20. Li T, Dobinson C, Scheim AI, Ross LE. (2013). Unique issues bisexual people face in
intimate relationships: A descriptive exploration of lived experience. Journal of Gay and
Lesbian Mental Health, 17(1): 21-39.
21. Bauer GR, Scheim AI. (2013). Sampling bias and transgender HIV studies. The Lancet
Infectious Diseases. 13: 832.

